Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8561617253692686,2.3927227321342106,0.0,0.0,0.0,8/22,2.58%,PTGDS;ALDH1A2;ADH7;ADH4;ABCA4;RBP1;CYP26B1;CRABP2
prerank,cadherin binding (GO:0045296),-0.4753182384087856,-2.2019650403196604,0.0,0.0,0.0,115/315,15.20%,PTPRM;DOCK9;SPTBN1;COBLL1;PTPRB;FMNL2;STXBP6;CDH11;ABI1;AHNAK;PDLIM5;MRTFB;BMPR2;DAB2IP;MYO1B;CALD1;ESYT2;BSG;ITGA6;VCL;TJP1;LRRFIP1;CLINT1;FXYD5;ACVR1;NOTCH3;PROM1;WASF2;YWHAE;MYH9;CDH13;IQGAP1;EGFR;CDH1;MACF1;PTPRJ;TMPO;TAGLN2;KDR;CAST;F11R;CTNNA1;YWHAB;EIF3E;PHLDB2;SERBP1;FLNA;CHMP2B;ITGB1;MB21D2;TJP2;PAK2;NUMB;PPFIBP1;RACK1;SNX1;EEF2;ANXA1;NCK1;CHMP4B;CLIC1;TRIM25;SPTAN1;EPN2;ALDOA;TRPC4;APC;SCYL1;SWAP70;KTN1;STK24;CNN2;RPL29;RPL7A;RPS26;LDHA;GAPVD1;SRC;TMOD3;VASN;PTPN1;RPL6;PPP1CA;EPS8L2;S100A11;PSMB6;CD2AP;YWHAZ;CTNNA3;FASN;PARVA;LRRC59;RPL24;PRDX6;CAPG;TES;LIMA1;FNBP1L;EHD4;ARHGAP1;PFN1;STK38;RPL34;SHTN1;IST1;TBC1D10A;GOLGA3;CIP2A;RAB11B;CDH2;RPL14;SNX2;CBL;VAPB;CEMIP2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.8471443217393938,-2.1068309735764825,0.0,0.0015206032351928913,0.003,6/12,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE2A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8733656496411788,2.0029757067432707,0.0,0.05089124639866447,0.087,3/10,0.48%,SLC6A13;SLC6A1;SLC6A12
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7521567017701863,1.9296062975408512,0.0,0.09618280872757301,0.229,7/15,10.60%,ALDH1A2;ADH4;ALDH1L1;ALDH7A1;ALDH1A1;ALDH3B1;ALDH2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5873010678127156,-1.9275156341522637,0.0021231422505307855,0.04392853790557242,0.111,11/34,12.45%,CYTH3;MYO10;MYO1B;ARAP2;PARD3;IQGAP1;ARAP3;ARAP1;ZFYVE16;JPH2;HIP1R
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.7066496294607593,-1.9209009970888236,0.0,0.036747911517161544,0.124,7/17,7.63%,ATP10A;ATP8B1;PITPNC1;ABCA1;PLTP;MTTP;ABCA3
prerank,histone demethylase activity (GO:0032452),0.6546411332897968,1.9134788687695707,0.001876172607879925,0.09313592180726461,0.287,10/27,11.87%,KDM7A;FBXL19;PHF8;JARID2;KDM5B;KDM6B;PHF2;KDM2A;KDM5C;KDM4A
prerank,amino acid:sodium symporter activity (GO:0005283),0.8204425310775053,1.8715568421001965,0.0019305019305019305,0.1324160585906998,0.44,4/11,3.99%,SLC6A13;SLC6A1;SLC6A12;SLC38A1
prerank,cAMP binding (GO:0030552),-0.7648107924631231,-1.8474348068374804,0.006024096385542169,0.08434279277869905,0.301,5/11,7.16%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6142428793595551,-1.8113017627814556,0.002044989775051125,0.11083508025405964,0.43,8/21,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,retinoic acid binding (GO:0001972),0.7412893446313061,1.8091629077971456,0.00597609561752988,0.2269519014154034,0.689,4/12,16.37%,CYP26B1;NR2F2;RXRA;RARA
prerank,carbohydrate:cation symporter activity (GO:0005402),0.769611162519134,1.8086269568623994,0.003929273084479371,0.19565954926088477,0.69,4/11,2.73%,SLC5A3;SLC5A10;SLC23A2;SLC23A1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.7072162934573084,1.800395248700045,0.005802707930367505,0.18701297827082042,0.72,11/15,16.66%,HS3ST3A1;HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST6;HS3ST5;HS6ST2;NDST2;HS2ST1
prerank,AMP binding (GO:0016208),0.7487694447752664,1.770473129533077,0.005964214711729622,0.23310057411944915,0.839,5/11,12.43%,PRKAG2;PRKAG3;ACSS2;MPPED2;PYGL
prerank,sulfotransferase activity (GO:0008146),0.5703717196829217,1.7674947749249308,0.0055762081784386614,0.21581841191200626,0.847,6/33,4.36%,HS3ST3A1;UST;CHST4;CHST15;HS6ST1;CHST10
prerank,vinculin binding (GO:0017166),-0.7247830033992191,-1.7559638697262343,0.0019083969465648854,0.18116901402155305,0.65,4/11,6.74%,UTRN;CTNNA1;ACTN1;PXN
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.7126486092925574,1.7390524763659636,0.006224066390041493,0.25854370191589826,0.912,6/12,19.45%,KDM7A;PHF8;PHF2;KDM4A;KDM1A;KDM3B
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5706688379699659,-1.7214114658481474,0.00205761316872428,0.23239886111198024,0.802,8/23,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6307275197121283,-1.719230115238399,0.0,0.18946716310503428,0.807,4/16,3.95%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6307275197121283,-1.719230115238399,0.0,0.18946716310503428,0.807,4/16,3.95%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,phospholipid transfer activity (GO:0120014),-0.5832196164774787,-1.7183740573061337,0.0063025210084033615,0.17399387321479873,0.813,16/21,28.25%,PITPNC1;CERT1;PLTP;PLEKHA8;TNFAIP8L3;MTTP;ABCA3;PRELID3B;PITPNB;GLTP;TRIAP1;C2CD2L;PRELID2;PLEKHA3;PITPNM1;CPTP
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5079790307415384,1.71123364936151,0.0036036036036036037,0.3056768715725608,0.958,13/55,9.21%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC23A2;SLC23A1;SLC16A12;SLC38A1;PDPN;SLC19A1;SLC38A9
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.5073435394189939,-1.7110491484912187,0.004842615012106538,0.17157473170426457,0.831,15/42,13.17%,STXBP6;PDLIM5;BSG;ESAM;CD200;PALLD;NPTN;ANXA1;ROBO4;TMOD3;PPP1CA;S100A11;DSCAML1;JAM3;EMB
prerank,actin binding (GO:0003779),-0.3876084491152872,-1.710889045825149,0.0,0.15876657368475522,0.831,36/170,11.65%,UTRN;SYNE1;ACTN4;PDLIM5;MYRIP;CALD1;ABLIM1;VCL;MICAL2;NOS3;TMSB4X;FXYD5;GSN;PARVB;SMTN;MYH9;MACF1;MTSS1;SSH2;ITGB1;CAP2;EPS8;MSRB2;KLHL2;ALDOA;CEACAM1;TPM2;SYNPO2;CAP1;MYO19;EPS8L2;MYO1F;TMSB10;PARVA;LIMA1;LDB3
prerank,ligand-gated ion channel activity (GO:0015276),0.5738438513249144,1.6979690003399552,0.011235955056179775,0.3181938124343682,0.973,8/30,8.71%,ANXA6;TRPV1;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,acid-thiol ligase activity (GO:0016878),0.710744012688303,1.6934341171801863,0.01984126984126984,0.3056298154039073,0.976,5/13,9.63%,ACSL1;ACSM2A;ACSM2B;AASDH;ACSS2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5753895076534596,1.6884755879824795,0.012522361359570662,0.29612446933591824,0.98,7/26,4.48%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A11;SLC16A12;MPC2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7215884922652374,1.6821925448972457,0.012195121951219513,0.2937981299981152,0.986,1/10,0.04%,PRKAG2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.4156912897511849,-1.6815424810369786,0.0,0.20115408511265964,0.914,23/100,10.77%,HIP1;CYTH3;MYO10;PLA2G4A;DAB2IP;MYO1B;ARAP2;PARD3;CERT1;IQGAP1;WIPI1;ARAP3;ANKFY1;SNX13;PLEKHA8;ARAP1;SH3PXD2B;OSBP;PLEKHA4;ZFYVE16;GOLPH3;PLEKHA5;JPH2
prerank,CARD domain binding (GO:0050700),-0.6427747954723665,-1.6705264475137451,0.013888888888888888,0.20788335784237041,0.926,9/14,23.22%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4;RIPK2;CASP1;BCL10
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6592280013736939,1.6680677923724756,0.027131782945736434,0.3084864016421615,0.989,2/15,0.80%,CCR9;ACKR2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.5354597327423904,-1.6647784593568222,0.00631578947368421,0.2061050968367698,0.935,11/28,20.49%,DAB2IP;TRAF5;TRIM37;CASP8AP2;FEM1B;BABAM2;MADD;TMBIM1;RIPK1;MYD88;TRAF4
prerank,cyclic nucleotide binding (GO:0030551),-0.5602946095667368,-1.630066901336504,0.022044088176352707,0.2668509599014976,0.979,5/21,7.16%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,alkali metal ion binding (GO:0031420),0.6832340758181813,1.6290518107356093,0.018404907975460124,0.39236217692692016,0.995,5/13,13.52%,ATP1A2;CAPN3;ACAT1;DRG1;HDAC4
prerank,calcium:sodium antiporter activity (GO:0005432),0.7125112597927303,1.6239607141504868,0.029914529914529916,0.38674226696011144,0.998,2/10,0.73%,SLC8A3;SLC24A3
prerank,Tat protein binding (GO:0030957),-0.6971874509101676,-1.616852258507162,0.015238095238095238,0.284859672726135,0.985,3/10,4.30%,ACTB;MDFIC;DNAJA1
prerank,fatty acid synthase activity (GO:0004312),-0.6842947180560013,-1.6155350521643768,0.03515625,0.2731216828404355,0.987,6/10,18.45%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;ELOVL4;MCAT
prerank,phospholipase C activity (GO:0004629),-0.5306345990053895,-1.6082967277638531,0.02032520325203252,0.27669910203059983,0.989,6/25,4.43%,PLCB4;EDNRA;PLCE1;PLCL1;PLCG1;PLCG2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7053963050182682,1.6079587006285119,0.03829787234042553,0.4130096394625596,0.999,4/10,11.87%,KDM7A;PHF8;KDM2A;KDM4A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.6655050594182286,1.6072336633058513,0.03543307086614173,0.39531887285730954,0.999,1/11,0.05%,PPP1R1A
prerank,lipase activity (GO:0016298),0.4978805092781118,1.5964273675754426,0.023214285714285715,0.4080283162272446,1.0,11/43,11.81%,CEL;LIPA;DDHD2;ABHD5;PLA1A;PNPLA8;SMPD3;SEC23IP;SMPD2;PLA2G15;ABHD3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.5024433753333485,-1.5942857244485087,0.022573363431151242,0.29436947708591277,0.996,11/30,14.78%,GAS6;CAST;RPS6KA3;CARD16;CST3;XIAP;TNFAIP8;SERPINB9;BIRC3;PTTG1;MT3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.6515026950471343,1.5877823260450645,0.020366598778004074,0.41628137303221624,1.0,5/13,10.60%,ALDH1A2;ALDH1L1;ALDH7A1;ALDH1A1;ALDH2
prerank,store-operated calcium channel activity (GO:0015279),-0.6762325680238055,-1.5824263668201197,0.025896414342629483,0.31047953329483946,0.999,5/10,9.94%,STIM2;TRPC3;TRPC6;TRPC4;TRPC1
prerank,semaphorin receptor binding (GO:0030215),-0.5348300100391087,-1.5753302289430224,0.03164556962025317,0.31425800193986425,0.999,13/23,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,SUMO binding (GO:0032183),-0.6340938693070269,-1.5735169760884868,0.024291497975708502,0.305852445167548,0.999,5/13,9.03%,RNF111;HERC2;SERBP1;CASP8AP2;USPL1
prerank,CoA-ligase activity (GO:0016405),0.6466307088999214,1.5732559341695098,0.03180914512922465,0.44142803611657117,1.0,4/14,9.63%,ACSL1;ACSM2A;ACSM2B;ACSS2
prerank,triglyceride lipase activity (GO:0004806),0.5770296443634335,1.5731289617140158,0.031007751937984496,0.42416618648859683,1.0,4/20,11.37%,CEL;DDHD2;ABHD5;PLA2G15
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.6312154766038305,-1.5712094038638629,0.027559055118110236,0.2987681236506993,0.999,3/12,2.68%,DAB2IP;VEGFC;ITGA5
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.44171616482860704,-1.5711980820537124,0.014084507042253521,0.2872770419718263,0.999,20/60,15.76%,NRP1;ROR1;TEK;NTRK3;NRP2;TIE1;INSR;MERTK;EGFR;CRIM1;KDR;MET;FLT1;FLT4;EPHB2;RET;ROR2;FGFRL1;ALK;CSF1R
prerank,death receptor binding (GO:0005123),-0.5943912437751562,-1.5676842363975376,0.03512396694214876,0.2851975845561779,0.999,11/15,31.52%,DAB2IP;NGF;CASP8AP2;FEM1B;MADD;TMBIM1;RIPK1;MYD88;EDA;FADD;PIDD1
prerank,ion channel activity (GO:0005216),0.4354998055822358,1.5662693305595166,0.01877133105802048,0.42833782443088025,1.0,13/80,8.71%,TRPM3;ANXA6;TRPM6;TRPV1;TMEM120B;GRIN3A;GRID2;GRIN2D;NALCN;GRIK5;GRIK2;UNC80;CHRNB2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6382827459664734,-1.5615245016642147,0.021696252465483234,0.28862497597518405,0.999,5/11,21.79%,MAP3K5;EGFR;MAP3K20;MAP3K6;MAP3K4
prerank,ligand-gated channel activity (GO:0022834),0.523600767514586,1.557324072786392,0.029250457038391225,0.43787333470954465,1.0,7/29,8.71%,ANXA6;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6593224622178842,-1.5562521982139166,0.021611001964636542,0.2892641786487627,0.999,5/11,7.63%,ATP10A;ATP8B1;ATP8A1;ATP11C;ABCA3
prerank,N-acetyltransferase activity (GO:0008080),0.5723337725858151,1.5539359285422367,0.043824701195219126,0.43119920145553575,1.0,4/19,6.56%,GNPNAT1;SAT1;ATAT1;NAT2
prerank,outward rectifier potassium channel activity (GO:0015271),0.6627042504883929,1.5480186393280155,0.054474708171206226,0.4332996914666338,1.0,4/11,7.16%,KCNK2;KCND3;KCNT1;KCND2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6091702820954623,1.5373167392026028,0.04693140794223827,0.4488640871680264,1.0,5/16,13.53%,IDO1;ETHE1;ADI1;HAAO;CDO1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4428233506112542,-1.535844242141552,0.013761467889908258,0.32625387190638594,0.999,23/42,28.81%,BCAR3;YWHAE;PIK3R1;SHE;YWHAB;PLCG2;VAV2;YES1;PFN1;FBXW7;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;NEDD4;SYK;RASA1;SHD;PTPN11;GRB2;PTPN3;SAMSN1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3463938613847862,-1.5294585355659742,0.0,0.3324725396173361,1.0,56/173,21.36%,KLF12;FOXP1;ZBTB16;ZFHX3;ELK3;TRPS1;ZEB1;LRRFIP1;FOXP2;PLAGL1;PPARD;TBX3;FOXO3;CTCF;PRDM16;TBX18;ZNF25;DACH1;JUN;BHLHE40;CREB3L1;KLF8;HES1;ZNF3;JDP2;TGIF1;ZNF436;HEYL;NACC2;PRDM5;ZBTB1;HEY2;MAFK;ETV6;ETS2;SREBF2;HHEX;TBX2;NACC1;NFIL3;ZBTB5;SKIL;SP2;ZBTB33;ZFP57;BCL6B;HEY1;ZBTB37;NR2F1;PRDM1;ZNF177;NFATC3;ATF3;ZBTB25;ZBTB45;THAP1
prerank,MAP kinase activity (GO:0004707),0.602460907585968,1.5257681443333244,0.06627680311890838,0.46964029639306215,1.0,5/14,12.42%,MAPK4;MAPK6;MAPK10;MAPK14;MAPK9
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.39136346462674027,-1.5231517973758748,0.01694915254237288,0.33804910672381966,1.0,23/72,16.64%,HIP1;STXBP6;MYO1B;MARK1;PARD3;SVIL;GSN;KCNJ2;SNX18;FCHO2;PLEKHA4;KCNQ1;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;VILL;AVIL;AMER2;SYTL2;LDLRAP1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.643486752008889,1.5177420168291567,0.08008213552361396,0.47963764506314116,1.0,3/10,1.76%,CACNA1D;CACNB1;CACNB3
prerank,LRR domain binding (GO:0030275),0.6038000840322094,1.513829822033642,0.06,0.4771409944785642,1.0,2/14,2.44%,ROBO1;PAWR
prerank,leak channel activity (GO:0022840),0.5598882854083345,1.511719055381854,0.05961538461538462,0.4697631156719669,1.0,3/18,5.43%,KCNK2;TMEM175;NALCN
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5486651750060951,1.5115479963214677,0.04046242774566474,0.4567930515861262,1.0,7/20,12.87%,LPGAT1;AGPAT4;ABHD5;MOGAT1;PLA2G15;DGAT2;LCLAT1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5434789338448707,-1.5078801682373153,0.047516198704103674,0.3667879318828914,1.0,7/18,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4159307928640451,-1.507040208987682,0.023310023310023312,0.3580871540130711,1.0,17/60,12.90%,ROR1;TEK;NTRK3;ACVR1;ACVRL1;TIE1;INSR;MERTK;EGFR;TGFBR2;KDR;MET;FLT1;FLT4;EPHB2;RET;ROR2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6007833635597937,-1.5065567650755352,0.0508130081300813,0.3490725750579948,1.0,7/12,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,actin monomer binding (GO:0003785),-0.5041302162725814,-1.5044687104401218,0.04842105263157895,0.34458558868621136,1.0,7/22,16.89%,NOS3;TMSB4X;MTSS1;TMSB10;LIMA1;PFN1;MYL4
prerank,BMP binding (GO:0036122),-0.6210810806041254,-1.502966094216155,0.0546875,0.3392452118587096,1.0,3/11,2.04%,BMPR2;GREM2;ENG
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5087254874163963,-1.5021994293208807,0.04329896907216495,0.3322384682647767,1.0,5/23,4.43%,PLCB4;EDNRA;PLCE1;PLCG1;PLCG2
prerank,voltage-gated potassium channel activity (GO:0005249),0.420503778960889,1.5000987006988553,0.02027027027027027,0.47841614535184634,1.0,14/80,10.77%,KCNK2;KCND3;KCNA3;KCNT1;KCNJ13;LRRC38;KCNJ5;KCNJ10;KCNC3;KCND2;KCNH2;KCNC2;KCNJ16;KCNH7
prerank,chemorepellent activity (GO:0045499),-0.500779691307205,-1.4977135884309372,0.04741379310344827,0.33437675243626247,1.0,14/25,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;EPHA7;SEMA4D;SEMA4F;SEMA6B
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5922662373599132,-1.4944991013781923,0.07115384615384615,0.3337977535120929,1.0,2/12,2.85%,PIEZO2;PIEZO1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5670784328158284,1.4944677059163727,0.0594059405940594,0.4822049088049788,1.0,6/18,10.60%,ALDH1A2;ALDH8A1;ADH4;ALDH1A1;ALDH3B1;ALDH2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5464655408494,-1.4942143963138401,0.05150214592274678,0.3264722783331209,1.0,6/18,9.92%,STXBP6;PDLIM5;ANXA1;TMOD3;PPP1CA;S100A11
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4445965822495777,1.4933079000010543,0.038181818181818185,0.4730779532368442,1.0,11/49,15.10%,ATP1A2;DUSP11;PXYLP1;PRUNE1;ARMT1;MPPED2;ACP6;PPP1CB;PTPRO;DUSP28;EPHX2
prerank,transforming growth factor beta binding (GO:0050431),-0.4997060225367626,-1.489315896547474,0.04157549234135667,0.3296329902068146,1.0,10/23,9.46%,LTBP4;LTBP1;ACVR1;ACVRL1;ENG;THBS1;TGFBR2;CD109;VASN;TGFB3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5370355567440035,1.4867988473772258,0.06578947368421052,0.48010322965491387,1.0,4/21,8.71%,P2RX6;TRPV1;GRIK2;CHRNB2
prerank,SH3 domain binding (GO:0017124),-0.4000785360409542,-1.4835022468586663,0.021479713603818614,0.33531069479299985,1.0,18/62,14.93%,AFAP1L1;ABI1;SHANK3;DAB2IP;CBLB;PTPN12;WASF2;AFAP1L2;PLSCR1;WIPF1;SGIP1;ABI3;GPX1;CD2AP;LANCL1;ADAM15;ARHGAP27;CBL
prerank,cGMP binding (GO:0030553),-0.6220191821894637,-1.4799660884629986,0.07142857142857142,0.3353390922459475,1.0,3/11,6.37%,RAPGEF2;PDE10A;PDE2A
prerank,death domain binding (GO:0070513),-0.6093688224269005,-1.4768530112652982,0.0486815415821501,0.3346228215637808,1.0,7/11,19.77%,BCL2L1;DAPL1;CRADD;RACK1;DAP;MCL1;RIPK1
prerank,C-C chemokine receptor activity (GO:0016493),0.5339842259988186,1.471016857886896,0.0888468809073724,0.5135569078327364,1.0,2/21,0.80%,CCR9;ACKR2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.4722458902441,-1.464833846911581,0.054878048780487805,0.3554905911144425,1.0,11/26,29.96%,CSGALNACT1;B3GNT2;CHSY3;B3GNT3;B3GALT5;B4GALNT3;B3GNT8;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.344312158361934,-1.456225386796527,0.0,0.3663036133798705,1.0,33/147,10.02%,DOCK9;CYTH3;PREX2;FARP1;FGD5;ARHGEF28;DOCK1;DOCK10;PLCE1;RAPGEF2;FGD6;RAP1A;BCR;SPATA13;RASGRF2;DENND6A;HERC2;MON1A;ARHGEF2;ARHGEF15;RAPGEF4;RAPGEF6;DOCK2;EIF2B2;GAPVD1;ABR;TIAM1;VAV2;EPS8L2;DENND2C;DOCK8;RABIF;DENND5B
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.5736795584747266,-1.4537722646525602,0.09090909090909091,0.36437455023309656,1.0,5/12,8.58%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,potassium ion leak channel activity (GO:0022841),0.5569522290406408,1.4537295049742849,0.07436399217221135,0.5518621211414731,1.0,2/15,4.96%,KCNK2;TMEM175
prerank,cell adhesion mediator activity (GO:0098631),-0.4795769262548229,-1.4527774242348073,0.04477611940298507,0.35904855982003575,1.0,9/24,13.17%,BSG;ESAM;PALLD;NPTN;ROBO4;DSCAML1;BCAM;JAM3;EMB
prerank,voltage-gated cation channel activity (GO:0022843),0.3952590662018178,1.4469146090310228,0.02321724709784411,0.5605095529151105,1.0,15/97,9.39%,CACNA1D;CACNA2D3;KCND3;CACNG7;KCNA3;CACNB1;CACNB3;LRRC38;GRIN3A;CACNA2D2;GRIN2D;KCNC3;KCND2;KCNH2;KCNC2
prerank,amyloid-beta binding (GO:0001540),-0.3704570132406252,-1.4464069062146327,0.01937046004842615,0.3660598854854354,1.0,22/79,18.83%,APBB2;COL25A1;FZD6;TGFB2;INSR;ITM2A;BCHE;CST3;IAPP;GRIN2B;APOE;EPHB2;CACNA1B;CD74;FZD4;GSAP;ITM2B;LRP1;APBB3;LDLRAP1;GRIN1;PFDN6
prerank,GTPase activator activity (GO:0005096),-0.30870564378486237,-1.441900236376143,0.0,0.3698345593986789,1.0,67/313,10.07%,ARHGAP31;NRP1;DOCK9;CYTH3;ARHGAP10;PREX2;TBC1D4;CHN2;FARP1;RABGAP1L;FGD5;ARHGEF28;DOCK1;DOCK10;PLCE1;RAPGEF2;ARHGAP42;RGS3;FGD6;RGS5;SIPA1L2;RASGRP3;RAP1A;STARD8;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;SPATA13;RASGRF2;ARAP3;DENND6A;STARD13;TBC1D12;HERC2;JUN;USP6NL;TBCD;TBC1D5;ARAP1;TBC1D2B;MON1A;ARHGEF2;SIPA1L3;ARHGEF15;ARHGAP32;TBC1D1;ARHGAP35;RAPGEF4;RAPGEF6;RGS6;DOCK2;EVI5L;EIF2B2;SEC23A;GAPVD1;ABR;TIAM1;VAV2;TBC1D13;EPS8L2;DENND2C;DOCK8;RABIF;DENND5B;RP2
prerank,gated channel activity (GO:0022836),-0.5508222042566746,-1.441224724725963,0.07058823529411765,0.3645938680074033,1.0,2/14,2.85%,PIEZO2;PIEZO1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5452009566095861,-1.4410179518156212,0.07142857142857142,0.35805902594730726,1.0,5/14,8.58%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6260103882812833,-1.43975468881618,0.07142857142857142,0.35407527924658183,1.0,2/10,3.32%,MECOM;PRDM16
prerank,syntaxin binding (GO:0019905),0.41324245941759186,1.43246516909696,0.041970802919708027,0.5943325420466293,1.0,18/61,12.83%,UNC13C;SYT12;SYT9;NAPB;SYT1;STX16;SNAP29;SNAP47;STXBP5L;NAPA;LRRK2;GOLGA2;SNAP25;NSF;SYT10;STXBP4;TMED9;CPLX1
prerank,death receptor activity (GO:0005035),-0.5886138027957389,-1.4277858767869847,0.07708333333333334,0.37471350026026035,1.0,5/11,12.55%,TNFRSF1B;FAS;TNFRSF11A;EDA2R;TNFRSF19
prerank,sialyltransferase activity (GO:0008373),-0.49542497476440606,-1.4268806408743888,0.06526315789473684,0.3703211950278688,1.0,11/20,19.98%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;ST3GAL1;ST6GALNAC5;ST8SIA6;ST8SIA2;ST6GALNAC2;ST3GAL2;ST6GAL2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5811590708592067,1.4244260441732444,0.10196078431372549,0.6075956664031195,1.0,4/13,5.24%,BMP7;BMP6;BMP3;BMP8A
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5052438087502216,-1.417946804490061,0.07495069033530571,0.384187965925577,1.0,6/19,13.67%,ABI1;GAS6;AFAP1L2;PAK2;EFNA5;CD24
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5904977950223175,1.417743845548457,0.09780439121756487,0.6171071440324786,1.0,5/12,9.99%,SLC25A42;SLC25A5;SLC19A1;SLC25A25;SLC25A23
prerank,ADP binding (GO:0043531),0.5028156790697669,1.417706463249254,0.10018552875695733,0.6038421464837738,1.0,7/25,10.19%,PRKAG2;MYO9B;PGK1;MYO3A;MSH6;ABCD1;MYO18A
prerank,methyl-CpG binding (GO:0008327),0.5083404710132036,1.41730209938028,0.09404990403071017,0.592276972134013,1.0,4/22,4.65%,CXXC5;ZBTB38;CXXC4;TET1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.39765516756714037,1.4161342354498063,0.03395585738539898,0.583170039132269,1.0,12/73,10.90%,LGR4;GCGR;PTH2R;NPR3;BDKRB1;OPRD1;CRHR1;BDKRB2;NMUR1;LTB4R2;GPR37;GRPR
prerank,potassium channel activity (GO:0005267),0.38792359966342427,1.4152525007511565,0.04241435562805873,0.5740718129520044,1.0,20/89,16.88%,KCNK2;KCND3;KCNA3;KCNT1;LRRC38;TMEM175;KCNC3;GRIK5;GRIK2;KCND2;KCNH2;KCNC2;KCNN4;KCNH7;KCNK4;KCNS3;TMEM38A;KCNA4;KCNQ3;KCNK10
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5536047468073948,-1.4100973177592213,0.10826771653543307,0.39684248798913335,1.0,5/13,10.62%,PIP5K1B;PIP4K2A;PIK3C2A;PIK3CA;PIK3CD
prerank,hydro-lyase activity (GO:0016836),0.44124779664600666,1.4089972893918632,0.06951871657754011,0.5826899485715824,1.0,11/41,10.93%,HACD3;ENO1;ACO1;NAXD;ENO4;HACD4;HACD1;FAHD2A;ECHDC3;ECHS1;ECHDC2
prerank,C-C chemokine binding (GO:0019957),0.5132804042016486,1.4064366734089837,0.10331384015594541,0.5795188610461283,1.0,2/22,0.80%,CCR9;ACKR2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5605427903619146,-1.4051041771129553,0.07991360691144708,0.4020578045594763,1.0,7/13,13.82%,IL1R1;ITGA5;PTPRJ;ERN1;PDGFC;PDGFD;VEGFA
prerank,neurexin family protein binding (GO:0042043),0.59580412845876,1.4020002342101487,0.1115702479338843,0.5823608087703782,1.0,4/10,7.03%,CEL;NLGN2;SYTL3;NLGN3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.502550836746772,-1.4011971593415316,0.09322033898305085,0.40513938862989274,1.0,7/18,14.78%,GAS6;RPS6KA3;XIAP;TNFAIP8;SERPINB9;BIRC3;MT3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.42859717049896073,-1.3978121545094762,0.05263157894736842,0.4066408804583045,1.0,10/38,10.77%,HIP1;PLA2G4A;DAB2IP;PARD3;WIPI1;SNX13;SH3PXD2B;PLEKHA4;PLEKHA5;JPH2
prerank,anion channel activity (GO:0005253),-0.3789605126403671,-1.3950400096189426,0.05185185185185185,0.40649158096914484,1.0,16/61,16.14%,SLC26A7;LRRC8D;CLIC4;ANO1;LRRC8C;LRRC8A;CLIC1;GABRA3;GLRB;CLCC1;LRRC8B;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,voltage-gated calcium channel activity (GO:0005245),0.45016229032311394,1.393833957814415,0.0890909090909091,0.597046892170007,1.0,6/37,4.27%,CACNA1D;CACNA2D3;CACNG7;CACNB1;CACNB3;CACNA2D2
prerank,frizzled binding (GO:0005109),0.44742138326454045,1.3913259831199483,0.09392265193370165,0.5948474848741414,1.0,6/34,9.38%,RNF43;WNT4;WNT5B;WNT7A;WNT6;FZD7
prerank,acylglycerol lipase activity (GO:0047372),-0.5775993213901878,-1.3905519699449782,0.11244979919678715,0.41107778676690787,1.0,3/11,12.54%,ABHD2;MGLL;ABHD6
prerank,muscle alpha-actinin binding (GO:0051371),-0.5158375722053135,-1.390506163599681,0.11674008810572688,0.40474973405087455,1.0,4/15,11.65%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,BMP receptor binding (GO:0070700),0.5811623496902498,1.3893690476665643,0.12598425196850394,0.589997087110095,1.0,4/12,5.24%,BMP7;BMP6;BMP3;BMP8A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.5421878829286587,-1.3888438200866757,0.1182170542635659,0.40271812040154703,1.0,6/13,28.79%,SREBF2;ECI1;ECH1;IDI1;DDT;MIF
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.34999951590729944,-1.3879566328202464,0.03333333333333333,0.3986130824214739,1.0,25/91,15.58%,HIP1;STXBP6;MYO1B;MARK1;PARD3;SVIL;GSN;KCNJ2;WIPI1;SNX18;FCHO2;SH3PXD2B;PLEKHA4;KCNQ1;PLEKHA5;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;VILL;AVIL;AMER2;SYTL2
prerank,GDP binding (GO:0019003),-0.3713859094542306,-1.382533479210243,0.04861111111111111,0.40461663398535624,1.0,28/63,26.43%,RAB14;RAP1A;RAB31;RALB;RAP2A;RASL12;RAB22A;KRAS;NRAS;GNAI3;RAB27A;RERG;NME2;RAB11B;RAB5C;RAP2B;MRAS;ARL8B;RRAGD;RAB27B;MIEF1;RAB35;RAB3B;RAB9B;RAB5B;TRIM23;RASEF;RHEBL1
prerank,protein tyrosine kinase activity (GO:0004713),-0.343028516952855,-1.3801501791107333,0.024390243902439025,0.4042419345636318,1.0,25/108,12.90%,ROR1;TEK;NTRK3;HIPK1;TIE1;INSR;MERTK;PEAK1;EGFR;KDR;BMX;TEC;MET;LYN;FLT1;SCYL1;SRC;FLT4;JAK1;YES1;EPHB2;DYRK1A;RET;PTK2B;ROR2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5013085156947503,1.3747706410254394,0.1018867924528302,0.6257646947952287,1.0,3/21,3.86%,FGF1;FGF4;FGF9
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4537788361355369,1.3738035427144824,0.1,0.6178202513742824,1.0,2/29,1.98%,PRKAG2;CDKN2A
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3988782046216824,-1.373455277998845,0.0735930735930736,0.41451497273171245,1.0,19/46,27.74%,GCNT2;EXT1;B3GNT2;MGAT5;MGAT4A;HEXA;GCNT1;MFNG;MGAT4B;LFNG;B3GNT3;B3GALT5;PIGQ;B3GNT8;MGAT3;EXT2;GCNT4;RFNG;B3GALT1
prerank,myosin binding (GO:0017022),-0.3709428017280996,-1.3673317486889096,0.04861111111111111,0.4229159645460763,1.0,10/55,7.50%,MYRIP;CALD1;SHROOM4;SPATA6;RHOA;GSN;RAB14;RAB6A;NKD2;MYOC
prerank,monocarboxylic acid binding (GO:0033293),0.5059131847728855,1.365229604370606,0.12092130518234165,0.6362172490856809,1.0,5/18,16.37%,CYP26B1;NR2F2;RXRA;PYGL;RARA
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4603210286373296,-1.3612353069340775,0.09959349593495935,0.43159431543108656,1.0,7/23,12.45%,HIP1;WIPI1;SH3PXD2B;PLEKHA4;PLEKHA5;JPH2;HIP1R
prerank,kinase activator activity (GO:0019209),0.44804700170387857,1.3587238114570859,0.11428571428571428,0.6468388796828772,1.0,4/30,4.06%,PRKAG2;GPRC5A;GPRC5C;GPRC5B
prerank,insulin-like growth factor I binding (GO:0031994),-0.5321576482845249,-1.3578325068061712,0.116,0.4331888864553675,1.0,4/13,5.12%,ITGA6;INSR;ITGB4;IGFBP6
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5251569866006387,1.35645362907991,0.11764705882352941,0.6434695782510748,1.0,6/15,24.14%,P2RX6;GPR87;P2RX4;PTAFR;GPR34;P2RY12
prerank,cardiolipin binding (GO:1901612),0.5820968838873946,1.3524659790060463,0.14853556485355648,0.646366618273663,1.0,3/10,17.58%,GSDME;GSDMD;UQCC3
prerank,chemokine receptor activity (GO:0004950),0.474870871407135,1.3462849884638424,0.1280148423005566,0.6554658653758462,1.0,2/24,0.80%,CCR9;ACKR2
prerank,phosphotyrosine residue binding (GO:0001784),-0.39742462048838373,-1.3459316421110796,0.07223476297968397,0.4561115366201874,1.0,19/37,28.81%,BCAR3;PIK3R1;SHE;PLCG2;VAV2;YES1;PFN1;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;SYK;RASA1;SHD;PTPN11;GRB2;PTPN3;SAMSN1
prerank,glutamate receptor binding (GO:0035254),-0.48026366621296557,-1.3441322611733155,0.11853448275862069,0.45452337604022475,1.0,2/17,0.56%,HIP1;SHANK3
prerank,protein tyrosine kinase binding (GO:1990782),-0.36097809942426334,-1.3426303507614896,0.08200455580865604,0.4520178968117393,1.0,17/71,11.52%,BMPR2;CBLB;ACVR1;GAS6;GRB14;CPNE3;ITGB1;ANGPT2;TJP2;RACK1;NCK1;CEACAM1;PTPN1;SOCS5;NEDD9;DUSP3;SQSTM1
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3011391298753785,-1.3307295315776109,0.022598870056497175,0.4754952993697912,1.0,66/196,24.01%,RHOJ;RAPGEF2;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;RAB31;GTPBP10;RALB;PDE10A;GNL3;GBP4;RAP2A;GCH1;GBP5;PDE2A;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;RERG;ARL5A;NME2;RAB11B;RAB5C;RAB1B;GLUD1;RAP2B;ARF5;ADSS1;GNL1;MRAS;NUDT16;RHOBTB3;ARL8B;ARHGEF5;CDC42;RRAGD;AGAP2;RAB27B;RHOB;RAC3;MIEF1;RAB35;ARL4D;TUBE1;TUBA4A;RND2;RHOT2;RAB3B;RAB9B;RAB5B;TRIM23
prerank,kinase binding (GO:0019900),-0.27299919678246914,-1.325459983484501,0.0,0.48309103993219005,1.0,88/434,13.98%,UTRN;TTC28;ACTB;LIMS1;GHR;FRMD5;CAV1;SLC12A7;SLC12A2;PDE8A;DAB2IP;PTN;RHOBTB1;RHOA;BCAR3;GSN;ACVRL1;PKD1;IQGAP1;EGFR;FOXO3;BCL2L1;PLCG1;BTG1;STAT3;EEF1A1;PTPRJ;PPP1R12A;CSPG4;IRAK3;PTPRK;STX1A;ESR1;CACUL1;PLCG2;FAS;FLNA;CAB39;CARD16;SPRED2;TFRC;SMAD1;PIK3IP1;PAK2;CIT;ADAM10;EEF2;MIDN;TRIM14;PRKCD;CALM3;RELB;RPS7;RB1CC1;ANKRA2;APC;SPRY2;RPS3;EMP2;CEACAM1;ACTA2;HDAC7;SRC;PTPN1;TIAM1;PFKL;BCAR1;CIR1;RPTOR;DUSP3;YWHAZ;PER1;CAV2;ACSL3;BAG5;FBXO5;HSPB1;SQSTM1;GSKIP;RND3;TRPV4;PEBP1;PTPRC;CD24;PGAM1;CNTLN;PPP1CC;AP2A1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.3722915621056435,-1.3184539195245075,0.08558558558558559,0.4945989463119716,1.0,17/56,16.25%,CBLB;GAS6;PIK3R1;GRB14;CPNE3;ANGPT2;RACK1;NCK1;PTPN1;SOCS5;DUSP3;SQSTM1;SH2B2;IRS1;CBL;DOCK4;SHC4
prerank,sterol binding (GO:0032934),0.3959559599254711,1.3175352238849474,0.10073260073260074,0.7425149705717303,1.0,12/56,9.10%,RORA;OSBPL8;ANXA6;SOAT2;SIDT1;INSIG2;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3736847398221585,1.3163523480412416,0.09262435677530018,0.7350511759875064,1.0,17/69,12.98%,LPGAT1;SPHK1;ASPG;SOAT2;PLAAT5;ZDHHC12;PLA2G4C;DBT;GLYAT;SOAT1;MOGAT1;ZDHHC1;ZDHHC16;PLA2G15;ZDHHC6;DGAT2;ZDHHC3
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.4502048858044415,-1.3160694655227556,0.12955465587044535,0.4878475329307594,1.0,11/21,32.24%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK13;CDK19;CDK1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.4502048858044415,-1.3160694655227556,0.12955465587044535,0.4878475329307594,1.0,11/21,32.24%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK13;CDK19;CDK1
prerank,lysine-acetylated histone binding (GO:0070577),0.48475872062738007,1.3153784709119867,0.14917127071823205,0.716130719402213,1.0,7/20,13.06%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,acetylation-dependent protein binding (GO:0140033),0.48475872062738007,1.3153784709119867,0.14917127071823205,0.716130719402213,1.0,7/20,13.06%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,epidermal growth factor receptor binding (GO:0005154),-0.4433251218546542,-1.315022763045448,0.10504201680672269,0.48410249992177967,1.0,9/25,28.19%,HIP1;PLSCR1;SNX1;SNX2;EFEMP1;FAM83B;EGF;GRB2;BTC
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4649233202608219,1.3147826535167884,0.17348927875243664,0.7073743134404714,1.0,4/22,8.69%,CPEB2;ELAVL4;EXOSC8;ELAVL1
prerank,retinoid X receptor binding (GO:0046965),-0.5396661596039776,-1.3147691593368807,0.16326530612244897,0.47864386550376564,1.0,6/11,14.83%,TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.4397862156115849,1.3132285247967088,0.12524461839530332,0.7027264426328436,1.0,5/27,6.01%,SLC22A6;SLC22A8;SLC5A5;SLC26A1;SLC25A11
prerank,lysine N-methyltransferase activity (GO:0016278),0.4922228474963688,1.3108918678996324,0.16377649325626203,0.7007481880643459,1.0,6/20,13.15%,KMT5A;EEF2KMT;ANTKMT;SETD4;SETD7;SMYD2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4028171171578581,1.3099941394840837,0.1310344827586207,0.693998492151108,1.0,10/49,7.90%,SYT11;SYT12;ANXA6;CPNE1;ANXA5;SYT9;CPNE4;PLA2G4C;SYT1;SYT13
prerank,nucleosomal DNA binding (GO:0031492),-0.46290002999878777,-1.309316849398766,0.13306451612903225,0.4867395994289727,1.0,5/21,8.41%,ACTB;H3-3A;SMARCC1;GATAD2B;RBBP4
prerank,protein phosphatase 1 binding (GO:0008157),0.470170321476115,1.3091544993743494,0.13333333333333333,0.6865760111708241,1.0,4/21,7.65%,SH3RF2;PPP1R3F;PPP1R16A;PHACTR4
prerank,histone methyltransferase binding (GO:1990226),0.5439429735672959,1.3085282561751805,0.18143459915611815,0.67911266533234,1.0,3/11,10.72%,CBX1;PHF1;LCOR
prerank,cation channel activity (GO:0005261),0.3558174062848648,1.3064720894610107,0.08231173380035026,0.6762261507767746,1.0,6/94,1.13%,TRPM3;CACNA1D;ANXA6;SLC24A3;TRPM6;TRPV1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5495856594830362,1.3056430149567162,0.16699410609037327,0.6694782857388205,1.0,4/11,11.47%,TRPV1;ITPR1;RYR2;TRPM2
prerank,transcription coactivator binding (GO:0001223),0.46973212528134467,1.3025976296996156,0.15030060120240482,0.6696958632883672,1.0,7/20,13.37%,RORA;SMAD3;THRB;CCNT2;MED25;ZBTB49;TERT
prerank,neuropeptide binding (GO:0042923),0.4903063197472143,1.2977489406734966,0.17523809523809525,0.6765129152075914,1.0,7/18,24.16%,OPRD1;NMUR1;GPR37;OPRM1;GPR149;OPRL1;NMUR2
prerank,calcium channel activity (GO:0005262),0.35410782115064193,1.2960412418608966,0.10641891891891891,0.6732197714238157,1.0,8/84,1.76%,CACNA1D;CACNA2D3;ANXA6;SLC24A3;CACNG7;TRPV1;CACNB1;CACNB3
prerank,Hsp90 protein binding (GO:0051879),-0.3950815767050362,-1.2932870384560275,0.11353711790393013,0.5227616693559561,1.0,9/33,13.25%,SLC12A2;KDR;ERN1;RPS3;PTGES3;AHR;UNC45B;HDAC6;CSNK2A1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5518211430119233,1.2931828932218021,0.16827852998065765,0.6736470611790356,1.0,3/11,8.02%,KCND3;KCNJ5;KCNH2
prerank,GTPase regulator activity (GO:0030695),-0.28778571347447496,-1.2905141230453934,0.030054644808743168,0.523326038904032,1.0,43/212,9.52%,ARHGAP31;NRP1;ARHGAP10;PREX2;TBC1D4;CHN2;RABGAP1L;DOCK1;RAPGEF2;ARHGAP42;SLIT2;RGS3;RGS12;RGS5;SIPA1L2;RASGRP3;STARD8;SH3BP4;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;ARAP3;STARD13;TBC1D12;JUN;USP6NL;TBCD;TBC1D5;ARAP1;TBC1D2B;SIPA1L3;ARHGAP32;TBC1D1;ARHGAP35;RGS6;EVI5L;IPO7;SEC23A;ABR;PDE6D;TBC1D13
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5123560217409097,-1.2899781136684283,0.15625,0.5187260927744061,1.0,7/12,32.24%,BRD4;MAPK1;CDK6;CDK8;CDK13;CDK19;CDK1
prerank,hormone receptor binding (GO:0051427),-0.49382331183414574,-1.28940771091329,0.15163934426229508,0.5139172849669155,1.0,6/14,21.50%,SOCS2;JAK1;NCOA6;NPPC;PTHLH;CCK
prerank,sodium:proton antiporter activity (GO:0015385),-0.5276071652995943,-1.2880845163987007,0.1744421906693712,0.5114410744913546,1.0,2/11,3.62%,SLC9A2;SLC9B2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.42763730374066894,1.286801863487674,0.15229357798165138,0.6851836804669151,1.0,10/34,13.72%,KMT5A;EEF2KMT;DOT1L;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2;MEN1
prerank,amino acid binding (GO:0016597),-0.4038221244382515,-1.2862938340668775,0.14168377823408623,0.5099545126803067,1.0,21/31,32.22%,NOS3;GRM7;SRR;GLRB;GRIN2B;GCLC;DDAH1;GLRA2;THNSL2;CAD;GRIN1;ASS1;DDAH2;AARS2;SHMT2;CASTOR1;AGXT;SHMT1;GNMT;NOS2;NOS1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4347054572766113,-1.2851217457721305,0.13953488372093023,0.5073971402646975,1.0,5/20,9.35%,MAGI3;CASK;TJP2;MPP1;DTYMK
prerank,protein kinase C activity (GO:0004697),-0.48381994274577933,-1.284853756466811,0.170873786407767,0.5025677241940812,1.0,5/14,7.90%,PRKCH;PRKD3;PRKD1;PRKCD;PRKCG
prerank,acetyltransferase activity (GO:0016407),0.42524684369116683,1.2847195319967382,0.15606936416184972,0.6829802902609117,1.0,5/31,4.93%,SPHK1;GNPNAT1;SAT1;DBT;ACAT1
prerank,insulin-like growth factor binding (GO:0005520),-0.48345491056668055,-1.2814640070634669,0.16837782340862423,0.5052038965968034,1.0,4/15,5.12%,ITGA6;INSR;ITGB4;IGFBP6
prerank,filamin binding (GO:0031005),0.5376255774873812,1.2795207781032232,0.1952191235059761,0.6902251102714227,1.0,4/11,11.10%,NEBL;RFLNA;CRMP1;TMEM67
prerank,translation initiation factor activity (GO:0003743),-0.39035130551141906,-1.276949035822968,0.12284482758620689,0.5107264801557544,1.0,12/36,17.56%,EIF3E;EIF3H;EIF3M;EIF2B2;MTIF3;EIF4E;EIF3F;AGO2;EIF1B;EIF3K;EIF4G3;EIF2B1
prerank,Wnt-activated receptor activity (GO:0042813),-0.4753256140833827,-1.2764256906485798,0.17416829745596868,0.5066736255023576,1.0,7/15,13.72%,ROR1;FZD6;LRP5;PKD1;FZD4;TSPAN12;FZD1
prerank,antiporter activity (GO:0015297),0.46375683424444913,1.2755245185707234,0.17013232514177692,0.6947384217103971,1.0,6/20,13.33%,SLC35E2B;SLC35E2A;SLC25A11;TMEM241;CLCN4;CLCN3
prerank,G protein-coupled receptor activity (GO:0004930),0.3025337763704539,1.2718848041529387,0.05421686746987952,0.6985119724434775,1.0,35/239,10.90%,TAS1R2;LGR4;GCGR;PTH2R;GPR135;GPR62;GPR143;NPR3;C5AR2;BDKRB1;OPRD1;ADGRG4;GPR87;CRHR1;ADRA2A;LPAR2;ADGRB2;ADGRB3;BDKRB2;GPR45;GPR12;GPR26;NTSR2;LPAR1;NMUR1;DRD3;ADGRV1;LTB4R2;GABBR1;C3AR1;ADGRL1;GPR37;ADGRG3;GABBR2;GRPR
prerank,pre-mRNA binding (GO:0036002),0.43834644654847615,1.2708459476659104,0.14689265536723164,0.6936667461621014,1.0,6/28,11.60%,CELF2;DDX5;HNRNPU;HNRNPL;PTBP1;SLBP
prerank,receptor antagonist activity (GO:0048019),0.4937929351312046,1.2703710028200061,0.18421052631578946,0.686935914838215,1.0,3/17,11.01%,ADH7;DKK3;FST
prerank,GTP binding (GO:0005525),-0.29223702242757205,-1.2673972213159599,0.05357142857142857,0.5235250198020943,1.0,55/172,22.95%,RHOJ;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;RAB31;GTPBP10;RALB;GNL3;GBP4;RAP2A;GCH1;GBP5;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;RRAGA;RAB27A;RND3;RERG;ARL5A;RAB11B;RAB1B;GLUD1;RAP2B;ARF5;ADSS1;GNL1;MRAS;NUDT16;RHOBTB3;ARL8B;ARHGEF5;CDC42;RRAGD;AGAP2;RAB27B;RHOB;RAC3;RAB35;ARL4D;TUBE1;TUBA4A;RND2;RHOT2
prerank,calcium channel regulator activity (GO:0005246),-0.38298324497215985,-1.264892958968067,0.14772727272727273,0.5243335627796377,1.0,5/37,4.52%,PRKG1;STIM2;YWHAE;STIMATE;SLC30A1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.35930824090791447,1.2638081471242661,0.13380281690140844,0.6998149628955208,1.0,18/74,15.83%,NADK2;SPHK1;GK;FAM20A;TKFC;PANK1;PIK3CB;NT5C3A;PANK2;TRPT1;DGKI;CHKB;PI4KA;SPHK2;DGKE;DGKD;IPPK;HK1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.28520796134575227,-1.2600424787379574,0.06005221932114883,0.5303822280827438,1.0,40/188,15.17%,MEF2C;PBX1;BNC2;ETS1;TCF12;FLI1;FOXO3;CTCF;RUNX1;STAT3;PRDM16;TBX18;SIX1;JUN;TFEB;SOX17;CREB3L1;VSX1;NFYA;PSPC1;XRCC5;ETV5;AR;KLF11;PRDM5;ELK1;AHR;KLF4;TAL1;MAFK;PER1;SOX7;HHEX;SOX18;LIN54;SOX12;SUV39H1;MTERF3;ARID5A;ATF6B
prerank,sterol transfer activity (GO:0120015),-0.45325834104756996,-1.2580559862117964,0.18473895582329317,0.53019400557695,1.0,7/17,11.77%,ABCA1;PLTP;NPC2;OSBP;MTTP;STARD4;GRAMD1A
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5335153621443411,1.2566315970928368,0.19678714859437751,0.7142720744961535,1.0,4/11,9.99%,SLC25A42;SLC19A1;SLC25A25;SLC25A23
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5372417328913817,-1.2562033303323683,0.2124756335282651,0.5293235221335093,1.0,4/10,3.05%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1
prerank,ligand-gated cation channel activity (GO:0099094),0.3463038981855841,1.2544995479141356,0.13036303630363036,0.7126908065278108,1.0,15/75,15.09%,P2RX6;KCNJ13;KCNJ5;GRIN3A;GRIN2D;KCNJ10;GRIK5;GRIK2;KCNH2;CHRNB2;KCNJ16;TRPM2;SHROOM2;TRPM8;GRIA2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.45429867216641345,1.2535360243391322,0.16865079365079366,0.692160043838872,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,serotonin receptor activity (GO:0099589),0.45429867216641345,1.2535360243391322,0.16865079365079366,0.692160043838872,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.45429867216641345,1.2535360243391322,0.16865079365079366,0.692160043838872,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.45905446735281963,-1.2532766155952137,0.1761006289308176,0.5263394960628067,1.0,7/16,27.92%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.45905446735281963,-1.2532766155952137,0.1761006289308176,0.5263394960628067,1.0,7/16,27.92%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,carboxylic acid binding (GO:0031406),-0.3784868389436119,-1.251882505551972,0.1336206896551724,0.5243894673103433,1.0,15/38,18.59%,NOS3;GRM7;SRR;GLRB;GRIN2B;EPDR1;GCLC;PSAP;SESN3;GLRA2;THNSL2;GLUD1;CAD;GRIN1;UBR1
prerank,metallocarboxypeptidase activity (GO:0004181),0.4406607250042961,1.2492597139724206,0.1871345029239766,0.6978266137670819,1.0,4/26,8.89%,AEBP1;CPN1;AGBL4;CPA2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5072258639952687,-1.2479833681002959,0.20710059171597633,0.5288057684380508,1.0,3/11,8.83%,LEF1;ZXDC;GATA2
prerank,FAD binding (GO:0071949),0.4374758623354934,1.2470881853375644,0.1787709497206704,0.6972191074102029,1.0,9/24,15.32%,DDO;AIFM1;MICAL3;QSOX1;KMO;NDOR1;SQLE;CYB5R1;MTHFR
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.27487681519748314,-1.2466310168398453,0.044444444444444446,0.5269572531907878,1.0,54/254,17.32%,MECOM;LEF1;MEF2C;ERG;ZBTB16;ELK3;ETS1;PLAGL1;TCF12;MEOX2;FOXO1;FOXO3;RUNX1;STAT3;NFATC1;PRDM16;PLSCR1;SIX1;NFIA;REL;JUN;ESR1;KLF7;SOX17;CREB3L1;SMAD1;ETV1;NRF1;ETV5;AR;ELF4;TFCP2L1;NFAT5;ELK1;IRF2;KLF4;RFXAP;HHEX;SOX18;FOXF2;FOSL2;MAFF;SOX12;TFCP2;NR4A2;ZNF445;ATF6B;FOXO4;NR1H4;ATF4;NFKB2;RREB1;FOXD2;SP7
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3167485605315391,1.2447132848097606,0.11688311688311688,0.6967401647519698,1.0,21/134,9.99%,SLC6A13;SLC6A1;SLC22A6;SLC13A3;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC25A42;SLC16A12;SLC26A1;SLC38A1;MPC2;SFXN2;PDPN;SLC19A1;SLC25A25;SLC38A9;SLC25A12;SLC25A23
prerank,hexosyltransferase activity (GO:0016758),-0.3091415246387622,-1.2443134092694803,0.1162227602905569,0.5273645112123257,1.0,31/101,24.08%,TMTC2;GCNT2;CSGALNACT1;EXT1;B3GNT2;B4GALT4;MTAP;TMTC1;GBE1;MGAT4A;B4GALT5;HEXA;CHSY3;GCNT1;MFNG;POGLUT3;MGAT4B;HAS1;LFNG;B3GAT3;ALG6;POMT2;TMTC3;HAS2;ALG5;B3GNT3;DPY19L3;B3GALT5;B4GALNT3;B3GNT8;EXT2
prerank,carboxypeptidase activity (GO:0004180),0.40111545145344446,1.2396866497124186,0.19666048237476808,0.7052689398716911,1.0,5/35,8.89%,AEBP1;CTSA;CPN1;AGBL4;CPA2
prerank,glutamate receptor activity (GO:0008066),0.47167969716351754,1.2394793542116056,0.20159680638722555,0.6984885329438058,1.0,6/19,16.59%,GRID2;GRIN2D;GRIK5;GRIK2;GRIA2;GRM8
prerank,amino acid transmembrane transporter activity (GO:0015171),0.374574476932313,1.2386626396913787,0.15693430656934307,0.6938140998861063,1.0,8/47,6.78%,SLC6A13;SLC6A1;SLC38A3;SLC7A11;SLC25A44;SLC38A1;SLC7A13;PDPN
prerank,metal ion:proton antiporter activity (GO:0051139),-0.48567188421011714,-1.2384721463075532,0.19057377049180327,0.5368207597348892,1.0,2/13,3.62%,SLC9A2;SLC9B2
prerank,growth factor receptor binding (GO:0070851),-0.3067849949643824,-1.2356593982777095,0.09848484848484848,0.5390799008253926,1.0,20/95,14.74%,HIP1;IL6ST;IL1R1;VEGFC;ITGA5;PTPRJ;PLSCR1;ERN1;SNX1;IL6R;IL1RAP;SRC;PDGFC;FGF2;FGF7;ESM1;PIBF1;PDGFD;VEGFA;SNX2
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2605903536665582,-1.2349036484511766,0.032679738562091505,0.5359469353274303,1.0,107/334,23.11%,PRKCH;SNRK;BMPR2;MARK1;NEK7;ACVR1;HIPK1;ACVRL1;MAP3K5;RPS6KA5;STK38L;STK3;EGFR;LIMK2;BCR;AKT3;ALPK1;TGFBR2;IRAK3;CDK14;RPS6KA3;TNIK;PRKD3;BRD4;NUAK1;CASK;CPNE3;MAP3K20;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;CIT;ERN1;CDC42BPA;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;CSNK1G3;PRKCG;RPS6KA2;STK24;CDK5;MAP4K4;EIF2AK3;STK33;MAPKAPK2;NEK3;BCKDK;VRK3;SQSTM1;GRK5;STK10;DYRK1A;PTK2B;STK32A;STK16;CSNK2A1;STK38;AKT2;PIK3R4;ACVR1C;IRAK2;PKN3;LIMK1;PRKACA;MKNK2;TAOK3;MAST2;MAP3K8;LATS1;MASTL;TAOK1;HUNK;STK35;MAPK12;CDK16;CDK6;MAPK3;CAMK1G;MARK3;STK17B;RIPK1;TRIO;CSNK1D;MAP3K6;DYRK2;CHEK1;ULK2;MYLK;SYK;ROCK1;TOP1;RIPK2;CDKL4;MAP3K4;SLK;SIK3;MAP4K3;MAPK11;CDK11B;GAK;STK32C
prerank,histone acetyltransferase binding (GO:0035035),0.4476066801910215,1.2338856274932253,0.21348314606741572,0.7008512147690062,1.0,6/21,18.95%,EPAS1;PAX6;KANSL1L;STAT1;CITED2;MEF2A
prerank,"DNA binding, bending (GO:0008301)",-0.47123474095277934,-1.2332055922555618,0.22058823529411764,0.5355778501838105,1.0,4/14,20.34%,LEF1;HHEX;TOP2A;HMGB1
prerank,transmitter-gated ion channel activity (GO:0022824),0.41922195637985255,1.2320521870345595,0.2047970479704797,0.6990222372354363,1.0,8/29,15.09%,GABRG1;GRID2;GRIN2D;GRIK5;GRIK2;GABRG3;GABRB2;GRIA2
prerank,rRNA binding (GO:0019843),-0.3599021783756707,-1.2294119773328402,0.1552511415525114,0.5396759118357316,1.0,12/42,17.02%,RPL5;RPLP0;RPS5;RPS3;RPL23;RPS9;NGRN;RPL12;CAVIN1;RPS13;GTF3A;PTCD3
prerank,N-methyltransferase activity (GO:0008170),0.44936227605761836,1.2290782925798955,0.2106299212598425,0.700945394329411,1.0,7/20,17.09%,FDXACB1;N6AMT1;RNMT;TRMT11;METTL5;METTL18;TRMT1L
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5119816736466067,-1.2273439238489197,0.21822033898305085,0.5396725908349449,1.0,3/11,9.26%,SGMS1;SGMS2;SAMD8
prerank,glucuronosyltransferase activity (GO:0015020),-0.44221556704589987,-1.2204437434678288,0.2033195020746888,0.5526487638952832,1.0,2/19,1.45%,CSGALNACT1;EXT1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.48403074465619783,-1.2204334405362653,0.23715415019762845,0.5477760090907253,1.0,3/12,10.41%,TRAF5;TRIM37;BABAM2
prerank,mRNA 3'-UTR binding (GO:0003730),0.33818525289714163,1.2204102248307354,0.1771523178807947,0.7200404474600237,1.0,25/79,20.69%,CPEB2;CELF2;DDX5;ANGEL2;ELAVL4;HNRNPA2B1;PABPC4L;HNRNPU;EXOSC8;CPEB4;UTP23;ELAVL1;RNF20;BOLL;FXR2;CSDC2;PCBP4;ELAVL2;CCT5;RNPS1;CPEB3;LARP4B;ILF3;ELAVL3;LARP1
prerank,myosin V binding (GO:0031489),-0.45283538922679445,-1.2194258858946967,0.2346723044397463,0.5454964026881446,1.0,8/15,23.01%,RAB14;RAB6A;RAB3A;RAB11B;RAB11A;RAB3D;RAB27B;RAB3B
prerank,mRNA 5'-UTR binding (GO:0048027),-0.40933763336304474,-1.2193391513390153,0.17920353982300885,0.5409557028062734,1.0,12/24,29.66%,RPL41;RPL5;GNL3;RPS7;SYNCRIP;FMR1;RPS13;NCL;SHMT2;SHMT1;IGF2BP2;IGF2BP1
prerank,phosphatidic acid binding (GO:0070300),-0.42331765578253333,-1.2191281251815,0.21301775147928995,0.5367467247259321,1.0,6/19,10.77%,PITPNC1;RAPGEF2;MARK1;PLTP;RAPGEF6;JPH2
prerank,protein phosphatase binding (GO:0019903),-0.29673164622353565,-1.217492509868385,0.1111111111111111,0.5360407997246645,1.0,24/117,10.09%,DAB2IP;MAP3K5;FOXO1;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;MFHAS1;ANAPC5;STRN3;RACK1;MET;PPP1R16B;PXN;KCNQ1;SHOC2;CEACAM1;SOD1;FLT4;EIF2AK3;JAK1;GTF2F1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.48933583335057407,-1.2159152080431141,0.21836734693877552,0.5354757042348752,1.0,2/12,3.62%,SLC9A2;SLC9B2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3731280464021866,1.2155927997079674,0.15630550621669628,0.728288322248849,1.0,3/48,0.80%,TRPM3;SLC41A1;TRPM6
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.48238971456758356,-1.2140727231227986,0.22937625754527163,0.5352353012166351,1.0,6/12,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,N-acyltransferase activity (GO:0016410),0.40036225863536323,1.2129181591653528,0.20817843866171004,0.7296410728836329,1.0,5/32,6.88%,NMT2;GNPNAT1;PLAAT5;SAT1;GLYAT
prerank,calcium-release channel activity (GO:0015278),0.46586008315136573,1.2127865338053954,0.2222222222222222,0.7230528710229966,1.0,5/17,11.47%,TRPV1;ITPR1;ITPR2;RYR2;TRPM2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5213939584725926,1.2127048390290116,0.2504816955684008,0.7164301677481892,1.0,2/10,3.91%,TRPV1;GABRG1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.41900957385972504,-1.2125268277121017,0.2128060263653484,0.5344666937830481,1.0,5/20,13.08%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,chemokine receptor binding (GO:0042379),-0.3768047641454196,-1.2119973098580294,0.18580375782881003,0.5313900903503004,1.0,24/35,50.19%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CCL19;CCL14;CX3CR1;CCL1;CCL3;XCL1;CXCL13;CXCL2;CKLF
prerank,peptidase inhibitor activity (GO:0030414),0.4045310231961587,1.2108690604598125,0.21338155515370705,0.7150038331266476,1.0,6/33,11.05%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4135542218441809,1.2072186880183136,0.2320754716981132,0.7192099999169577,1.0,3/27,2.73%,SLC8A3;SLC41A1;SLC23A1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.38187366433117303,-1.2028249828631286,0.194,0.5491538098943333,1.0,7/30,13.08%,SLC39A10;SLC40A1;SLC30A1;SLC39A8;SLC31A1;SLC39A7;SLC30A5
prerank,ionotropic glutamate receptor activity (GO:0004970),0.45727080364889383,1.2021170801551408,0.24618320610687022,0.7278948803942745,1.0,4/17,7.15%,GRIN3A;GRIN2D;GRIK5;GRIK2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4928533729404893,1.2013113551848489,0.22469635627530365,0.72369192749974,1.0,2/12,1.69%,ADH4;NQO1
prerank,ligand-gated calcium channel activity (GO:0099604),0.4411519205053073,1.1961672776862002,0.2504604051565378,0.7326183453316656,1.0,6/19,13.91%,TRPV1;ITPR1;GRIN2D;RYR2;TRPM2;TRPM8
prerank,platelet-derived growth factor binding (GO:0048407),0.4964532031450636,1.1940001220973973,0.2667946257197697,0.7325793361147032,1.0,3/11,5.94%,COL5A1;PDGFRA;COL1A2
prerank,RNA polymerase binding (GO:0070063),0.4361180817523169,1.1931238148214387,0.23340040241448692,0.728614774418882,1.0,5/18,13.51%,PABPN1;CCNT2;TAF10;TCERG1L;YTHDC2
prerank,cholesterol binding (GO:0015485),0.370416388446457,1.1926478483863767,0.2018348623853211,0.7234611089122972,1.0,10/47,9.10%,OSBPL8;ANXA6;SOAT2;SIDT1;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,retinoic acid receptor binding (GO:0042974),-0.4378252515647108,-1.1918087538601918,0.2510729613733906,0.571557256137625,1.0,7/17,14.83%,ACTN4;TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,chemokine activity (GO:0008009),-0.3782473925585174,-1.191513103013434,0.2217573221757322,0.5676346474685378,1.0,22/31,50.19%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CCL19;CCL14;CCL1;CCL3;XCL1;CXCL13;CXCL2;CKLF
prerank,copper ion binding (GO:0005507),0.37066098347220283,1.1909978264663834,0.22346368715083798,0.7218651552276583,1.0,14/42,22.11%,MOXD1;LOXL3;SUMF1;LACC1;CUTC;RNF7;ATP7A;IL1A;PRNP;P2RX4;AOC2;PAM;ATP13A2;COA6
prerank,channel activity (GO:0015267),0.3715935369014132,1.1892139576796619,0.19413919413919414,0.7209242364466276,1.0,6/41,10.41%,P2RX6;TRPV1;TMEM120B;PDPN;MPV17;BCL2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.4091040719060272,1.188642243980755,0.248565965583174,0.7163960925915781,1.0,6/28,13.92%,GABRG1;GRID2;GRIK5;GRIK2;CHRNB2;GABRG3
prerank,steroid hydroxylase activity (GO:0008395),-0.440524170784391,-1.187885461268652,0.2624254473161034,0.5720874315572103,1.0,3/16,5.23%,CYP7B1;CYP1B1;CYP39A1
prerank,DNA replication origin binding (GO:0003688),-0.3995469961851246,-1.1848488318758423,0.2509881422924901,0.5747477953040984,1.0,12/23,32.32%,KAT7;ORC1;ORC2;CDC45;ORC5;POLA1;MCM3;MCM5;MCM6;GRWD1;ORC3;CDC6
prerank,protein heterodimerization activity (GO:0046982),0.28834874056167387,1.1838860816721455,0.1143317230273752,0.7244285098508422,1.0,36/178,14.90%,ATP1A2;EPAS1;BMP6;NPAS3;ABCG5;TOP2B;RRAGC;MIGA2;ARNT2;TENM1;PGLYRP3;SIM1;CHUK;ZHX1;ATP1B2;ADRA2A;ADD2;BDKRB2;ADCY8;IKBKG;FZD9;LSM5;PAFAH1B2;BCL2;GABBR2;USF1;TAF1;BHLHE41;QTRT2;MICU1;CYBA;ARNT;QTRT1;FXR2;DGKD;SMC3
prerank,phosphatase inhibitor activity (GO:0019212),-0.4149999351543268,-1.183723204622286,0.2422360248447205,0.5730479100143456,1.0,9/20,31.29%,PTN;MGAT5;PPP1R2;BOD1L1;SET;TESC;PPP1R1B;LMTK2;ANP32E
prerank,protein kinase binding (GO:0019901),-0.2419743948396728,-1.1836988193887412,0.04693140794223827,0.5686105722599418,1.0,90/479,13.98%,UTRN;ACTB;LIMS1;GHR;FRMD5;CAV1;PDLIM5;SLC12A7;SLC12A2;BMPR2;DAB2IP;PTN;RHOBTB1;RHOA;ACVR1;ACVRL1;PKD1;IQGAP1;FOXO3;BCL2L1;CAVIN2;PLCG1;STAT3;EEF1A1;PTPRJ;PPP1R12A;CSPG4;IRAK3;PTPRK;ESR1;CACUL1;PLCG2;ADCY4;GCH1;ITGB1;SPRED2;TFRC;TJP2;SMAD1;PAK2;CIT;RACK1;ADAM10;EEF2;TRIM14;PRKCD;KCNQ1;CALM3;RELB;RPS7;RB1CC1;ANKRA2;APC;SPRY2;RPS3;NBR1;EMP2;CEACAM1;ACTA2;HDAC7;HDAC9;PTPN1;MAPKAPK2;BCAR1;CIR1;NEDD9;RPTOR;DUSP3;YWHAZ;CAV2;ACSL3;BAG5;FBXO5;HSPB1;SQSTM1;GRK5;GSKIP;TPR;ROR2;RND3;TRPV4;STK38;PEBP1;PTPRC;CD24;IRS1;PGAM1;CNTLN;PPP1CC;AP2A1
prerank,metalloexopeptidase activity (GO:0008235),0.3607908025175596,1.1828710474895339,0.21960072595281308,0.7214213118741731,1.0,4/51,2.65%,AEBP1;METAP2;CPQ;CPN1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5076776835538163,-1.1821454376898588,0.28125,0.5683284060588377,1.0,7/10,31.29%,ANKRD13A;DNAJC2;ANKRD13B;USP15;ANKRD13D;FAAP20;LAPTM5
prerank,signal sequence binding (GO:0005048),-0.3645327428411986,-1.181732092079606,0.2018140589569161,0.5650093744058263,1.0,10/35,15.22%,NFKBIA;AP2B1;TIMM22;CAT;BABAM2;IPO5;KDELR3;CEMIP;SEC61A1;KPNA2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.38641776190446675,-1.1815171977203112,0.22151898734177214,0.5612612317827237,1.0,3/25,6.75%,HIP1;ARAP3;PLEKHA4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.45061172106945585,1.1764932966788966,0.25616698292220114,0.7340347108444066,1.0,8/16,25.04%,SLC13A3;SLC25A11;SLC25A12;SLC38A7;SLC25A13;SLC13A5;SLC25A18;SLC1A4
prerank,clathrin adaptor activity (GO:0035615),-0.4517369535113169,-1.1752493820932897,0.26666666666666666,0.5722229649203149,1.0,6/15,16.64%,HIP1;STON2;AP2B1;HIP1R;AP2A1;LDLRAP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4872192239543748,1.1749080465897594,0.2714570858283433,0.7324304414945655,1.0,2/14,1.22%,ADH7;ADH4
prerank,GTPase activity (GO:0003924),-0.2653646006384725,-1.1736947299032219,0.10112359550561797,0.5717163281471098,1.0,59/192,21.10%,RHOJ;DNM3;RHOBTB1;RHOA;RAB14;RAP1A;ATL3;EEF1A1;RAB6A;RAB31;GTPBP10;RALB;GNA11;GBP4;RAP2A;GCH1;GBP5;GNB1;ARHGDIB;EEF2;RASL12;NKIRAS1;BMS1;GFM1;RAB22A;DNAJC27;GNG5;GNB2;RAB3A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;RERG;SAR1A;RAB11B;GNA12;RAB5C;RAB1B;GFM2;RAP1GAP;RAP2B;GNL1;MRAS;SRPRA;RHOBTB3;RAB11A;GNA14;ARL8B;CDC42;RRAGD;AGAP2;RAB27B;RHOB;MTG1;RAC3;RAB35
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.36999158112704134,-1.1732248139745083,0.2125,0.5685089150162955,1.0,10/32,14.08%,SLC6A6;SLC1A5;SLC7A5;SFXN1;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,secondary active transmembrane transporter activity (GO:0015291),0.34565458095551216,1.172684370150354,0.22608695652173913,0.7327718806654208,1.0,7/51,6.17%,SLC22A6;SLC22A8;SLC5A5;SLC35E2B;SLC35E2A;SLC25A11;TMEM241
prerank,E-box binding (GO:0070888),-0.3621843147409785,-1.1718070395555826,0.22943722943722944,0.567571728043553,1.0,8/34,11.58%,ZEB1;BHLHE40;HES1;AHR;TAL1;PER1;SREBF2;TWIST1
prerank,phosphatase activity (GO:0016791),0.3277092851980371,1.1714173294462455,0.2,0.7302970806615289,1.0,14/73,15.10%,ATP1A2;PON1;LPIN1;DUSP11;PXYLP1;PRUNE1;ARMT1;PLPPR3;ACP6;CILP2;PPP1CB;PTPRO;DUSP28;EPHX2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3847379752155038,-1.1712106990303726,0.24166666666666667,0.5650308188104252,1.0,8/24,10.77%,PLA2G4A;DAB2IP;CERT1;PLEKHA8;OSBP;GOLPH3;PLEKHA5;JPH2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3215009247336925,1.170830418319751,0.20642978003384094,0.7258781282446498,1.0,14/85,12.53%,CEL;LIPA;ASPG;PON1;PLAAT5;PLA2G4C;DDHD2;ABHD5;TARS2;MRPL58;PAFAH1B2;PLA2G15;ABHD3;GDE1
prerank,hyaluronic acid binding (GO:0005540),-0.4902494207803098,-1.169768806676309,0.2596899224806202,0.564376885424001,1.0,3/10,11.98%,LAYN;CD44;CEMIP
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3598400646310487,-1.1691611266514363,0.24675324675324675,0.5619326815425865,1.0,4/35,1.79%,PLCB4;PLCE1;GPCPD1;PLCL1
prerank,ion channel inhibitor activity (GO:0008200),-0.3488595972859136,-1.1679887983697648,0.22016460905349794,0.5605446746135522,1.0,10/35,16.14%,NEDD4L;STX1A;SLC30A1;CAMK2D;RACK1;KCNMB2;MCUB;STX7;STX8;CFTR
prerank,ATPase binding (GO:0051117),-0.30919089479534007,-1.1657156331131318,0.2198581560283688,0.5619787508883595,1.0,17/71,9.94%,PDE4D;CAV1;SLC2A13;EGFR;ABCA1;ATP6V0A4;ESR1;RALB;NKD2;GABARAPL2;AR;CHMP4A;PPP3CA;UBXN1;SRC;ATP6V0A1;TRPC1
prerank,syntaxin-1 binding (GO:0017075),0.419247116936112,1.1642486821219833,0.27915869980879543,0.73941331128307,1.0,11/22,24.17%,UNC13C;SYT1;LRRK2;SNAP25;NSF;CPLX1;CPLX2;STXBP3;SYNPR;SNPH;STXBP2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3570286574030036,-1.1642439526671613,0.2310838445807771,0.5614369108095172,1.0,13/35,24.52%,PEAK1;BMX;TEC;LYN;SRC;YES1;DYRK1A;PTK2B;BTK;HCK;SYK;FYN;FES
prerank,ubiquitin protein ligase binding (GO:0031625),-0.25152165004663646,-1.1606536602516775,0.10248447204968944,0.5659499627847496,1.0,89/254,24.80%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;EGFR;PRR5L;NFKBIA;MID1;RPL5;TNFRSF1B;UBC;MFHAS1;FAF2;SPOPL;HERC2;JUN;DNAJA1;RALB;NKD2;GABARAPL2;SMAD5;RPS27A;TRIM37;UBB;AXIN2;XRCC5;UBE2J1;MAP1LC3B;ANKRA2;APC;UBXN1;USP7;SLC22A18;TXNIP;ARIH1;JAK1;YWHAZ;PER1;PRDX6;RPL23;BAG5;SQSTM1;ISG15;FZD4;UBE2L3;RRAGA;HDAC6;GABARAP;CD40;FBXW7;CCT2;HM13;UBE2J2;PRKAR2B;AUP1;PA2G4;BAG1;PRKACA;UBE2A;RTN4;SLF2;PCBP2;UBE2G1;RPA2;UCHL1;RIPK1;ARRB2;TRIB2;TRAF4;DIO2;FAF1;SKI;GLMN;RNF40;FHIT;SMAD6;BCL10;TRIB3;ATXN3;UQCRC1;TSG101;TMBIM6;CUL3;MUL1;CXCR4;SUMO2;CASP8
prerank,dynactin binding (GO:0034452),0.4831855911836233,1.1604079542927495,0.2907216494845361,0.7446209537144243,1.0,3/12,9.94%,SNX6;HTT;BICD1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.48119699919639836,-1.157742667296744,0.3062015503875969,0.568755233377742,1.0,5/11,13.43%,TRPC3;TRPC6;TRPC4;TRPC1;ITPR3
prerank,histone deacetylase binding (GO:0042826),-0.2971464673523231,-1.1556062433611363,0.19458128078817735,0.5697967835799882,1.0,27/88,19.85%,LEF1;MEF2C;YWHAE;MIER1;GLI3;YWHAB;NIPBL;HES1;ANKRA2;NACC2;HDAC9;RBBP4;HEY2;CIR1;TAL1;MTA1;NACC1;HDAC6;SP2;KPNA2;TOP2A;HDAC2;MIER2;MTA3;CCND1;PRDM1;SPI1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.30655414317719115,-1.1553985426739553,0.21748878923766815,0.5663355662990132,1.0,27/70,29.96%,GCNT2;CSGALNACT1;EXT1;B3GNT2;MGAT4A;HEXA;CHSY3;GCNT1;MFNG;POGLUT3;MGAT4B;HAS1;LFNG;B3GAT3;HAS2;B3GNT3;B3GALT5;B4GALNT3;B3GNT8;EXT2;GCNT4;RFNG;POGLUT1;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.45926686220393625,1.1545344396426016,0.28793774319066145,0.7564671245774668,1.0,6/14,22.61%,AIFM1;NOX1;KMO;CYBA;NCF1;MICAL1
prerank,GABA receptor binding (GO:0050811),0.48683445220457844,1.154489135170084,0.2795275590551181,0.7506663093511438,1.0,3/11,8.63%,TRAK1;SHISA7;JAKMIP1
prerank,lipoprotein particle binding (GO:0071813),-0.39251762357268477,-1.1538511500874618,0.256198347107438,0.5659351958487078,1.0,5/20,4.66%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4331551841195495,-1.1521340862819052,0.2924901185770751,0.5666781389818841,1.0,5/15,16.14%,SLC26A7;SLC26A2;SLC39A8;SLC26A6;CFTR
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.45927462681048115,-1.1504623503827782,0.30128205128205127,0.5667808824437216,1.0,8/13,32.05%,SH3BP4;ARHGDIB;ARHGDIA;RANBP1;GPSM2;GDI1;ITGB1BP1;GDI2
prerank,phosphatidylinositol binding (GO:0035091),-0.2869392334665487,-1.145080362087394,0.20544554455445543,0.575822169174722,1.0,22/91,17.43%,HIP1;PITPNC1;ESYT2;PARD3;SCARB1;MCF2L;ANKFY1;SNX13;FCHO2;TNFAIP8L3;SNX1;ZFYVE16;ESYT3;AIDA;SNX10;HIP1R;ITPR3;SNX2;PITPNB;PIGK;EPB41;DENND1B
prerank,tRNA methyltransferase activity (GO:0008175),-0.41725202173442477,-1.144255613121496,0.27613412228796846,0.5740851662964237,1.0,7/16,19.64%,METTL2A;METTL2B;THUMPD2;FTSJ1;TRMT44;TYW3;LCMT2
prerank,cholesterol transfer activity (GO:0120020),-0.4152725273099006,-1.1434664851045495,0.286,0.5722301869973566,1.0,6/16,11.77%,ABCA1;PLTP;NPC2;MTTP;STARD4;GRAMD1A
prerank,diacylglycerol kinase activity (GO:0004143),-0.46933347693906713,-1.1421081241530813,0.32093933463796476,0.5715333984346054,1.0,3/11,3.98%,DGKH;DGKZ;AGK
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3808024765151897,-1.141753469155585,0.26521739130434785,0.5685995984076181,1.0,4/25,2.70%,FMO1;MICAL2;NOS3;FMO2
prerank,ATP hydrolysis activity (GO:0140603),0.36335961662925537,1.141751917317047,0.259391771019678,0.7838425408600125,1.0,11/41,11.47%,HSPA1A;ABCA4;RUVBL2;TDRD9;ABCB10;ATAD1;CHD3;TOR1B;ABCD1;MYO18A;CLU
prerank,low-density lipoprotein particle binding (GO:0030169),-0.41687587130366766,-1.141623286950414,0.2868525896414343,0.5652101973305941,1.0,5/16,4.66%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,cytokine activity (GO:0005125),0.29194859232098697,1.1412450791769897,0.18330605564648117,0.7791833988007758,1.0,12/131,7.55%,BMP7;BMP6;WNT4;IL18;WNT5B;WNT7A;IL17D;BMP3;BMP8A;WNT6;NRG1;INHA
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.4222183391080027,1.1369707553839168,0.2947976878612717,0.786378076539901,1.0,4/19,7.15%,GABRG1;GRID2;GRIK5;GRIK2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3862570238793265,1.1368303152077586,0.2907801418439716,0.78075990157874,1.0,1/26,0.05%,PPP1R1A
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.22616002589221915,-1.1343544070182252,0.05752212389380531,0.5780712178451359,1.0,148/731,17.32%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ZFHX3;ELK3;EBF1;ZEB1;LRRFIP1;RARB;TBX15;FOXP2;ETS1;PLAGL1;TCF12;MEOX2;PPARD;FOXO1;TBX3;TEAD4;PBX3;RUNX2;FOXO3;CTCF;RUNX1;EBF2;STAT3;DACH2;NFATC1;PRDM16;H3-3A;TBX18;SIX1;NFIA;REL;DACH1;GLI3;JUN;ESR1;TBX1;NFIX;KLF7;BPTF;TFEB;SOX17;BHLHE40;PRRX2;CREB3L1;SMAD5;SMAD1;IRF9;NFYA;KLF8;HES1;ETV1;NR3C2;JDP2;NLRC5;NRF1;SP3;AR;ELF4;TFCP2L1;ZBTB11;KLF11;RFX7;TGIF1;RELB;HEYL;NACC2;ZKSCAN1;NRIP1;PRDM5;NFAT5;ZBTB1;FOXQ1;ZNF83;BACH2;HEY2;GATA2;ELK1;AHR;NR2C1;NFE2L1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;PER1;ZSCAN18;CEBPD;ZKSCAN8;SOX7;NFATC2;ZBTB41;SREBF2;TWIST1;TEAD1;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;POU2F1;RARG;TBX2;NACC1;HDAC6;NFIL3;MAFF;SOX12;HSF5;KLF2;ZBTB5;TFCP2;NR4A2;ZNF445;SKIL;E2F5;SP2;ATF6B;FOXO4;NR1H4;ATF4;ZFP1;ZBTB33;SP4;SIX4;NFKB2;ZNF691;ZFHX4;ZSCAN25;RREB1;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;ZNF496;SP7
prerank,protein homodimerization activity (GO:0042803),-0.2310378582369235,-1.1323911588523974,0.06666666666666667,0.5790054224740249,1.0,122/589,15.39%,HIP1;ABCG2;SYNE1;GHR;ACTN4;PECAM1;ECE1;DAB2IP;ZBTB16;SLIT2;LRRFIP1;EXT1;LRP6;ANO1;FOXP2;B2M;ACVR1;FAP;TGFB2;PIP4K2A;MAP3K5;RBPMS;MYH9;BCL2L1;ZHX3;STAT3;MID1;RASIP1;TBX18;IRAK3;MKLN1;F11R;NOD1;MFF;MID2;TBX1;DEFA6;ACTN1;SCARB2;FLNA;GBP4;PANK3;BHLHE40;ACOX1;GCH1;TFRC;GSS;CISD2;MGLL;TPD52;TRIM37;CAMK2D;GBP5;XDH;S100A13;NECTIN3;ERN1;RACK1;HES1;TPM4;ADAM10;SNX1;TRPC6;PDE2A;NRF1;TRIM14;IL6R;SRR;CHMP4B;CHMP4A;DPY30;NACC2;ZBTB1;SPPL3;CEACAM1;TPM2;ABCD2;PEX7;CUBN;AOX1;PDGFC;FLT4;FBXO4;CAT;AHR;APOE;S100A6;S100A11;DROSHA;CAV2;MFSD1;PSAP;DSCAML1;YARS2;S100A16;HSPB1;STK10;FZD4;ASMT;PHB2;HHEX;TPST2;BLM;HIP1R;TPR;RRAGA;RPE;SMCHD1;NFS1;ENPP1;VEGFA;HOGA1;CIP2A;HM13;ZNF318;SNX2;IRAK2;S100A10;VAPB;NQO2;BAK1;RAP1GAP
prerank,Toll-like receptor binding (GO:0035325),-0.47643349429946497,-1.13146996822696,0.32563025210084034,0.5776484357827025,1.0,7/11,34.79%,DAB2IP;MYD88;CD36;TLR6;TLR1;S100A9;TLR2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.22523996523928297,-1.130192430185458,0.05429864253393665,0.576982311115723,1.0,152/732,18.02%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ZFHX3;ELK3;EBF1;ZEB1;LRRFIP1;RARB;TBX15;FOXP2;ETS1;PLAGL1;TCF12;MEOX2;PPARD;FOXO1;TBX3;TEAD4;PBX3;RUNX2;FOXO3;CTCF;RUNX1;EBF2;STAT3;DACH2;NFATC1;PRDM16;H3-3A;TBX18;SIX1;NFIA;REL;DACH1;GLI3;JUN;ESR1;TBX1;NFIX;KLF7;BPTF;TFEB;SOX17;BHLHE40;PRRX2;SMAD5;SMAD1;IRF9;NFYA;KLF8;HES1;ETV1;NR3C2;JDP2;NLRC5;NRF1;SP3;AR;ELF4;TFCP2L1;ZBTB11;KLF11;RFX7;TGIF1;RELB;HEYL;FOXN3;NACC2;ZKSCAN1;NRIP1;PRDM5;NFAT5;ZBTB1;FOXQ1;ZNF83;BACH2;HEY2;GATA2;ELK1;AHR;NR2C1;NFE2L1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;PER1;ZSCAN18;CEBPD;ZKSCAN8;SOX7;NFATC2;ZBTB41;SREBF2;TEAD1;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;POU2F1;RARG;TBX2;NACC1;HDAC6;NFIL3;MAFF;SOX12;HSF5;KLF2;ZBTB5;TFCP2;NR4A2;ZNF445;SKIL;E2F5;SP2;ATF6B;FOXO4;NR1H4;ATF4;ZFP1;ZBTB33;SP4;SIX4;NFKB2;ZNF691;ZFHX4;ZSCAN25;RREB1;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;ZNF496;SP7;MKX;FOXN2;JUNB;ZBTB37;PRRX1
prerank,protein kinase regulator activity (GO:0019887),0.30623162551709443,1.1274566789539127,0.24740484429065743,0.8031878397861597,1.0,8/95,4.22%,PRKAG2;SH3BP5L;PRKAG3;GPRC5A;GPRC5C;GPRC5B;CCNT2;SH3BP5
prerank,G protein-coupled receptor binding (GO:0001664),0.2887371011912837,1.1269526532279204,0.2278688524590164,0.798850285464867,1.0,22/132,14.28%,RNF43;WNT4;HSPA1A;WNT5B;TULP3;WNT7A;GPRC5B;ARR3;NTS;GPRASP2;WNT6;ARRB1;ARHGEF11;FZD7;RSPO1;C1QBP;BICD1;USP20;GRK3;GNAO1;PSMC5;HSPA1B
prerank,estrogen receptor binding (GO:0030331),-0.34816069519994725,-1.1262213745573415,0.2942430703624733,0.5830764262813228,1.0,11/32,14.83%,LEF1;TACC1;WIPI1;ESR1;NRIP1;DDX54;PHB2;DCAF13;RERG;NCOA6;ARID5A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.4350102363451287,-1.1243121813245534,0.3265720081135903,0.5840953818716561,1.0,6/14,23.56%,OTUD7B;MINDY1;USP7;MINDY2;USP15;ATXN3
prerank,transcription coregulator binding (GO:0001221),0.3348616425011895,1.1234058270484957,0.2765957446808511,0.8031466097713592,1.0,16/50,17.96%,RORA;SMAD3;THRB;CCNT2;USP11;PHF1;MED25;LCOR;ZBTB49;TERT;CTBP2;PER2;CHD6;RELA;MTF2;HDGF
prerank,R-SMAD binding (GO:0070412),0.42095913352974673,1.1229873147033809,0.33072407045009783,0.7984197903172566,1.0,8/18,21.84%,DDX5;SMAD3;PAX6;MEN1;PMEPA1;SMAD4;SMAD2;TRIM33
prerank,histone acetyltransferase activity (GO:0004402),0.3717984215018602,1.121526645104402,0.29541284403669726,0.7970539927110079,1.0,11/30,19.95%,MCM3AP;KAT5;ARRB1;TAF10;CLOCK;KAT14;TAF1;BAZ1A;TADA3;KAT6B;KAT8
prerank,enoyl-CoA hydratase activity (GO:0004300),0.48714187953259025,1.1214384560574928,0.3320079522862823,0.7915173869403226,1.0,4/10,19.29%,ECHDC3;ECHS1;ECHDC2;HSD17B4
prerank,kinase activity (GO:0016301),0.2984489219288907,1.1193125953894336,0.24662162162162163,0.791732313115905,1.0,27/109,17.57%,NADK2;SPHK1;GK;TKFC;PANK1;STK39;PSTK;PIK3CB;COQ8B;PGK1;PANK2;LRRK2;DGKI;CHKB;TAF1;EPHA4;PI4KA;SPHK2;DGKE;DGKD;IPPK;ABL1;CERK;CDKL5;PKMYT1;IP6K2;CDK5R1
prerank,transaminase activity (GO:0008483),0.4790038123097811,1.116405315865466,0.33476394849785407,0.7948020473736523,1.0,6/11,27.07%,BCAT2;GOT1;GOT2;BCAT1;PSAT1;ABAT
prerank,double-stranded DNA binding (GO:0003690),-0.22887922829928714,-1.1163430271209807,0.0860655737704918,0.5997221380638398,1.0,125/531,21.40%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;RARB;TBX15;TCF12;MEOX2;PPARD;FLI1;RAD51B;TBX3;EGFR;RUNX2;FOXO3;POLR3F;NFATC1;TBX18;SIX1;CRY1;GLI3;JUN;ESR1;TBX1;NFIX;TFEB;BHLHE40;PRRX2;CREB3L1;SMAD5;VSX1;IRF9;LHX6;AIM2;HES1;ETV1;NR3C2;JDP2;XRCC5;REXO4;SP3;ETV5;ELF4;TFCP2L1;KLF11;RFX7;TGIF1;MBNL2;RPS3;NFAT5;FOXQ1;BACH2;HEY2;GATA2;ELK1;HMBOX1;AHR;NR2C1;IRF2;KLF4;HOXA6;ETS2;CPSF4;CEBPD;SOX7;NFATC2;SREBF2;TEAD1;SOX18;DMC1;KIN;RARG;TBX2;MAFF;SOX12;HSF5;KLF2;TFCP2;NR4A2;ZNF445;SP2;ATF6B;FOXO4;ATF4;ZFP1;ZBTB33;SIX4;NFKB2;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;TDG;FOXN2;JUNB;NEIL3;ZBTB37;NR2F1;ZCCHC3;HIVEP1;FOXE1;PRDM1;IRF5;SOX8;ZNF177;PAX3;RAD51AP2;HOXA4;FOXL2;NFATC3;XPA;HMGB1;LMX1B;ATF3;HSF4;ZBP1;CENPX;ZBTB45;JUND;MAU2;TOP1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.3559259147017636,-1.1142224258280522,0.2791666666666667,0.6009574168517882,1.0,10/29,25.31%,PTPRJ;NFATC1;GCH1;NBR1;MAPKAPK2;TPR;DUSP6;DUSP1;PRMT1;DUSP7
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.328581762011343,1.113938549387909,0.2844364937388193,0.7972350205598272,1.0,9/55,11.47%,CACNA1D;ANXA6;SLC24A3;TRPV1;ITPR1;PKD2L2;ITPR2;RYR2;TRPM2
prerank,chloride channel activity (GO:0005254),-0.3023238281221175,-1.1132032212979928,0.2762836185819071,0.5994970480702804,1.0,13/59,16.14%,SLC26A7;CLIC4;ANO1;TTYH2;CLIC1;GABRA3;GLRB;CLCC1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,double-stranded RNA binding (GO:0003725),-0.28721364867185856,-1.1119867939570907,0.2611764705882353,0.5987220705722904,1.0,22/70,23.33%,MBNL1;RFTN1;LRRFIP1;AGO1;ADARB1;ACTN1;DHX33;TFRC;SIDT2;AGO2;DROSHA;IFIH1;FMR1;FXR1;AGO4;MRPL44;ZBP1;MSN;EIF4H;PRKRIP1;ZFR;TARBP2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.28881856386637517,-1.109928419979809,0.2572944297082228,0.5998795122464594,1.0,14/71,12.01%,PTPRM;PTPRB;PTPRG;PTPN12;PTP4A2;PTPRJ;PALD1;PTPRK;UBASH3B;PTPN1;DUSP3;PTP4A3;PTPRZ1;DUSP23
prerank,ATP binding (GO:0005524),0.2600438291137247,1.105045403721997,0.24076809453471196,0.818205652179974,1.0,37/266,12.43%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;OAS2;WNK3;BMPR1A;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;PRKCI;KSR1;MSH6;ABCD1;OAS3;TGFBR1;MYO18A;PEX1;MTHFS;DARS2;RTEL1;SYN3;PYGL
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.23899702323879965,-1.1040168854265888,0.16938110749185667,0.6103786881828493,1.0,92/269,24.80%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;EGFR;PRR5L;NFKBIA;MID1;RPL5;TNFRSF1B;UBC;MFHAS1;FAF2;SPOPL;HERC2;JUN;DNAJA1;RALB;NKD2;GABARAPL2;SMAD5;RPS27A;TRIM37;UBB;AXIN2;XRCC5;UBE2J1;MAP1LC3B;ANKRA2;APC;UBXN1;USP7;SLC22A18;TXNIP;ARIH1;JAK1;YWHAZ;PER1;PRDX6;HGS;RPL23;BAG5;SQSTM1;ISG15;FZD4;UBE2L3;RRAGA;HDAC6;GABARAP;CD40;FBXW7;CCT2;HM13;UBE2J2;PRKAR2B;AUP1;PA2G4;BAG1;PRKACA;UBE2A;RTN4;SLF2;PCBP2;UBE2G1;RPA2;UCHL1;RIPK1;ARRB2;TRIB2;TRAF4;DIO2;FAF1;DTX3L;SKI;GLMN;RNF40;FHIT;SMAD6;BCL10;TRIB3;ATXN3;UQCRC1;TSG101;TMBIM6;CUL3;MUL1;CXCR4;SUMO3;SUMO2;CASP8
prerank,endopeptidase regulator activity (GO:0061135),0.3515353158778375,1.1021977868299933,0.32304900181488205,0.8205787242369644,1.0,8/40,13.27%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2;APH1A;ABCA2
prerank,potassium channel regulator activity (GO:0015459),0.3378209296470991,1.101646516317816,0.31569965870307165,0.816533446359236,1.0,10/49,14.30%,KCNIP3;LRRC38;SLC5A3;WNK3;DLG1;WNK4;DPP10;KCNIP4;ENSA;KCNS3
prerank,neuropeptide receptor activity (GO:0008188),0.3698330539700856,1.0983211079475161,0.3087971274685817,0.8206076234626074,1.0,5/29,13.54%,GPR143;NMUR1;GPR37;GRPR;OPRM1
prerank,histone methyltransferase activity (GO:0042054),0.3624181427475862,1.0978921386923106,0.3180147058823529,0.8163112668066193,1.0,9/32,15.21%,KMT5A;DOT1L;PRMT2;N6AMT1;SETD7;SMYD3;SMYD2;MEN1;NTMT1
prerank,zinc ion binding (GO:0008270),-0.2361970826447704,-1.0956212682259094,0.17664670658682635,0.6267009924333306,1.0,66/293,15.19%,LIMS1;MSRB3;SHANK3;MYRIP;ECE1;ZEB1;CBLB;TNFSF10;CTCF;PLSCR1;ENPEP;KLF7;KAT6A;ZDHHC20;GCH1;ADH5;ARHGEF2;CRIP1;RNF125;TNKS;SEC24D;S100A13;MSRB2;ZNF3;CRIP2;HHIP;PDE2A;PAPPA;ARIH2;GRIN2B;HPF1;ZFPM2;SEC23A;SOD1;PTPN1;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;ADH1A;ARIH1;KLF4;RABIF;RPS29;SIRT5;TES;RPS27;PTGR2;BLM;ACE2;SLC30A5;LNPEP;ENPP1;SEC24B;LANCL1;CLIP1;SMPDL3A;IFIH1;MT3;CA2;ADAM33;NQO2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.23990835390169105,-1.0943174439006966,0.18731117824773413,0.6259213237561849,1.0,74/248,21.10%,RHOJ;DNM3;RHOBTB1;RHOA;ATP2B1;RAB14;RAP1A;MYH9;ATL3;EEF1A1;RAB6A;RAB31;GTPBP10;RALB;GNA11;GBP4;RAP2A;GCH1;GBP5;MYL6;GNB1;ARHGDIB;EEF2;ABCA3;RASL12;ABCD2;NKIRAS1;BMS1;CHD1L;GFM1;MYO19;RAB22A;DNAJC27;GNG5;DYNC1I1;GNB2;RAB3A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;SMCHD1;RERG;SAR1A;RAB11B;GNA12;RAB5C;RAB1B;GFM2;RAP1GAP;KIF1C;RAP2B;CFTR;GNL1;RUVBL1;MRAS;SRPRA;KIF20B;RHOBTB3;RAB11A;GNA14;ARL8B;ABCG4;CDC42;GPR88;RRAGD;AGAP2;RAB27B;RHOB;MTG1;RAC3;RAB35
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.304630506394204,-1.0910664783638993,0.32421052631578945,0.6303995124235177,1.0,13/53,14.08%,SLC47A1;SLC1A5;SLC7A5;SFXN1;SLC1A3;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,ubiquitin protein ligase activity (GO:0061630),0.2592015952609727,1.0900258924373012,0.2747747747747748,0.8344499394536704,1.0,58/228,21.20%,RNF220;RNF152;RNF43;SH3RF2;ASB2;PDZRN3;DTX1;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;TRIM71;SHPRH;RNF14;UBE4B;TRIM35;DTX2;PELI3;DTX3;RNF135;BRAP;TOPORS;FBXO6;RNF10;RNF6;PRPF19;RNF121;HLTF;RNFT1;RLIM;RING1;FBXO17;RNF138;RNF5;RNF7;RNF130;TRIM3;MDM2;RBBP6;ANKIB1;RNF139;RNF13;FBXL22;TRIM63;RNF26;RNF180;TRIM2;TRIM13;BFAR;TRIM41;NFX1;MYCBP2;UBOX5;HECW1;TRIM9;TRIM32
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.47349437385754223,1.0892593839272617,0.3705263157894737,0.8311463846153987,1.0,5/10,24.97%,NSD1;SMYD2;NSD3;SETD2;SETD5
prerank,ephrin receptor binding (GO:0046875),-0.3804475703068361,-1.0879352367471355,0.37393162393162394,0.6341869594745067,1.0,6/21,8.94%,ANKS1A;CHN1;LYN;EFNA5;SRC;PTPN1
prerank,metal ion binding (GO:0046872),-0.22299634598054852,-1.0857423591569832,0.19262295081967212,0.63577221580907,1.0,120/477,21.26%,CDH11;SNRK;SPARC;LTBP4;SPOCK2;RAPGEF2;PLA2G4A;ESYT2;CSGALNACT1;SLIT2;STIM2;MARK1;GSN;MAP3K5;RASGRP3;THBS1;STK38L;STK3;MICU3;CDH13;IQGAP1;CDH1;PLSCR1;IRAK3;EML1;PLSCR4;FBN1;ASPN;RAP2A;MAP3K20;GSS;TPD52;MCTP2;S100A13;ERN1;TPM4;HSPE1;PDE2A;CDC42BPA;ANXA1;SRR;TPT1;CALM3;PPP3CA;NCS1;TGM2;SYT4;PAPOLA;ADCY2;HMGCLL1;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;ESYT3;HPRT1;APOE;S100A6;NOTCH4;S100A11;GCLC;RP2;SNN;DYSF;HACL1;CRACR2A;S100A16;POSTN;FKBP9;COMP;RET;RPE;STK38;ARSA;ANXA7;MICU2;ITPR3;CALML4;ENPP1;LRP1;CDH2;ACVR1C;AGRN;MT3;S100A10;CEMIP2;MCTP1;AOC3;MAST2;DSG2;TOP2A;TDG;LATS1;GRIN1;PDXK;NUDT16;NUDT12;STK26;MAPK12;DSPP;MT2A;ASAH2;RASGRP2;CABYR;ACER3;DUT;ADGRL3;CDH23;MAP2K7;CALU;MAP3K6;DYRK2;SLIT1;SLIT3;MTPAP;CDH24
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.41395891401046914,1.0839077023820425,0.3593155893536122,0.8422294295426314,1.0,2/18,9.08%,HSD17B2;DHRS11
prerank,protease binding (GO:0002020),-0.2704575511087976,-1.0808278318985747,0.28337874659400547,0.6437161424206681,1.0,18/99,12.61%,VWF;SLC2A13;FAP;F3;FN1;UBC;CARD16;ITGB1;CRADD;CST3;CCBE1;SERPINE1;SPATA2;PSAP;COL1A1;SERPINB9;COMP;ECM1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.43014803380897004,1.0782093192460394,0.34509803921568627,0.8537009070405014,1.0,3/14,8.02%,KCND3;KCNJ5;KCNH2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33054554510554496,-1.0771365847399603,0.33856502242152464,0.6487848539395827,1.0,10/33,16.46%,DCUN1D3;RNF144A;RNF144B;RNF125;RPS3;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,semaphorin receptor activity (GO:0017154),-0.4520185198424687,-1.0761143748456832,0.368,0.6475381094847276,1.0,2/11,0.78%,NRP1;NRP2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3429164514190746,-1.0760940347671473,0.33112582781456956,0.6438784411358487,1.0,9/27,16.46%,DCUN1D3;RNF144A;RNF144B;RNF125;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,MAP kinase kinase activity (GO:0004708),0.43340044062203376,1.0756709205320525,0.38132295719844356,0.8555197321773158,1.0,4/15,10.91%,MAP2K6;LRRK2;MAPK10;MAPK14
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.42215537318736907,-1.0749797733298154,0.3894523326572008,0.6429502148925822,1.0,4/13,10.34%,THUMPD2;TRMT10A;FTSJ1;TRMT10B
prerank,cytokine receptor binding (GO:0005126),-0.2825071274854472,-1.0747569840917461,0.2966751918158568,0.639901914356427,1.0,13/83,10.02%,KITLG;IL6ST;OSMR;LIFR;TGFB2;VEGFC;SOCS2;SPRED2;CXCL12;IL6R;IL34;IL1RAP;JAK1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3453720832547017,1.0746083951690484,0.3239171374764595,0.8531588774514358,1.0,8/38,14.45%,TFPI;SERPINA10;FURIN;SERPIND1;HRG;SPINT2;SERPINA9;SERPINE3
prerank,voltage-gated ion channel activity (GO:0005244),0.4342780550965871,1.07358761379856,0.38671875,0.8505105287249465,1.0,6/14,24.41%,KCNA3;KCND2;VDAC1;VDAC2;VDAC3;HCN1
prerank,adenyl ribonucleotide binding (GO:0032559),0.24981981468215742,1.0691923282879066,0.31008902077151335,0.8589282411403758,1.0,38/291,10.79%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;PRKAG3;OAS2;WNK3;BMPR1A;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;SLC19A1;MYO3A;PRKCI;KSR1;MSH6;ABCD1;OAS3;ACSS2;MPPED2;TGFBR1;MYO18A;PEX1;MTHFS
prerank,cytokine receptor activity (GO:0004896),-0.27550620658368924,-1.0686797018098353,0.32273838630806845,0.6509377826698199,1.0,16/83,11.84%,GHR;IL6ST;IL1R1;OSMR;LIFR;F3;CD44;IL17RD;IL6R;IL20RB;IL1RAP;CNTFR;IL4R;IL1RL2;CD74;FZD4
prerank,pentosyltransferase activity (GO:0016763),0.3482444291667486,1.0685478607269305,0.3622641509433962,0.8553784781146854,1.0,16/36,24.24%,LARGE1;TNKS2;LACC1;PARP14;PARP4;UPP2;PARP16;QTRT2;QTRT1;SIRT1;UMPS;ART4;PARP10;QPRT;PNP;TIPARP
prerank,receptor ligand activity (GO:0048018),0.25292036830949666,1.0675529644004023,0.29673590504451036,0.852830821265186,1.0,23/245,7.55%,BMP7;FGF1;BMP6;WNT4;IGF1;IL18;FGF4;WNT5B;METRNL;WNT7A;IL17D;TAFA3;CHGB;FGF9;BMP3;NRTN;TNFSF13;BMP8A;NTS;COLEC10;WNT6;NRG1;INHA
prerank,bHLH transcription factor binding (GO:0043425),0.39611324570687534,1.064730934431587,0.3915547024952015,0.8559028417842602,1.0,7/19,17.54%,SMAD3;FHL2;MAP3K10;USF1;BHLHE41;SIRT1;KDM1A
prerank,poly-pyrimidine tract binding (GO:0008187),0.37324671851355334,1.0639035293620016,0.34911242603550297,0.8529059448383188,1.0,5/23,8.08%,RBM11;PABPC4L;HNRNPU;PATL1;PTBP1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4578997150603498,1.0634908691804112,0.39436619718309857,0.8487586661263314,1.0,4/11,13.74%,PRMT2;FBXO11;PRMT9;PRMT3
prerank,PDZ domain binding (GO:0030165),0.304715428658713,1.063314714815664,0.3339222614840989,0.8439301884929656,1.0,13/61,11.42%,TGFBR3;ARHGAP29;CXXC4;GRID2;FZD8;FZD3;LLGL2;NSF;FZD7;DLG4;PDZK1;PLEKHA2;SYNJ2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.45462123398142856,1.0626098903926486,0.39227642276422764,0.8406196316540563,1.0,2/10,15.15%,CDKN2A;HEXIM2
prerank,transcription corepressor binding (GO:0001222),0.3649487280196346,1.062590410547825,0.3694029850746269,0.835472044839439,1.0,8/27,17.96%,RORA;USP11;PHF1;LCOR;CTBP2;PER2;MTF2;HDGF
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.43679688746959966,-1.0622775095824717,0.3717171717171717,0.6588773818090798,1.0,4/11,15.88%,BAG5;PFN1;GRPEL1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),-0.43679688746959966,-1.0622775095824717,0.3717171717171717,0.6588773818090798,1.0,4/11,15.88%,BAG5;PFN1;GRPEL1;BAG1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.25151038973058715,1.059640427804796,0.3102409638554217,0.8388180339525286,1.0,57/232,21.20%,RNF220;RNF152;RNF43;SH3RF2;ASB2;PDZRN3;DTX1;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;TRIM71;SHPRH;RNF14;TRIM35;DTX2;PELI3;DTX3;RNF135;BRAP;TOPORS;FBXO6;RNF10;RNF6;PRPF19;RNF121;HLTF;RNFT1;RLIM;RING1;PIAS4;FBXO17;RNF138;RNF5;RNF7;RNF130;TRIM3;MDM2;RBBP6;ANKIB1;RNF139;RNF13;FBXL22;TRIM63;RNF26;RNF180;TRIM2;TRIM13;BFAR;TRIM41;NFX1;MYCBP2;HECW1;TRIM9;TRIM32
prerank,magnesium ion binding (GO:0000287),-0.24884185290144012,-1.0589727591004996,0.3055555555555556,0.6630222157840503,1.0,35/135,21.15%,SNRK;MARK1;MAP3K5;STK38L;STK3;PLSCR1;IRAK3;RAP2A;MAP3K20;GSS;ERN1;PDE2A;CDC42BPA;SRR;PAPOLA;ADCY2;HPRT1;GCLC;RP2;HACL1;STK38;MAST2;TOP2A;TDG;LATS1;PDXK;NUDT16;NUDT12;STK26;MAPK12;DUT;MAP2K7;MAP3K6;DYRK2;MTPAP
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.21395191522615115,-1.058499163803098,0.22709163346613545,0.660482091670102,1.0,131/597,20.49%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;BNC2;RARB;TBX15;ETS1;TCF12;MEOX2;PPARD;FLI1;KAT7;TBX3;RUNX2;FOXO3;CTCF;RUNX1;STAT3;NFATC1;PRDM16;TBX18;SIX1;GLI3;JUN;ESR1;TBX1;NFIX;DHX33;TFEB;SOX17;BHLHE40;PRRX2;CREB3L1;SMAD5;VSX1;IRF9;NFYA;PSPC1;LHX6;HES1;ETV1;NR3C2;JDP2;XRCC5;SP3;ETV5;AR;ELF4;TFCP2L1;KLF11;RFX7;TGIF1;PRDM5;MBNL2;NFAT5;FOXQ1;BACH2;HEY2;GATA2;ELK1;HMBOX1;AHR;NR2C1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;CPSF4;PER1;CEBPD;SOX7;NFATC2;SREBF2;TEAD1;HHEX;SOX18;RARG;TBX2;ORC1;MAFF;SOX12;HSF5;SUV39H1;KLF2;MTERF3;TFCP2;NR4A2;ZW10;ARID5A;SP2;ATF6B;FOXO4;ATF4;ZFP1;ZBTB33;SIX4;NFKB2;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;FOXN2;ORC2;JUNB;ZBTB37;NR2F1;HIVEP1;CDC45;FOXE1;PRDM1;IRF5;ORC5;SOX8;ZNF177;PAX3;SPI1;HOXA4;POLA1;FOXL2;NFATC3;XPA;HMGB1;LMX1B;ATF3
prerank,nuclear export signal receptor activity (GO:0005049),-0.44632603726128595,-1.0567854521347324,0.37474541751527496,0.6611383443243585,1.0,7/11,36.04%,XPO5;XPO6;NUP214;XPO7;NUP42;RAN;XPO1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3329508168216414,-1.0536500633398505,0.38826185101580135,0.6652473871008553,1.0,5/31,8.97%,SLC12A7;SLC12A2;ABCC9;SLC12A6;KCNK5
prerank,transforming growth factor beta receptor binding (GO:0005160),0.394907106738838,1.0521667314892325,0.396584440227704,0.8560302309826936,1.0,2/18,0.92%,TGFBR3;SMAD3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.396185304024702,1.0491577463656865,0.38276553106212424,0.8600596539434254,1.0,3/17,7.80%,DPYD;DHCR24;PTGR1
prerank,NAD+ binding (GO:0070403),-0.4232518995513971,-1.0488174084932136,0.402321083172147,0.673608054410908,1.0,4/12,23.64%,SIRT5;HADH;GLUD1;SIRT6
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.34278384140043366,-1.0484450627190525,0.39880952380952384,0.6708803370236508,1.0,10/27,23.27%,POLR3F;POLR3H;POLR1F;POLR3B;PRIMPOL;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,alpha-tubulin binding (GO:0043014),0.3421055281939339,1.0474226581105874,0.39204545454545453,0.8598299916692982,1.0,13/31,28.25%,EML4;DNAL1;TBCE;CDK5R1;DLEC1;WASHC1;PACRG;SETD2;SPAST;ARL8A;FNTA;TBCEL;RACGAP1
prerank,titin binding (GO:0031432),0.42660586729099825,1.0463634378240447,0.40388349514563104,0.8580732039874946,1.0,2/13,3.50%,ACTN2;CAPN3
prerank,protein kinase inhibitor activity (GO:0004860),-0.31110345285866375,-1.0449917432711493,0.39323467230443976,0.6760368878715319,1.0,16/42,23.95%,YWHAB;SPRED2;CIT;RACK1;NCK1;SPRY2;CDKN1C;RPTOR;PARVA;GSKIP;TAOK3;SOCS3;IBTK;PRKRIP1;CDKN1B;SOCS1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4354876629568832,-1.0447905758295255,0.4349593495934959,0.6729100692532853,1.0,3/10,6.88%,FAP;NAALAD2;PRCP
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.34372168121659114,-1.0373388856423067,0.4112903225806452,0.6874682090226034,1.0,10/27,23.27%,POLR3F;TENT2;POLR3H;POLR1F;POLR3B;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,phosphatidylglycerol binding (GO:1901611),-0.4008008052399584,-1.0361811159357037,0.4311023622047244,0.6867097564630577,1.0,2/13,4.66%,PITPNC1;PLTP
prerank,ubiquitin-protein transferase activity (GO:0004842),0.23773822216862847,1.035531044496135,0.3606789250353607,0.8859118350175978,1.0,84/346,21.25%,RNF220;RNF152;RNF43;UBE2E2;DDB2;SH3RF2;ASB2;PDZRN3;DTX1;HECTD3;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;DZIP3;MAEA;TRIM71;KLHL13;SHPRH;RNF14;FBXO11;TRIM35;DTX2;PELI3;DTX3;RNF135;TRAF7;BRAP;TOPORS;FBXO6;RNF10;RNF20;RNF6;PRPF19;RNF121;TAF1;HLTF;RNFT1;UBE2W;OBI1;FBXO9;RLIM;PML;RING1;RNF31;FBXO17;RNF138;RNF5;RNF7;UBE2R2;RBCK1;RNF130;RNF213;KLHL20;TRIM3;MDM2;RBBP6;UBE2S;ANKIB1;RNF139;RNF13;FBXL22;KCTD13;TRIM63;RNF26;RNF180;FBXO22;TRIM2;TRIM13;BFAR;FBXL5;KLHL42;TRIM41;NFX1;RNF146;MYCBP2;RMND5A;KLHL21;HECW1;TRIM9;TRIM32;RNF103-CHMP3
prerank,potassium:proton antiporter activity (GO:0015386),-0.43352134722245184,-1.0354680378012062,0.4146341463414634,0.684998585481553,1.0,1/10,0.96%,SLC9A2
prerank,microtubule plus-end binding (GO:0051010),-0.3584078034091812,-1.0347625676954757,0.4008438818565401,0.6831890820061951,1.0,12/20,27.22%,DST;CLIP4;APC;CLIP2;CLIP1;PAFAH1B1;MAPRE2;DCTN1;KNSTRN;STIM1;MAPRE3;FBXW11
prerank,protein kinase activator activity (GO:0030295),0.300376870295432,1.0324847593074142,0.38501742160278746,0.8899439076365623,1.0,6/60,4.06%,PRKAG2;RICTOR;GPRC5A;FAM20A;GPRC5C;GPRC5B
prerank,ribosomal large subunit binding (GO:0043023),0.4447384776898948,1.0316023719803493,0.41700404858299595,0.8873150618713544,1.0,3/11,7.87%,CPEB2;CPSF6;NEMF
prerank,snoRNA binding (GO:0030515),-0.33111316399964186,-1.030493939122837,0.41649484536082476,0.6899914452085629,1.0,19/30,33.66%,XRCC5;BMS1;NUDT16;NUFIP1;NOP58;NHP2;NUDT16L1;DKC1;IMP4;NOP56;NUDT1;NOP10;DDX21;DHX37;NUDT7;TSR1;ISG20;NOP14;HEATR1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.33787756605879543,1.0286082835613224,0.41541353383458646,0.8911635620079099,1.0,6/32,11.87%,KDM7A;BBOX1;TET1;PHF8;KDM2A;KDM4A
prerank,telomeric DNA binding (GO:0042162),-0.32395487187870337,-1.027970946035907,0.41451990632318503,0.692334310791793,1.0,14/32,26.19%,RPA1;XRCC5;HMBOX1;TERF2IP;BLM;ZBTB48;NCL;PURA;TEN1;CTC1;TINF2;UPF2;HNRNPD;TERF2
prerank,DNA polymerase activity (GO:0034061),0.3624256545153061,1.0263450682518862,0.40262172284644193,0.8926266252165683,1.0,8/22,19.85%,POLM;REV1;TERT;POLI;POLE;POLG;POLN;POLE4
prerank,lipoprotein particle receptor binding (GO:0070325),-0.32894892655483954,-1.0258403901641624,0.42184154175588867,0.6938369599487837,1.0,8/27,16.64%,DNAJA1;ANKRA2;APOE;LRP1;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.38471987896478943,-1.024297746892256,0.422,0.6941605489854025,1.0,4/15,10.77%,PLA2G4A;SH3PXD2B;PLEKHA5;JPH2
prerank,acetylcholine receptor activity (GO:0015464),0.37328473994292877,1.0236559378310595,0.4155597722960152,0.8959858376169476,1.0,3/22,10.95%,CHRM2;CHRNB2;CHRM1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.35009611199390567,1.023049454489582,0.4120982986767486,0.8925774550754259,1.0,6/28,10.91%,PRKAA2;TNK2;MAP2K6;LRRK2;MAPK10;MAPK14
prerank,metalloaminopeptidase activity (GO:0070006),-0.37263437802012656,-1.0220582262891746,0.4271255060728745,0.6962561764282198,1.0,5/16,25.28%,ENPEP;LNPEP;RNPEPL1;ERAP1;XPNPEP1
prerank,NAD binding (GO:0051287),0.35279927703352576,1.0212425373988936,0.4277673545966229,0.892632802584141,1.0,4/26,10.60%,ADH4;SORD;ALDH1A1;ALDH2
prerank,beta-tubulin binding (GO:0048487),0.3395253389293878,1.0212091612198495,0.40250447227191416,0.8876223915560462,1.0,17/31,28.25%,GJB6;EML4;IFT74;PDCD5;HTT;SMC3;CCT5;CDK5R1;DLEC1;PACRG;LRPPRC;SPAST;ARL8A;BCAS3;MAP1S;EMD;RACGAP1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.364167358989232,-1.0206786870391313,0.4268292682926829,0.6959806127354076,1.0,12/19,38.63%,HELQ;WRNIP1;RFC4;MCM5;MCM6;RFC2;DSCC1;HELB;CHTF18;PIF1;DHX9;POLQ
prerank,active ion transmembrane transporter activity (GO:0022853),0.32662023225037273,1.0173627582586564,0.41682242990654206,0.8938589273956072,1.0,8/37,12.68%,SLC22A6;SLC22A8;ATP13A3;COX7A1;COX7A2L;UQCRH;CYB5A;COX10
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.41225761603651145,-1.0124386090573478,0.44017094017094016,0.7134914898638244,1.0,5/11,26.19%,RPA1;TERF2IP;RPA2;CTC1;TERF2
prerank,glutathione transferase activity (GO:0004364),0.35949701320544675,1.0124196618616752,0.42115384615384616,0.9034082526736098,1.0,7/23,18.30%,GSTM2;PTGES;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3389916980097959,1.0104374509072396,0.43283582089552236,0.904245347950351,1.0,8/32,19.38%,KCNA3;KCNC3;KCNH2;KCNC2;KCNS3;KCNA4;KCNQ3;KCNQ5
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3121943057921238,1.0102595166855224,0.4265232974910394,0.89981200024489,1.0,11/44,13.72%,KMT5A;DOT1L;KMT2A;N6AMT1;NSD1;SETD4;KMT5C;SETD7;SMYD3;SMYD2;MEN1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3778567885619353,-1.0102565838539015,0.44047619047619047,0.7151194268014143,1.0,2/14,1.84%,SLC26A7;SLC26A2
prerank,ATPase activator activity (GO:0001671),0.37177247964119287,1.0087174427508936,0.45972495088408644,0.899336711034522,1.0,4/20,9.18%,ATP1B3;ATP1B2;DNAJB4;DNAJC10
prerank,phosphatase binding (GO:0019902),-0.2491727710928123,-1.0066413566670334,0.43041237113402064,0.7207306292603812,1.0,35/105,21.62%,MAP3K5;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;CRY1;ANAPC5;RACK1;MET;PXN;MAPK1;SHOC2;CEACAM1;FLT4;EIF2AK3;JAK1;GTF2F1;TERF2IP;NFATC2;VRK3;SYTL2;CSRNP2;MAST2;PPP6R1;ELL;CARHSP1;RPA2;MAPK3;TRPC4AP;JAK3;MAP2K7;JUP;SH3YL1
prerank,tau-protein kinase activity (GO:0050321),0.3604291027083234,1.0063775561360093,0.43478260869565216,0.9014053669364261,1.0,3/20,4.82%,ROCK2;PHKG2;TTBK2
prerank,DNA polymerase binding (GO:0070182),0.3782518016935449,1.0052693369312073,0.44223107569721115,0.8996234520212011,1.0,6/18,19.36%,FANCD2;FANCI;RTEL1;SMG6;HSP90AA1;LONP1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3768850862790813,-1.0047543320505896,0.4503311258278146,0.7217746504790337,1.0,1/15,0.90%,PLA2G4A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3870681180793936,-1.0045707656333758,0.453781512605042,0.718733468730286,1.0,6/15,17.11%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3
prerank,GTPase binding (GO:0051020),-0.22496291111297348,-1.0033741257910802,0.4143646408839779,0.7179831301751951,1.0,36/194,12.53%,SPTBN1;CAV1;RABGAP1L;FGD5;PLCE1;FGD6;SH3BP4;IQGAP1;ABCA1;RASIP1;UNC13B;ANKFY1;CDC42EP5;EXOC4;USP6NL;FLNA;ARHGEF2;STRN3;PAK2;EPS8;GNB1;ARHGDIB;RUSC2;YBX3;RAPGEF4;RAPGEF6;EVI5L;SOD1;PDE6D;ATG16L1;WHAMM;CDC42EP2;GNB2;FNBP1L;RANBP9;ARHGAP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4314865723543134,-1.0023521060047,0.4891518737672584,0.7136205745898444,1.0,6/10,41.11%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;DUSP16
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4314865723543134,-1.0023521060047,0.4891518737672584,0.7136205745898444,1.0,6/10,41.11%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;DUSP16
prerank,nuclear receptor coactivator activity (GO:0030374),-0.2810565282150005,-1.0023027345018016,0.4282511210762332,0.7103053585687993,1.0,19/52,23.82%,ACTN4;TACC1;ETS1;DCAF6;ACTN1;SLC30A9;FGF2;ELK1;SS18;TMF1;NCOA6;ENY2;MED14;ZMIZ2;ZMIZ1;MED13;NCOA3;CCDC62;MED24
prerank,methylated histone binding (GO:0035064),0.2894630563745316,1.000134206592213,0.4230769230769231,0.9095949686578424,1.0,11/62,11.87%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;TAF1;KDM4A
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.4104857861177856,-0.9994668757646287,0.46238938053097345,0.7138647341832475,1.0,6/12,21.15%,TENT2;PAPOLA;TENT4B;TENT5C;TENT5A;MTPAP
prerank,fibroblast growth factor binding (GO:0017134),-0.34845263383521746,-0.9976505761391379,0.46284501061571126,0.7147902295396198,1.0,6/21,17.34%,THBS1;GLG1;S100A13;FGFRL1;GPC1;FGFR3
prerank,RNA binding (GO:0003723),-0.19123883009531595,-0.9972372723566234,0.4863013698630137,0.7123615835370787,1.0,300/1321,19.29%,SPTBN1;MBNL1;SYNE1;SORBS2;ACTN4;AHNAK;DCN;RFTN1;TMSB4X;LRRFIP1;FNDC3B;FNDC3A;YWHAE;SPATS2L;RBPMS;RPS15;MYH9;RPL38;RPL18A;RPL41;MACF1;RBM3;STAT3;EEF1A1;RPS12;RPS20;ZMAT3;AGO1;DARS1;FAU;QKI;RPL32;RPL5;ADARB1;CAST;ZC3H7A;UBC;RPS10;DAP3;CTNNA1;CS;DHX32;RPL10;RPS23;RPS24;JUN;GTPBP10;EIF3E;RPL7;ALKBH1;RPL37A;ACTN1;KCTD12;SERBP1;FLNA;EIF3H;DHX33;GNL3;SMC1A;CCDC9B;CPNE3;TFRC;MAP3K20;DCP1B;CISD2;RPS17;DNAJC21;RPS16;MRPL20;CSNK1E;RPL39;RPS27A;FASTKD1;PABPC1;TRNAU1AP;PSPC1;RBM33;MAP4;EXOSC1;PRR3;FCF1;RACK1;RPL13;SNRNP200;HSPE1;XRCC5;EEF2;YBX3;PPIA;RPLP0;CDC40;RPL30;REXO4;RBM28;RPS5;TRIM56;SMNDC1;RPL35A;PSMA6;TPT1;RPS8;RPF1;SYF2;TRIM25;MRPL21;NOVA2;PUM2;SIDT2;SNRPD1;RPS7;RPL22;ALDOA;MYBBP1A;MBNL2;RPS3;RPS28;KTN1;G3BP1;FRG1;RPL29;SPEN;BMS1;SRP19;RPL7A;RPS26;LSM7;GFM1;THUMPD1;PTPN1;SURF6;RPL6;RPL18;RPS25;EIF4E;TENT4B;PELP1;AGO2;RPL36;TRMT10A;COL14A1;DDX54;RPL28;RBM42;GTF2F1;YWHAZ;FASN;RPL27;DROSHA;TRMT10B;LARP1B;RSRC2;CPSF4;ZCCHC24;LRRC59;TCF20;RTF1;RPL24;FBRSL1;WDR33;RPL23;RPL17;MRPL23;TES;DIDO1;YARS2;SECISBP2L;S100A16;MRPS31;HSPB1;IPO5;RPS9;RPS27;SNRPD2;YLPM1;NCBP2;NMD3;NCOA5;NGRN;TDRD7;RPL22L1;SYNCRIP;TNS1;PDIA4;RRP7A;DCAF13;RBM7;KIN;TPR;SAP18;R3HDM1;UBE2L3;RPL21;FUS;MRPL10;ELAC2;ERH;PFN1;ACAA2;RPL34;ANXA7;HNRNPAB;PEBP1;RPL10A;RBM6;LRP1;KMT2C;PPP1CC;RPL12;RBFOX2;POLR1G;TASOR;UBAP2L;PUM1;RPL35;RBMS3;CMSS1;CCDC124;RPL14;ZC3H4;CAVIN1;MRPL12;IFIH1;ALDH18A1;SRP14;DDX27;DDX23;EIF1B;ESF1;NCBP1;KPNA2;SRSF3;AQR;DHX38;TEP1;KIF1C;EIF4G3;RPL19;HELZ;DDX49;GLRX3;DHFR;FMR1;RPL37;RPS18;PA2G4;PPIE;RRP12;PDAP1;RPS13;RBM10;UNC50;RPS15A;TBRG4;RTN4;DDX25;RPP21;RPP38;RBM25;DNAJC2;RRBP1;PTCD3;FXR1;MRPS12;PCBP2;MRPL1;NUSAP1;ADAT1;N4BP1;TOP2A;HDAC2;DUS3L;MRPL43;SRPRA;DYNC1H1;PWP2;AGO4;MRPL45;NUDT16;HMGN2;BARD1;MANF;CSTF1;ZCCHC3;MCAT;PCBP1;ASS1;XPO5;MRPL44;RIDA;AIMP1;DSP;USP10;CKAP4;NTPCR;ZC3H12A;NUFIP1;UBTF;DIMT1;RBM46;CHCHD1
prerank,GABA receptor activity (GO:0016917),0.35975466426214514,0.9967268547247101,0.4722753346080306,0.9148985099455982,1.0,6/21,18.56%,GABRG1;GABBR1;GABBR2;GABRG3;GABRB2;GABRB3
prerank,thioesterase binding (GO:0031996),-0.40984128359293853,-0.9965322483955559,0.4656964656964657,0.7106814273497721,1.0,3/11,20.49%,TRAF5;CDC42;TRAF4
prerank,DNA binding (GO:0003677),0.2167170158478018,0.995157936906407,0.48740554156171284,0.9147070574168772,1.0,157/694,20.17%,DENND4A;RORA;EPAS1;HLF;NUPR1;SMAD3;DDB2;APLP2;SPHK1;MSX2;CXXC5;THRB;SCRT1;CHD4;ARID4A;NR6A1;PPARA;NFYB;ESRRA;SLTM;ERCC1;PMS2;SIM1;POLRMT;TET1;MEIS1;AIFM1;PCID2;PQBP1;PAX6;IKZF1;RBPJ;DNMT3A;AUNIP;ARID3A;HNRNPU;TFPT;HOXA7;PBX4;NFYC;ZKSCAN3;SUPV3L1;E2F1;CEBPA;MEIOB;SPRTN;NR2F2;CHD3;MSH4;KDM5B;NLRP3;PHF1;MBD4;MAFA;MSH6;PPARGC1A;HINFP;MAX;ZNF711;NR1H3;ZDHHC1;ZBTB22;ZIC2;SSBP2;TDP2;RXRA;CLOCK;CR2;PRDM2;PSIP1;SSBP1;PARP4;MRE11;TOPORS;CSRNP3;BCL2;WBP11;BCLAF3;E2F4;CSRNP1;STAT1;USF1;BATF;ZFPL1;FUBP1;MBD1;TAF1;ZBTB49;SOX9;PURB;MSH3;TERT;HDAC4;FOXC1;MEN1;ARNT;PLAGL2;RAD51D;RNF138;CENPC;POLR3C;POLE;AIFM2;TLR8;PRKDC;RPA3;RBM5;SAFB2;ERF;ABL1;HIC2;MCM7;POLR2D;HDGFL2;ILF2;POLG;GTF3C1;LHX4;TRNP1;MCMDC2;SAFB;CLSPN;CAMTA2;SOX6;RELA;MTF2;RAD52;SRRT;TCF7L2;TCF4;HDGF;SMC1B;NHEJ1;TSHZ3;ZBTB6;ARID5B;MLXIPL;MLX;FOXL1;TFAP4;POU6F1;MEF2A;SOX2;HMCES;LONP1;MEIS3;RFX2;COLEC11;DDIT3;POLR2A;SNAPC1;GTF3C4;POU2F2;ILF3;CGGBP1;DDX3X;SPTY2D1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40591909896730066,-0.994891338020692,0.47107438016528924,0.7113267171724029,1.0,3/11,13.26%,DAB2IP;ROR2;STK38
prerank,symporter activity (GO:0015293),0.4423252133930472,0.9947968553548077,0.46893787575150303,0.910819959425894,1.0,1/10,0.70%,SLC5A5
prerank,ephrin receptor activity (GO:0005003),0.3752198490307268,0.9944290277815564,0.46790890269151136,0.9021868964952252,1.0,5/17,15.96%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3752198490307268,0.9944290277815564,0.46790890269151136,0.9021868964952252,1.0,5/17,15.96%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,galactosyltransferase activity (GO:0008378),0.42385273399113965,0.9943765325802467,0.4744094488188976,0.8975389039688024,1.0,4/11,8.84%,B4GALT2;B4GALT1;B3GALT6;B4GALT3
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4024068800804529,-0.9923557082539729,0.48412698412698413,0.7144788697140132,1.0,4/12,17.44%,SLC6A6;SLC38A5;SLC36A4;SLC7A8
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.32313240567913404,0.9908513758510321,0.47920433996383366,0.9028996472710629,1.0,12/35,15.95%,TRMT9B;TARS2;NT5C3A;MRPL58;BCDIN3D;DUS1L;TRPT1;QRSL1;QTRT2;QTRT1;MTFMT;DTWD2
prerank,ion gated channel activity (GO:0022839),-0.3284629533587411,-0.9907682657138603,0.4608695652173913,0.714650360968552,1.0,5/24,16.00%,KCNT2;ANO1;TTYH2;ANO4;ANO2
prerank,methylation-dependent protein binding (GO:0140034),0.29339178117608533,0.9896549621265857,0.4597495527728086,0.9015249912279452,1.0,10/57,11.87%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;KDM4A
prerank,serine-type endopeptidase activity (GO:0004252),0.2765204368485943,0.9857768450233966,0.4784110535405872,0.9081369988421876,1.0,16/80,18.74%,PCSK4;FURIN;F10;PLAT;HTRA2;PLG;CORIN;CTRL;KLK8;CTSH;PRSS36;HGF;KLK1;PRSS53;DPP4;RHBDF1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.42525047651506964,0.983903815093659,0.4672131147540984,0.9086797295749466,1.0,3/10,15.51%,RENBP;GFUS;DSE
prerank,DNA-binding transcription factor binding (GO:0140297),0.23982555031537203,0.9831392583950535,0.5008,0.9063338258639942,1.0,36/189,14.03%,ZMYND8;SMAD3;MAGEA2;CXXC5;BEX1;FHL2;CHD4;PPARA;NFYB;POU1F1;GTF2I;IFI27;RBPJ;ATN1;KAT5;NLRP3;MIER3;HES6;MAP3K10;DMAP1;BBS5;LDB2;LDB1;BCL2;STAT1;USF1;TTC8;TAF1;ZBTB49;BHLHE41;PURB;PIAS4;GABPA;HDAC4;NOC2L;PSMC5
prerank,transcription cis-regulatory region binding (GO:0000976),-0.20580917401238624,-0.9783942665724494,0.5361216730038023,0.7408048908444377,1.0,60/406,12.36%,LEF1;FOXP1;MEF2C;ACTN4;PBX1;ELK3;TRPS1;BNC2;ETS1;PLAGL1;TCF12;FLI1;FOXO3;CTCF;RUNX1;STAT3;PRDM16;AGO1;TBX18;SIX1;ZNF25;DACH1;GLI3;JUN;ZBTB46;TFEB;SOX17;CREB3L1;VSX1;NFYA;PSPC1;LHX6;ZNF3;XRCC5;TWIST2;SP3;ETV5;AR;KLF11;ZNF436;FOXN3;PRDM5;RPS3;ELK1;AGO2;AHR;IRF2;KLF4;TAL1;MAFK;ETV6;RFXAP;PER1;SOX7;TWIST1;TEAD1;HHEX;SOX18;FOXF2;FOSL2
prerank,sequence-specific DNA binding (GO:0043565),0.2153440375668981,0.9780353946690846,0.5166002656042497,0.9157839882188951,1.0,70/590,11.18%,MAF;RORA;EPAS1;HLF;CREB5;SMAD3;OSR1;NR2E1;HMX2;MSX2;CXXC5;OVOL2;THRB;ZSCAN29;ZBTB38;CXXC4;SCRT1;MYBL2;FBXL19;NR6A1;ARNT2;PPARA;ZNF23;ESRRA;POU1F1;SLTM;UBP1;HOXB9;KMT2A;POLRMT;MAFG;TET1;PAX6;RBPJ;HNRNPU;ZBTB26;HOXA7;PBX4;DRGX;ZKSCAN3;E2F1;DPF1;HOXB6;BCL11B;NR2F2;TEF;KLF15;KDM5B;NLRP3;HES6;MAFA;PPARGC1A;KDM2A;MAX;ZNF711;E2F8;ZBTB22;HOXB4;RXRA;CLOCK;PRDM2;SMG5;CSRNP3;BCL2;E2F4;CSRNP1;USF1;BATF;MBD1;TAF1
prerank,chemokine binding (GO:0019956),0.3369162826754648,0.9768583018062724,0.47184466019417476,0.9145500823986666,1.0,3/30,6.78%,CCR9;ACKR2;PDPN
prerank,phosphatase activator activity (GO:0019211),-0.37752317290283083,-0.9755523867400138,0.48156182212581344,0.7441944870310692,1.0,6/14,20.73%,CALM3;PPP2R5C;GTF2F1;BMP2;B3GAT3;PPP2R5B
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.29026046426495644,-0.975292450811581,0.4827586206896552,0.74147042975908,1.0,16/40,23.06%,METTL2A;METTL2B;THUMPD2;NNMT;PCMTD2;PRMT7;ASMT;DNMT3B;PCMTD1;SUV39H1;ICMT;GAMT;MEPCE;LCMT1;DNMT1;HNMT
prerank,metalloendopeptidase activity (GO:0004222),-0.2553318084396516,-0.9745982050659804,0.5,0.7398083501423324,1.0,17/76,17.35%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;ADAMTS17;ADAMTS6;ADAM10;ADAMTS1;ADAM19;ADAMTS14;MMP11;ADAMTS20;ADAMTS2;ADAM33;PHEX;ADAMTS12;MMP2
prerank,nucleotidase activity (GO:0008252),-0.357346355809798,-0.9738304393475793,0.4887525562372188,0.738272543635158,1.0,5/15,22.12%,BPNT2;NT5C1A;NT5E;NT5C;ACP3
prerank,endodeoxyribonuclease activity (GO:0004520),0.36009851843500285,0.9732294830834859,0.4990825688073395,0.920110524558378,1.0,4/20,16.96%,ERCC1;MBD4;MRE11;EXOG
prerank,anion transmembrane transporter activity (GO:0008509),-0.39015779127148364,-0.9709276258717385,0.505091649694501,0.7418608474532883,1.0,3/12,4.90%,ABCG2;SLCO2B1;SLC39A8
prerank,voltage-gated chloride channel activity (GO:0005247),0.42633893769021397,0.9707920221150884,0.516597510373444,0.9225404642836453,1.0,4/10,13.33%,CLCN6;CLCN2;CLCN4;CLCN3
prerank,voltage-gated anion channel activity (GO:0008308),0.3831797648430051,0.9663388290033439,0.5182926829268293,0.9307211222379161,1.0,6/15,17.31%,CLCN6;CLCN2;CLCN4;CLCN3;VDAC1;VDAC2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3192680469563117,0.9643635018612061,0.4744525547445255,0.9317050809122486,1.0,5/29,9.70%,SLC13A3;SLC26A1;SLC25A11;SLC19A1;SLC25A12
prerank,proton transmembrane transporter activity (GO:0015078),0.30205129353121485,0.963906801279622,0.48148148148148145,0.9282004849604264,1.0,9/39,13.33%,COX7A1;COX7A2L;ATP6V1B2;UQCRH;CLCN4;CYB5A;MFSD3;COX10;CLCN3
prerank,calcium ion binding (GO:0005509),0.22327543064589137,0.9631988471814248,0.5552367288378766,0.9255279803809023,1.0,45/323,12.06%,SYT11;SYT12;DSC2;DSC3;ANXA6;MAN1C1;ADAMTS13;FBLN1;PON1;CPNE1;PLSCR2;ENPP3;ANXA5;CDH15;CDH3;CDH17;S100A4;CAPN3;SMOC2;SYT9;ITPR1;PLA2G4C;SYT1;CDH10;CALR3;CDH18;SYT13;CRNN;ADGRV1;SLC25A12;SLC25A23;SYT10;GJB2;ITPR2;AMY1C;AMY1B;AMY1A;RYR2;GALNT3;TRPM2;CANX;DMP1;CCDC47;KCNIP4;CPNE6
prerank,transition metal ion binding (GO:0046914),0.21837785435733928,0.9628691023705324,0.559322033898305,0.9219082299925841,1.0,59/397,12.63%,MOXD1;UPB1;ZMYND8;SMAD3;KDM7A;ADH7;ADH4;ADAMTS13;CXXC5;SORD;CXXC4;ENPP5;CHD4;FBXL19;ENPP3;ETHE1;PITRM1;PPM1M;BBOX1;GLRA1;LOXL3;KMT2A;ARG2;TET1;PHF8;LARGE1;B4GALT1;LACC1;GALT;CHD3;QPCT;KDM5B;PHF2;CSRP1;KDM2A;CPA2;TDP2;RXRA;TRAF7;PRDM2;MPPED2;NSD1;CUTC;HRG;DOHH;ZFPL1;MBD1;PLA2G15;GALNT3;KDM5C;EPRS1;ENDOU;RABGGTB;KDM4A;GYG1;GALNT2;RBAK;FDX1;PIAS4
prerank,small GTPase binding (GO:0031267),-0.22095873596276966,-0.9616168625195283,0.5618279569892473,0.7610171955894777,1.0,26/169,9.06%,CAV1;RABGAP1L;FGD5;PLCE1;FGD6;SH3BP4;IQGAP1;ABCA1;UNC13B;ANKFY1;CDC42EP5;EXOC4;USP6NL;FLNA;ARHGEF2;STRN3;PAK2;EPS8;ARHGDIB;RUSC2;YBX3;RAPGEF4;RAPGEF6;EVI5L;SOD1;PDE6D
prerank,peptidase activator activity (GO:0016504),-0.32782480205819897,-0.9597566191757833,0.49032258064516127,0.7619683448662518,1.0,7/22,21.47%,CAV1;CASP8AP2;PCOLCE;ADRM1;PSMD14;PSENEN;PSME1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2918414882522253,0.9568395184573044,0.5284090909090909,0.9341881242116923,1.0,11/49,13.57%,OPTN;DZIP3;TNIP3;IKBKG;ABRAXAS1;ZFAND6;SPRTN;TNIP2;IKBKE;BAG6;OTUD7A
prerank,solute:proton symporter activity (GO:0015295),-0.35493946391699505,-0.9559474457325116,0.5317919075144508,0.7676523363746428,1.0,3/16,13.11%,SLC2A13;SLC39A8;SLC2A9
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.2155453280300032,-0.9536244316494182,0.5895316804407713,0.7697601317677348,1.0,29/181,11.88%,ACTB;ACTN4;TACC1;MDFIC;PPARD;TBX3;NFKBIA;LMO2;STAT3;NFATC1;MIER1;CRY1;JUN;DNAJA1;BHLHE40;HES1;PSMA6;AR;NRIP1;SPEN;HEY2;ZFPM2;ARID1A;ELK1;KLF4;TAL1;MYOCD;HSPB1;MTA1
prerank,manganese ion binding (GO:0030145),0.2904753213112726,0.953539943582657,0.5088028169014085,0.9387030792034406,1.0,12/48,15.25%,PPM1M;ARG2;LARGE1;B4GALT1;TDP2;MPPED2;GALNT3;ENDOU;GYG1;GALNT2;GALNT1;ABL1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4047125767983846,0.9533087108582867,0.5178571428571429,0.9347267036954061,1.0,6/11,25.96%,UBE4B;PRPF19;UBOX5;AMFR;UBR5;RBX1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.3798115477836831,-0.9518434047861775,0.50390625,0.7706777635242952,1.0,3/12,13.71%,PIK3R1;SH2B2;IRS1
prerank,adrenergic receptor binding (GO:0031690),0.3636592242833646,0.9501249364459259,0.5347091932457786,0.9388899099908388,1.0,5/16,9.85%,MAGI2;ADRA2A;ARRDC3;DLG4;C1QBP
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.35377150801979435,-0.9474275218637915,0.5338983050847458,0.7778087397998611,1.0,6/16,22.81%,CD38;RPS3;OARD1;TDG;NEIL3;SMUG1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.38340689608735423,-0.9471154257188636,0.5132075471698113,0.7751101941835223,1.0,5/12,13.71%,INSR;PIK3R1;SOCS2;IGF2;IRS1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.20319376921274498,0.9449749521502596,0.667905824039653,0.949018176517739,1.0,91/831,10.09%,AEBP1;ZKSCAN2;MAF;RORA;EPAS1;HLF;CREB5;SMAD3;KCNIP3;NPAS3;OSR1;NR2E1;HMX2;MSX2;SOX5;OVOL2;THRB;ZSCAN29;ZBTB38;SCRT1;MYBL2;CREBRF;NR6A1;ARNT2;PBX2;ZNF431;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;UBP1;HOXB9;TFDP2;SIM1;ENO1;HOXB3;MAFG;MEIS1;PEG3;CCAR1;RUVBL2;MLXIP;PAX6;IKZF1;RBPJ;IKZF2;MZF1;DNMT3A;HNRNPU;ZFHX2;ZBTB26;HOXA7;PBX4;RFX8;NFYC;DRGX;ZKSCAN3;E2F1;CEBPA;HOXB6;BCL11B;NR2F2;TEF;KLF15;ZSCAN22;HOXA3;ZNF569;KDM6B;ZNF467;HES6;MAFA;HINFP;HIF3A;MAX;NR1H3;E2F8;ZBTB22;HDX;ZIC2;HOXB4;RXRA;CLOCK;ZFP90;PRDM2;NSD1;SALL3;FOXP4
prerank,metallopeptidase activity (GO:0008237),-0.2323660139756034,-0.944582028010782,0.6063569682151589,0.7779930803825056,1.0,26/113,18.06%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;EIF3H;ADAMTS17;LAP3;ADAMTS6;ADAM10;PAPPA;ADAMTS1;ADAM19;ADAMTS14;MMP11;METAP1D;ADAMTS20;ACE2;LNPEP;ADAM15;ADAMTS2;ADAM33;PHEX;ADAMTS12;MMP2;NUDT16;PSMD14
prerank,phospholipase A2 activity (GO:0004623),0.31954165973199916,0.942729931890426,0.5348837209302325,0.951006969678504,1.0,6/26,16.09%,PLAAT5;PLA2G4C;PNPLA8;PLA2G15;ABHD3;PLAAT3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.38436213756543985,0.94235277977354,0.5242914979757085,0.9474947783039008,1.0,4/13,17.39%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.30796906129491586,0.9414906553097442,0.5245009074410163,0.9454536556594293,1.0,7/33,13.15%,CTR9;CCAR2;HNRNPU;LLPH;CDC73;RPRD2;SMYD2
prerank,endopeptidase inhibitor activity (GO:0004866),0.26250417891933553,0.9400695539459424,0.5278246205733558,0.9449839765653457,1.0,8/82,5.67%,TFPI;ITIH2;COL4A3;TIMP3;RENBP;SERPINA10;FURIN;SERPIND1
prerank,serine-type peptidase activity (GO:0008236),0.2526186443667472,0.9391235539957109,0.5885245901639344,0.9428671023601601,1.0,19/96,18.74%,PCSK4;FURIN;PREP;F10;PLAT;HTRA2;PLG;CORIN;CTRL;KLK8;CTSH;ENDOU;PRSS36;HGF;KLK1;ST14;PRSS53;DPP4;RHBDF1
prerank,GTPase inhibitor activity (GO:0005095),0.3803346251076783,0.9380890411135823,0.5254582484725051,0.9412225428442228,1.0,3/13,6.94%,CPEB2;TNK2;ARL2
prerank,solute:sodium symporter activity (GO:0015370),0.3217720535987541,0.9354821218205238,0.5590994371482176,0.9440010219308105,1.0,4/27,9.13%,SLC5A3;SLC5A10;SLC4A9;SLC34A3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3338708431955934,0.9349298353305958,0.5344506517690876,0.9413050621638628,1.0,7/21,19.85%,POLM;REV1;POLI;POLE;POLG;POLN;POLE4
prerank,MHC class II protein complex binding (GO:0023026),-0.3923619509952956,-0.9342155252512256,0.5590062111801242,0.7987527375407991,1.0,2/11,11.83%,YWHAE;CD74
prerank,cation transmembrane transporter activity (GO:0008324),0.28867385518772415,0.9335697735090019,0.581573896353167,0.940774246655639,1.0,10/48,15.68%,SLC41A1;SLC38A3;SLC6A9;SLC38A1;SFXN2;SLC38A9;SLC66A1;SLC22A2;SLC38A7;MMGT1
prerank,protein phosphatase regulator activity (GO:0019888),0.2806967708870121,0.933048882332666,0.5670840787119857,0.9378594449663563,1.0,6/53,8.96%,PPP2R2B;PPP1R16A;DMPK;PPP4R4;PHACTR4;EIF2AK2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.37031935704659386,0.9327926720069079,0.5284552845528455,0.9342763782266325,1.0,4/14,8.72%,ACO1;CIAO3;NDUFS1;EXO5
prerank,hormone activity (GO:0005179),0.2754670206301332,0.9322982708047026,0.5693693693693693,0.9313771849734046,1.0,6/54,11.22%,IGF1;METRNL;CHGB;INHA;VIP;GRP
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4053106802189854,0.9321120200096747,0.53276955602537,0.9276501912407089,1.0,3/10,14.21%,OTUD4;STAMBP;DESI2
prerank,histone deacetylase activity (GO:0004407),-0.3401224367497967,-0.9299940248196744,0.5714285714285714,0.805531850638618,1.0,7/19,23.64%,MIER1;HDAC9;HDAC6;HDAC2;MIER2;SIRT7;SIRT6
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.315667246391105,-0.9282639258984314,0.55,0.8061215840571931,1.0,7/22,16.64%,DNAJA1;ANKRA2;APOE;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,neuropeptide receptor binding (GO:0071855),0.37381486769614436,0.9279139663205686,0.5274509803921569,0.9347955901726869,1.0,2/14,7.70%,NTS;SHANK1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.37282834080273974,-0.9274650671649204,0.5537848605577689,0.8043466768227227,1.0,6/12,15.28%,PIK3C2A;PIK3R6;PIK3CA;PIK3CD;PIK3C3;IPMK
prerank,ubiquitin binding (GO:0043130),-0.24278801115229495,-0.9254127354432753,0.6014319809069213,0.8058152955459531,1.0,27/73,26.65%,FAF2;NBR1;UBXN1;VPS36;DDI2;USPL1;MVB12B;HSPB1;SQSTM1;RAD23B;UBXN2A;FBXW7;AUP1;ADRM1;N4BP1;TOP2A;UCHL1;NEDD4;GGA3;FAF1;TOM1L1;NUP62;TSG101;CXCR4;OTUB2;RNF168;OTUB1
prerank,Notch binding (GO:0005112),0.3394728747874367,0.9253293439073192,0.5618860510805501,0.9374234499239736,1.0,3/22,3.42%,SNED1;DTX1;GALNT11
prerank,myosin II binding (GO:0045159),-0.3960132922071445,-0.9246631444104652,0.5669291338582677,0.8040741961958445,1.0,2/10,1.86%,SHROOM4;GSN
prerank,inward rectifier potassium channel activity (GO:0005242),0.32095082182885304,0.9236762583564991,0.5605214152700186,0.9375662208190849,1.0,5/24,9.74%,KCNJ13;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.369075116008197,-0.9232014264193233,0.5557809330628803,0.8040432255534838,1.0,11/12,53.08%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,glycine binding (GO:0016594),0.3940485631407049,0.9226970636477896,0.55078125,0.9359421751916973,1.0,3/11,6.12%,GRIN3A;GLRA1;GLDC
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.39261969102700983,0.9223895026452589,0.5431372549019607,0.9325922562618738,1.0,3/10,16.80%,CRMP1;DPYSL2;OPLAH
prerank,androgen receptor binding (GO:0050681),0.32083193124488263,0.92163912583208,0.5614366729678639,0.9304863986976892,1.0,6/25,10.62%,DDX5;PRMT2;RNF14;NSD1;PRKCB;RNF6
prerank,heme binding (GO:0020037),0.26452278624855086,0.9192685481039723,0.5933098591549296,0.9328761603516047,1.0,14/65,14.39%,CYP26B1;CYP11B1;SDHD;FLVCR1;EIF2AK1;CYP27A1;CYCS;HCCS;SDHC;HRG;SLC48A1;CYB5A;CYP51A1;PGRMC1
prerank,telomerase RNA binding (GO:0070034),0.32901550615824615,0.9174866773810044,0.5548902195608783,0.9336484287577261,1.0,10/22,25.38%,HNRNPU;SMG5;TERT;SMG6;GAR1;SNRPB;PINX1;DCP2;HNRNPC;WRAP53
prerank,ribosomal small subunit binding (GO:0043024),0.3477459958281305,0.9171491152022129,0.5498084291187739,0.930534302976948,1.0,1/17,0.46%,CPEB2
prerank,cAMP response element binding (GO:0035497),0.4005264972553002,0.9158632240159954,0.5621181262729125,0.9298256147578962,1.0,1/10,0.61%,CREB5
prerank,lipase activator activity (GO:0060229),0.39971704233165956,0.9129601462419603,0.5705521472392638,0.9334974341499919,1.0,2/10,6.70%,ARHGAP6;PDPK1
prerank,nucleotide diphosphatase activity (GO:0004551),0.3728182381531287,0.9114870944389538,0.5634920634920635,0.9331044364478325,1.0,4/14,13.39%,ENPP5;NUDT4;CILP2;NUDT11
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2660950863962701,0.910562342375695,0.6141592920353982,0.9313169881777006,1.0,14/60,16.68%,LRRK1;PPM1M;PPEF2;CTDSPL;PPM1G;LRRK2;PPM1D;PPP1CB;CDC14B;PPP6C;PPP2CB;PPP3R1;UBLCP1;PPM1B
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3164190874134887,0.9099077481884214,0.5788461538461539,0.9291578904552363,1.0,6/27,10.59%,SLC41A1;SLC23A1;ITPR1;TUSC3;MAGT1;ITPR2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.26871254373598885,0.9082912960954093,0.5890909090909091,0.9293828589892028,1.0,15/53,17.54%,DDO;DPYD;AIFM1;MICAL3;QSOX1;KMO;NDOR1;GCDH;SQLE;AIFM2;LDHD;CYB5R1;MTHFR;ILVBL;KDM1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.34927139075393104,0.9075335846777335,0.5886075949367089,0.9235575821109024,1.0,6/16,14.53%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.34927139075393104,0.9075335846777335,0.5886075949367089,0.9235575821109024,1.0,6/16,14.53%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2060072349279405,0.9069766278056446,0.747599451303155,0.9209957368118707,1.0,47/431,10.43%,ATP1A2;PRKAG2;ANXA6;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;RRAGC;OAS2;WNK3;RHOBTB2;BMPR1A;RAB42;RAB21;ATL1;GBP3;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;ARL2;PRKCI;LRRK2;KSR1;ARL5B;MSH6;ABCD1;RIT1;RHOQ;OAS3;TUBG1;DRG1;TGFBR1;RHOU;MYO18A;PEX1
prerank,ankyrin binding (GO:0030506),0.3326712957617325,0.9064372105583696,0.5805243445692884,0.9184552402236643,1.0,2/19,2.85%,CACNA1D;FLNC
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.33828898004590124,-0.9058762857641257,0.5995893223819302,0.8413360244662589,1.0,3/15,12.49%,SLC1A5;SLC1A3;SLC1A1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.36036790653163386,-0.9057960195837702,0.598343685300207,0.8379529006673085,1.0,3/12,10.37%,ENTPD1;ENTPD6;ENTPD2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3634911181387583,0.9053722388289818,0.5893909626719057,0.9173668417816705,1.0,4/14,21.75%,CAPN3;CAPN15;CAPN10;CAPN11
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3449733413690854,-0.9050741167640681,0.5857142857142857,0.8361401066793851,1.0,4/14,12.11%,SPOCK2;NGF;RECK;LXN
prerank,hexose transmembrane transporter activity (GO:0015149),-0.36724306935511697,-0.90349544544231,0.5701943844492441,0.8362681557897642,1.0,2/12,6.34%,SLC2A1;SLC2A3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.27537078504168333,-0.9021339287499438,0.6263048016701461,0.8322558055389342,1.0,9/34,19.45%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.27537078504168333,-0.9021339287499438,0.6263048016701461,0.8322558055389342,1.0,9/34,19.45%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,calcium activated cation channel activity (GO:0005227),-0.3301264736640697,-0.9007628059634357,0.6070686070686071,0.831878883380856,1.0,7/17,31.53%,ANO1;KCNMB2;ANO6;ANO10;KCNN1;KCNMB4;KCNMA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3533603884252694,0.8977736985404117,0.5988372093023255,0.9318696413896511,1.0,6/14,26.55%,SLC7A11;SLC25A12;SLC38A7;SLC25A13;SLC25A18;SLC17A8
prerank,SH2 domain binding (GO:0042169),-0.2865788465362986,-0.8972977366885284,0.6202247191011236,0.8359104325062837,1.0,8/31,13.71%,AFAP1L2;SH3PXD2B;RACK1;SRC;SQSTM1;SH2B2;TRPV4;IRS1
prerank,nuclear receptor binding (GO:0016922),0.2338442999820794,0.8955225220979239,0.6700167504187605,0.933532806406186,1.0,19/111,11.18%,PPARGC1B;DDX5;SMAD3;BRD8;HMGN3;SMARCD3;PRMT2;RNF14;MED1;PPARGC1A;TAF10;MED25;RXRA;NSD1;PRKCB;RNF6;LCOR;STAT1;TAF1
prerank,FMN binding (GO:0010181),-0.36139478941994174,-0.8934260631395555,0.6161417322834646,0.8409309809445016,1.0,5/11,32.22%,NOS3;POR;PNPO;NOS2;NOS1
prerank,microtubule minus-end binding (GO:0051011),0.362200660837252,0.8927599499929968,0.5932539682539683,0.9364580625112834,1.0,3/13,9.37%,TUBGCP5;CEP290;TUBGCP4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.36630539965081377,-0.8918425650232134,0.6142857142857143,0.8407839401208999,1.0,4/11,19.68%,AKR1B1;AKR1A1;RDH11;DHRS13
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27158084442906166,-0.8911078069501999,0.6437768240343348,0.8389155685931252,1.0,3/35,3.38%,FOXP1;H3-3A;AGO1
prerank,protein kinase C binding (GO:0005080),-0.2625291876367403,-0.8894977200223785,0.6425339366515838,0.8389256288692937,1.0,14/43,18.88%,PDLIM5;CAVIN2;ADCY4;RACK1;HDAC7;HDAC9;HSPB1;SQSTM1;GRK5;TRPV4;IRS1;TOP2A;HINT1;DSP
prerank,tau protein binding (GO:0048156),0.27874066993560564,0.8875913952275296,0.6473779385171791,0.9453248166979978,1.0,4/40,4.82%,ROCK2;MAP2;PICALM;TTBK2
prerank,SUMO transferase activity (GO:0019789),0.33686692660309026,0.8868951983800039,0.6044176706827309,0.9430687439430466,1.0,4/16,16.70%,TOPORS;PIAS4;HDAC4;MDM2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3300392657105958,-0.8858971710905371,0.5954825462012321,0.8430763904799297,1.0,8/15,33.62%,SCARB1;ZFYVE16;SNX10;EPB41;WDFY3;ZFYVE9;SESTD1;SCIN
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.36878614789498965,0.8857501902753467,0.61328125,0.9418791294287475,1.0,4/12,18.56%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,adenylate cyclase binding (GO:0008179),0.3796846236045689,0.8793406753617361,0.5738636363636364,0.9530951833955958,1.0,1/10,0.47%,ADCY5
prerank,ubiquitin-specific protease binding (GO:1990381),0.3309723554308568,0.8786652328899489,0.6129629629629629,0.9509858924645511,1.0,8/19,28.29%,DERL1;LCOR;BAG6;CHMP3;SART3;AMFR;SUMO1;PRKN
prerank,microtubule binding (GO:0008017),-0.19546757380334656,-0.8773116760570225,0.8263305322128851,0.8583449030312924,1.0,77/222,27.46%,MTUS1;DNM3;DST;STARD9;MACF1;MID1;EML1;MID2;FAM161A;GABARAPL2;ARHGEF2;SGIP1;MAP4;CLIP4;MAP7D3;MAP1LC3B;APC;RPS3;CDK5;MAP4K4;NEFM;WHAMM;MAP9;FGF13;MACO1;DYNC1I1;CLIP2;KIF23;RMDN1;HDAC6;TRPV4;GAS2L1;REEP3;CLIP1;VAPB;KATNB1;KIF1C;MAP1B;FMR1;PAFAH1B1;MAST2;TOGARAM1;NUSAP1;PEX14;CEP295;GAPDH;CRIPT;KIF20B;RAB11A;CCDC69;KIF13A;REEP1;RP1;MAPRE2;PRC1;DCTN1;TPX2;KNSTRN;FSD1;KIFC1;MAP6D1;CDK5RAP2;POLB;STIM1;SYBU;NDEL1;KIF22;REEP2;VAPA;KIF14;KATNA1;MAPRE3;CCSAP;CCDC170;CAMSAP2;FBXW11;DNM1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.34185232700983426,0.8758849195171903,0.6316831683168317,0.9538304208513962,1.0,2/15,10.02%,KMT2A;SETD4
prerank,palmitoyltransferase activity (GO:0016409),0.29718922331463493,0.8750828217780215,0.6226415094339622,0.95185705386537,1.0,9/28,17.44%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,iron ion binding (GO:0005506),0.268550211976378,0.8743654961893115,0.6678635547576302,0.9497738654056809,1.0,9/48,13.53%,KDM7A;ETHE1;TET1;PHF8;HAAO;PHF2;DOHH;FDX1;CDO1
prerank,solute:anion antiporter activity (GO:0140323),-0.3331623056270978,-0.8737969151315661,0.650197628458498,0.8625145395951316,1.0,2/14,1.84%,SLC26A7;SLC26A2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.3563067407484681,-0.8735567356691292,0.6386036960985626,0.8595426871719031,1.0,7/11,36.66%,KCNMB2;KCNU1;KCNN3;KCNN1;KCNMB4;KCNMA1;KCNMB1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.3746936656477764,0.8732633218978226,0.6019417475728155,0.9487109477726396,1.0,4/10,9.52%,SHISA7;SHANK1;NSF;DLG4
prerank,protein phosphatase 2A binding (GO:0051721),-0.2972938104487292,-0.8722647981549996,0.6530612244897959,0.8589839402486065,1.0,4/23,5.44%,DAB2IP;FOXO1;MFHAS1;STRN3
prerank,sequence-specific mRNA binding (GO:1990825),-0.374307451410583,-0.8708153495532097,0.6387225548902196,0.8586539944371432,1.0,4/10,25.44%,DHFR;FMR1;RBM24;TYMS
prerank,GABA-A receptor activity (GO:0004890),0.32355746910205563,0.8695876591381121,0.6374045801526718,0.9535738054081995,1.0,4/18,18.56%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3540243757969477,-0.8693581371735661,0.6196078431372549,0.8581590210707095,1.0,7/11,55.10%,SLC25A47;SLC25A45;SLC22A4;SLC22A3;SLC22A1;SLC25A48;SLC25A29
prerank,phospholipase activator activity (GO:0016004),0.37807360945543017,0.8681618621070687,0.5946502057613169,0.9531747346613596,1.0,2/10,6.70%,ARHGAP6;PDPK1
prerank,RNA polymerase II complex binding (GO:0000993),0.28768669526350776,0.8671859251036023,0.6598513011152416,0.9516941002046367,1.0,7/32,13.15%,CTR9;CCAR2;HNRNPU;CDC73;SCAF1;RPRD2;SMYD2
prerank,potassium ion antiporter activity (GO:0022821),0.33442886962500384,0.8670694294894884,0.6345381526104418,0.948279389564265,1.0,3/15,15.53%,SLC24A3;SLC9A9;SLC9A3
prerank,gap junction channel activity (GO:0005243),0.3055606559186548,0.8641383638624214,0.6245283018867924,0.9511457898266537,1.0,3/22,12.96%,GJB6;GJB2;GJA3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.34714873555644504,-0.863939628016608,0.6228239845261122,0.8655909684045077,1.0,5/12,22.29%,CISD2;XDH;AOX1;ISCA2;FXN
prerank,ATPase regulator activity (GO:0060590),-0.2610373153381091,-0.8635899403324657,0.6844547563805105,0.8628868973123495,1.0,11/38,17.83%,DNAJC1;DNAJA1;FNIP2;DNAJA2;BAG5;PFN1;GRPEL1;KATNB1;BAG1;PLN;TOR1AIP2
prerank,chemoattractant activity (GO:0042056),-0.2788177653959666,-0.8622520084813312,0.6708860759493671,0.8622865635002388,1.0,5/26,13.82%,VEGFC;BMP4;FGF2;FGF7;VEGFA
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3218762829102521,-0.860770674682381,0.6481481481481481,0.862017007646674,1.0,5/16,16.14%,SLC26A7;SLC26A2;SLC1A1;SLC26A6;CFTR
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3463649606397208,0.858768129370148,0.6164383561643836,0.9593201206653373,1.0,5/13,30.04%,DICER1;SLX4;DNASE1L2;DNASE1L1;ENDOV
prerank,voltage-gated sodium channel activity (GO:0005248),-0.289079369961282,-0.8569717986920945,0.7043478260869566,0.8663680965423715,1.0,6/22,21.60%,CACNA1G;SCN4B;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,wide pore channel activity (GO:0022829),0.3001438536469357,0.856452252423137,0.64,0.9607499580577745,1.0,3/23,12.96%,GJB6;GJB2;GJA3
prerank,hexosaminidase activity (GO:0015929),0.35325471901801564,0.854023264844718,0.6524271844660194,0.962380862038532,1.0,4/12,13.35%,NAGA;HEXD;SPAM1;HYAL1
prerank,thyroid hormone receptor binding (GO:0046966),0.28297822159795694,0.852892938489445,0.6763565891472868,0.9612987951802276,1.0,5/28,9.97%,BRD8;HMGN3;PRMT2;MED1;NSD1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3411085319983629,-0.8512799020450318,0.65439672801636,0.8741714060164671,1.0,8/12,35.91%,GNS;ARSA;SGSH;ARSJ;IDS;SULF1;ARSI;SULF2
prerank,MAP kinase phosphatase activity (GO:0033549),0.3591542137307537,0.8503312152266688,0.6646586345381527,0.9631181061958481,1.0,1/12,1.62%,DUSP29
prerank,miRNA binding (GO:0035198),-0.26678018601770215,-0.8496514218449697,0.7170626349892009,0.873894369107177,1.0,9/30,19.09%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A
prerank,ferrous iron binding (GO:0008198),-0.28971745779465097,-0.849456038211751,0.6855345911949685,0.8709032549450176,1.0,9/21,29.61%,FTO;ALKBH1;FTL;ALKBH2;FXN;EGLN3;FECH;FTH1;ACP5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.34163808918261873,-0.8481080625490818,0.6633064516129032,0.8700587205675928,1.0,5/12,31.02%,CNOT6L;PAN3;TOE1;CNOT1;NOCT
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3023002211275111,0.8477198400170884,0.6824196597353497,0.9650059828474029,1.0,8/24,17.44%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,mRNA binding (GO:0003729),0.20102100378248108,0.8456394160511249,0.8406015037593985,0.9654924310354726,1.0,54/249,20.35%,CPEB2;CELF2;DDX5;SRRM2;NOVA1;SRSF5;ANGEL2;CPSF6;ELAVL4;ACO1;HNRNPA2B1;PABPC4L;RBM47;HNRNPU;PTBP2;NCBP3;UNK;CPEB4;HNRNPL;PTBP1;UTP23;ELAVL1;SRRM4;C1QBP;RNF20;YTHDC1;FUBP1;SLBP;NUP98;BOLL;UPF3B;PURB;FXR2;RBM5;CSDC2;ETF1;GRSF1;PCBP4;SNIP1;ELAVL2;CCT5;RNPS1;RBPMS2;PTBP3;SRSF6;CELF6;CPEB3;RBFOX1;LARP4B;PUM3;SF3B1;EIF2A;DDX3X;EIF3A
prerank,O-acyltransferase activity (GO:0008374),0.28631620239264494,0.8446180676504981,0.6924493554327809,0.964102881534054,1.0,6/30,12.75%,SOAT2;PLA2G4C;SOAT1;MOGAT1;PLA2G15;DGAT2
prerank,phospholipase inhibitor activity (GO:0004859),0.3700785485494062,0.8445435642464665,0.6693227091633466,0.9606289480565622,1.0,1/10,2.90%,ANXA5
prerank,sodium channel regulator activity (GO:0017080),-0.2536374204796862,-0.8423712044921738,0.7142857142857143,0.8776338207645114,1.0,6/37,13.84%,NEDD4L;FXYD5;CAMK2D;FXYD6;FGF13;SCN4B
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.305527720800708,-0.8422023961295984,0.6832669322709163,0.8746280283812878,1.0,5/17,18.32%,DTYMK;NME6;CLP1;NME2;AK4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.34053916330091466,-0.8416275609702331,0.7157057654075547,0.8722850899345608,1.0,3/11,17.86%,ALKBH1;RPS3;NEIL3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.300871615486592,0.8416217873666691,0.6779661016949152,0.9631616380254413,1.0,8/22,17.80%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2;ATP2A1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2306568830034309,-0.8410177059464318,0.7718120805369127,0.8701495396953239,1.0,22/57,29.48%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15;UQCR10;NDUFA4L2;CYBRD1;UQCRC1;NDUFB8;COX4I2;CYB561D2;NDUFA9
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.35172182744186997,0.8396546958299668,0.6850094876660342,0.963658729673343,1.0,6/11,22.88%,CASP3;CFLAR;CASP12;PYCARD;CASP9;CASP6
prerank,anion:anion antiporter activity (GO:0015301),0.3143809477227206,0.8395175212356086,0.6659919028340081,0.960349477887376,1.0,6/17,16.05%,SLC26A1;SLC25A5;SLC25A11;SLC19A1;SLC4A3;SLC26A11
prerank,ribosome binding (GO:0043022),-0.24746861530437345,-0.8388349115388433,0.7298474945533769,0.8707760904497879,1.0,13/46,16.86%,NAA16;SERBP1;RACK1;EEF2;SRP19;MTIF3;TMCO1;GTPBP6;SEC61A1;NOMO1;FMR1;NCLN;NAA10
prerank,RNA cap binding (GO:0000339),0.3273033025714779,0.8380635915038666,0.6693711967545639,0.9596827774465311,1.0,7/16,21.40%,CYFIP2;NCBP3;CYFIP1;EIF4E2;SNUPN;LARP1;DCPS
prerank,pyrophosphatase activity (GO:0016462),0.25174193330163275,0.8359998385740558,0.7353463587921847,0.960147213251331,1.0,10/50,14.68%,BNIPL;FITM2;ENPP3;PRUNE1;PRUNE2;NUDT4;CILP2;TRPM2;NUDT11;PPA1
prerank,cytochrome-c oxidase activity (GO:0004129),0.3267876101401004,0.8343100450142024,0.6837121212121212,0.9598662070134107,1.0,4/15,12.68%,COX7A1;COX7A2L;CYB5A;COX10
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.33463542629444115,0.8335288548173319,0.6653992395437263,0.9580472786884858,1.0,2/13,4.09%,GABRG1;GLRA1
prerank,cation:chloride symporter activity (GO:0015377),0.3663001850722129,0.8313637141736518,0.6490196078431373,0.9591809638972998,1.0,3/10,11.41%,SLC6A1;SLC12A5;SLC12A1
prerank,endopeptidase activity (GO:0004175),-0.18042489005151013,-0.8303089232585731,0.9517045454545454,0.883246251908547,1.0,47/257,18.92%,ADAMTSL3;ECE1;ADAMTSL1;HTRA3;PCSK5;FAP;F3;USP24;ADAMTS5;ADAMTS17;PIK3IP1;ADAMTS6;ADAM10;PSMA6;ADAMTS1;PSMB7;USP46;CASP7;ADAM19;ADAMTS14;USP7;DDI2;CTSO;USP35;PSMB6;MMP11;MALT1;CTSB;PSMB5;ADAMTS20;ACE2;USP47;TPP2;PSMB8;ADAMTS2;ADAM33;TYSND1;RHBDD1;CTSF;PHEX;ADAMTS12;CTSS;MMP2;PSMB4;UCHL1;PSEN2;USP10
prerank,poly(U) RNA binding (GO:0008266),0.30014158281922043,0.8302875796253619,0.71484375,0.9579433959613533,1.0,3/20,6.28%,RBM11;PABPC4L;PATL1
prerank,NADP binding (GO:0050661),-0.25581098569371846,-0.8296884845070699,0.7440347071583514,0.8812027158098933,1.0,8/32,21.35%,NOS3;ME1;CAT;QDPR;DHFR;CBR3;KCNAB1;GRHPR
prerank,pseudouridine synthase activity (GO:0009982),-0.3276984017220763,-0.8296477137936878,0.7014925373134329,0.8780296004205309,1.0,5/13,29.11%,PUS3;PUS7L;DKC1;PUSL1;RPUSD3
prerank,glucose transmembrane transporter activity (GO:0005355),0.32486008437312686,0.8268703477370722,0.6548507462686567,0.961238271327843,1.0,2/17,2.69%,SLC5A3;SLC5A10
prerank,kinase inhibitor activity (GO:0019210),-0.26108794393632473,-0.8256848911110934,0.7262931034482759,0.8818492482566069,1.0,11/33,23.95%,LRP6;YWHAB;NCK1;CDKN1C;PARVA;GSKIP;TAOK3;SOCS3;PRKRIP1;CDKN1B;SOCS1
prerank,Hsp70 protein binding (GO:0030544),0.2727949765919956,0.8250158978200733,0.7050359712230215,0.961541349327173,1.0,7/31,15.61%,DNAJC18;DNAJB14;PPEF2;DNAJC10;GPR37;TSC1;DNAJB2
prerank,NADPH binding (GO:0070402),-0.32523193731895284,-0.8249133134248876,0.6964656964656964,0.8799929584510794,1.0,5/13,21.35%,QDPR;DHFR;CBR3;KCNAB1;GRHPR
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.30441773644161446,-0.8246347977472319,0.7103004291845494,0.8772881730631105,1.0,7/18,20.35%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3;AGAP2
prerank,damaged DNA binding (GO:0003684),0.2590611305898371,0.824165109968056,0.7364746945898778,0.9597206792924884,1.0,4/44,5.75%,DDB2;ERCC1;XRCC1;AUNIP
prerank,poly-purine tract binding (GO:0070717),0.2796436206639128,0.8233984191351043,0.6994219653179191,0.9577541994745608,1.0,5/27,8.35%,ELAVL4;PABPC4L;HNRNPU;PATL1;TIA1
prerank,phospholipase activity (GO:0004620),0.23245140966826253,0.8221428365228354,0.7830342577487766,0.9568285786808987,1.0,15/67,16.09%,ASPG;PLAAT5;PLA2G4C;DDHD2;PNPLA8;SMPD3;SEC23IP;SMPD2;PLA2G15;ABHD3;GDE1;PLBD2;PLCB3;PDIA3;PLAAT3
prerank,poly(A) binding (GO:0008143),0.29581838756619266,0.8220082786700494,0.6978131212723658,0.9536703497823683,1.0,4/21,8.35%,ELAVL4;PABPC4L;HNRNPU;TIA1
prerank,chloride channel inhibitor activity (GO:0019869),0.34916703512237623,0.8201237798424,0.6787234042553192,0.9539179952079557,1.0,2/10,6.71%,WNK3;WNK4
prerank,WW domain binding (GO:0050699),0.28638331825159724,0.8197333043937238,0.691089108910891,0.9512550301133655,1.0,7/26,16.67%,NDFIP1;TNK2;CDC25C;WBP11;PMEPA1;NDFIP2;SCNN1A
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.30771427981765354,-0.8191650919239144,0.6987951807228916,0.8832437715283683,1.0,5/14,17.39%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,ribonuclease activity (GO:0004540),0.24034733326247715,0.8190441193646912,0.7574626865671642,0.9491031086156653,1.0,11/56,16.96%,RNASEH2A;YBEY;CPSF3;EXOSC8;EXOSC2;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,5'-3' exonuclease activity (GO:0008409),0.3340621943835005,0.8185255698870074,0.7095516569200779,0.9467416492605648,1.0,3/14,16.96%,CPSF3;MRE11;EXOG
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.33188795818795025,-0.817613079806837,0.7045454545454546,0.8826807943920784,1.0,3/12,14.21%,SPPL3;DDI2;HM13
prerank,growth factor activity (GO:0008083),0.22925112527246463,0.8128919849024343,0.7986688851913477,0.9540649671593475,1.0,12/74,15.61%,FGF1;FGF4;FGF9;NRTN;NRG1;INHA;ENDOU;BDNF;HBEGF;CSPG5;IL6;HGF
prerank,motor activity (GO:0003774),-0.22178789139972405,-0.8128637619762737,0.828125,0.887468696336476,1.0,19/60,25.85%,MYH9;STARD9;DYNC1I2;MYL6;DYNLRB1;DNAH2;DYNC1I1;KIF23;KIF1C;KIF24;DNAH3;KIF20B;KIF13A;GPR88;MYO1E;KIFC1;KIF22;KIF4A;KIF14
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.33728261815552707,0.8125551590171123,0.6780684104627767,0.9513526978976876,1.0,6/12,21.40%,CYFIP2;NCBP3;CYFIP1;EIF4E2;LARP1;DCPS
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.31428518840709097,-0.8120828327784206,0.7450592885375494,0.8854906575662469,1.0,4/14,18.32%,DTYMK;NME6;NME2;AK4
prerank,methyltransferase activity (GO:0008168),0.2444856565730404,0.8116036111463074,0.7706093189964157,0.9497020871092057,1.0,15/46,21.97%,METTL27;ARMT1;N6AMT1;NSUN3;BCDIN3D;TRMT11;COMT;NSUN2;PRMT3;NTMT1;RRP8;COMTD1;COQ3;AS3MT;PRMT5
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.2737676247677381,-0.8108194293571916,0.7610441767068273,0.8844714980253151,1.0,7/24,19.48%,EEF2K;CAMK2D;MAPKAPK2;PTK2B;PHKA2;MKNK2;CAMK1G
prerank,actinin binding (GO:0042805),0.29497269215944594,0.8098727475422874,0.7078039927404719,0.9494803863584242,1.0,3/21,8.50%,CACNA1D;CSRP3;CSRP1
prerank,translation elongation factor activity (GO:0003746),0.32229016987807346,0.8095628360167508,0.7122736418511066,0.9467880625668462,1.0,2/14,5.24%,GTPBP1;TUFM
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.31621666807784066,-0.8037043700092149,0.7395626242544732,0.8928258100273996,1.0,3/13,6.98%,SLC38A5;SLC7A7;SLC7A1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.34309364540703313,0.8016073512288255,0.7073170731707317,0.9578742410500058,1.0,3/10,18.78%,NOX1;CYBA;NCF1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3010945440110856,-0.8007833987564573,0.7193347193347194,0.8943203354711331,1.0,4/14,16.72%,TSEN2;ELAC2;RPP21;RPP38
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.28612747801873323,0.8004251123230689,0.7450592885375494,0.956729800334083,1.0,5/22,13.57%,OPTN;IKBKG;SPRTN;IKBKE;OTUD7A
prerank,chloride channel regulator activity (GO:0017081),0.313053043765362,0.7998984531866804,0.7242063492063492,0.9544032960932024,1.0,2/14,6.71%,WNK3;WNK4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.2611574078788333,0.79983887644014,0.7454545454545455,0.951238375667043,1.0,10/33,21.98%,CTR9;CCAR2;HNRNPU;CDC73;RPRD2;SMYD2;RRN3;SUPT4H1;SPTY2D1;WDR43
prerank,peptide hormone receptor binding (GO:0051428),0.3324730256820103,0.7924443912914567,0.7355371900826446,0.9606440523293427,1.0,3/11,19.82%,VIP;PSMC5;GNRH1
prerank,aspartic-type peptidase activity (GO:0070001),-0.33674384566725146,-0.7912102413488319,0.728421052631579,0.9061537099403728,1.0,2/10,8.63%,CTSD;DDI2
prerank,I-SMAD binding (GO:0070411),-0.3055302955538267,-0.7905597925756905,0.7552742616033755,0.9039225036078091,1.0,3/13,5.44%,SMURF1;SMAD5;SMAD1
prerank,ligand-gated anion channel activity (GO:0099095),0.29912148800774097,0.7869607323174389,0.7575757575757576,0.9666991137036104,1.0,5/17,18.56%,GABRG1;GLRA1;GABRG3;GABRB2;GABRB3
prerank,leucine zipper domain binding (GO:0043522),0.3428578609057596,0.7837574439801946,0.7434343434343434,0.96881055949615,1.0,1/10,2.44%,PAWR
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.24007393677979438,-0.7834266612067291,0.8073593073593074,0.9117479886357978,1.0,7/34,12.38%,STK3;IQGAP1;CAB39;CALM3;SPRY2;IGF2;INCENP
prerank,transferrin receptor binding (GO:1990459),0.3341536957888076,0.7784940836999489,0.7411273486430062,0.9740905471184318,1.0,2/10,6.34%,CHUK;IKBKG
prerank,MHC class I protein binding (GO:0042288),0.317539394384233,0.7781960795998376,0.7577519379844961,0.9712553201037544,1.0,1/13,2.18%,DERL1
prerank,mannosyltransferase activity (GO:0000030),-0.27331727312895693,-0.7776066138408143,0.7702970297029703,0.9170855928030709,1.0,2/21,5.06%,TMTC2;TMTC1
prerank,tubulin binding (GO:0015631),0.18234797160249264,0.7738436160719554,0.9718518518518519,0.9748473253796749,1.0,33/295,10.61%,GJB6;FMN1;MTUS2;MAP2;EML4;KIF5C;TTLL6;CLIP3;IFT74;IRAG2;EML2;PLK1;PRUNE1;CLASP1;DNAL1;KIF3C;PDCD5;KIF16B;ABRAXAS1;AGBL4;TBCE;KIF13B;TUBGCP5;LRRK2;GOLGA2;HTT;SKA2;TUBGCP4;NDRG1;DRG1;APC2;SBDS;RITA1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.33807365590168276,0.7727918753147297,0.7553816046966731,0.9732881341243714,1.0,1/10,0.63%,DSC2
prerank,DNA secondary structure binding (GO:0000217),-0.243190376723815,-0.7723977313631247,0.8177676537585421,0.9213579574582046,1.0,5/31,12.68%,MEF2C;RAD51B;XPC;BLM;LIN54
prerank,endoribonuclease activity (GO:0004521),0.24880973363783965,0.7723504806488378,0.8063943161634103,0.9707543163374202,1.0,8/32,16.96%,YBEY;CPSF3;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.3221000758429673,-0.7700320186889684,0.7672583826429981,0.9215385432180139,1.0,7/11,43.28%,NAA16;NAA10;NAA15;NAA50;NAA60;NAA40;NAA11
prerank,single-stranded RNA binding (GO:0003727),0.23710053297471384,0.7689511931211308,0.8333333333333334,0.9729017659121281,1.0,15/43,25.35%,RBM11;HNRNPU;PTBP1;ZFR2;SRA1;AGO3;TLR8;POLR2D;LONP1;ILF3;DDX3X;DHX58;SNRPC;JMJD6;U2AF2
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3299924257976161,-0.7679521033170568,0.7702970297029703,0.9213342041863521,1.0,4/10,29.65%,NAA16;NAA10;NAA15;NAA50
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.27008180886170874,-0.7672755616805266,0.8103092783505155,0.9190687309327793,1.0,5/20,16.55%,EIF3H;USP7;EIF3F;USP47;USP50
prerank,protein phosphatase activator activity (GO:0072542),0.31477250210311025,0.7671551143288329,0.7584158415841584,0.972401068383331,1.0,2/13,7.65%,IGFBP3;PHACTR4
prerank,single-stranded DNA binding (GO:0003697),0.20907649234568443,0.7655747961945722,0.898360655737705,0.9714289296859863,1.0,22/93,19.36%,ERCC1;PMS2;HNRNPU;MEIOB;SPRTN;SSBP2;TDP2;SSBP1;WBP11;FUBP1;PURB;MSH3;RAD51D;RNF138;POLR3C;RPA3;MCM7;POLR2D;MCMDC2;RAD52;HMCES;LONP1
prerank,mRNA methyltransferase activity (GO:0008174),0.31501121558321343,0.764214168207656,0.7644628099173554,0.97042127940347,1.0,5/12,23.41%,RNMT;NSUN2;TRMT61B;TRMT10C;METTL8
prerank,NF-kappaB binding (GO:0051059),0.27111432075394376,0.7640134224007965,0.8115942028985508,0.9675881901022589,1.0,5/24,17.40%,CDKN2A;CPNE1;COMMD7;COMMD6;RELA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.31327947935461903,0.7627052015719471,0.75,0.966311672121988,1.0,1/11,4.43%,ARG2
prerank,alpha-actinin binding (GO:0051393),-0.25399723821057596,-0.7616971751191115,0.7954022988505747,0.9233487364449561,1.0,4/24,11.65%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,UDP-galactosyltransferase activity (GO:0035250),0.3212006320029981,0.756104541427469,0.7607003891050583,0.9727575655189006,1.0,2/10,7.91%,B4GALT1;B3GALT6
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.32045969674886093,0.7556902850489514,0.7571701720841301,0.9702747452020215,1.0,5/10,22.88%,CASP3;CFLAR;CASP12;CASP9;CASP6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.29321049659342463,0.7491254334665014,0.788235294117647,0.9761535233885729,1.0,4/15,17.39%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,lipid phosphatase activity (GO:0042577),-0.2897767846925743,-0.7475694158383531,0.7888446215139442,0.9386946784692813,1.0,5/14,24.39%,PLPP1;PLPP3;SGPP1;PLPP2;PLPP6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2237688245100319,0.7465945377733798,0.8710865561694291,0.976536071594262,1.0,10/54,15.49%,UPB1;ASPG;PM20D1;MIER3;ASPA;GLS2;HINT3;HDAC4;NAAA;SIRT1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.220653398341681,-0.7451385603957129,0.8730853391684902,0.9386357431338622,1.0,7/38,16.64%,SHANK3;PIK3R1;NCK1;SPATA2;SH2B2;IRS1;LDLRAP1
prerank,lysophospholipase activity (GO:0004622),-0.25953705311347175,-0.7442793216079086,0.8523908523908524,0.936532439866719,1.0,4/20,14.39%,PLA2G4A;MGLL;ABHD4;PLA2G6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2087361991100952,0.7441435346766125,0.899505766062603,0.9767525356197573,1.0,15/75,19.29%,ADH7;ADH4;SORD;ME2;PTGR1;DHRS11;BDH1;SDR42E1;GFUS;LDHD;LDHB;PRXL2B;HSD17B11;HMGCR;HSD17B4
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.22974467930052003,-0.7411233538033909,0.8655097613882863,0.9373674165389068,1.0,11/34,21.77%,UBE2D3;UBE2J1;UFC1;UBE2F;UBE2L3;UBE2Q1;UBE2J2;UBE2A;UBE2G1;UBE2QL1;UBE2Z
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2680233955805124,-0.7372267496117376,0.8126272912423625,0.9387637369484737,1.0,5/16,17.39%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,general transcription initiation factor binding (GO:0140296),-0.2464412619747383,-0.7357193714169528,0.8772635814889336,0.9375375140479487,1.0,5/25,17.42%,ESR1;AR;AHR;HHEX;RUVBL1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.30889857224541784,0.7356748492835932,0.7773279352226721,0.9849734480973878,1.0,4/12,17.40%,RUVBL2;STAT1;TAF1;RELA
prerank,exonuclease activity (GO:0004527),0.22143017255716488,0.7352409051066241,0.8883071553228621,0.9824412206486681,1.0,8/46,16.96%,ENPP3;CPSF3;EXOSC8;MRE11;EXOSC2;AEN;POLG;EXOG
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32494350991714793,0.7345894777656707,0.7717601547388782,0.9801650003911471,1.0,10/10,67.53%,APEX1;MGME1;TATDN1;DCLRE1A;POLD1;EXD2;EXO1;DCLRE1B;DCLRE1C;FEN1
prerank,P-type ion transporter activity (GO:0015662),-0.2927125062229585,-0.7329400373340632,0.8340080971659919,0.9378418584012903,1.0,2/12,8.58%,ATP2B1;ATP2A3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.31807976682702577,0.7328583041253164,0.7676767676767676,0.9794288700565832,1.0,2/10,4.38%,PIK3R3;PIK3CB
prerank,deubiquitinase activity (GO:0101005),-0.18802932367983635,-0.7296628961549732,0.9473684210526315,0.9386544297170901,1.0,24/88,25.22%,USP53;USP24;EIF3H;USP46;OTUD7B;MINDY1;USP7;USP35;EIF3F;MINDY2;USP47;USP50;JOSD1;PSMD14;UCHL1;USP10;ZC3H12A;UCHL5;USP15;CYLD;ATXN3;OTUB2;USP1;UFD1
prerank,phospholipase binding (GO:0043274),0.30251753674535653,0.7296104778193317,0.7804878048780488,0.9804630676199833,1.0,2/13,6.70%,ARHGAP6;PDPK1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.20132550930823628,0.7293110890075941,0.9259896729776248,0.9778283610221061,1.0,23/78,23.29%,CAPN3;USP11;CASP3;USP12;USP18;USP26;USP40;CFLAR;CTSH;USP20;PDIA3;USP42;USP9X;USP48;CASP12;CAPN15;USP16;PYCARD;CAPN10;CAPN11;CASP9;CASP6;LGMN
prerank,endonuclease activity (GO:0004519),0.22058750995271076,0.7259655062223966,0.9094202898550725,0.9791381606810283,1.0,10/49,16.96%,YBEY;CPSF3;MBD4;MRE11;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,regulatory RNA binding (GO:0061980),-0.21676617447150817,-0.7255980682265977,0.8956521739130435,0.9402752665011151,1.0,12/38,25.43%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A;PIWIL2;TARBP2;MATR3
prerank,CCR chemokine receptor binding (GO:0048020),-0.23226103018057812,-0.7242458779689941,0.8593406593406593,0.9385332123525547,1.0,19/28,48.65%,CCL13;CCL25;CCR2;NARS1;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL19;CCL14;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,peptidoglycan binding (GO:0042834),0.32345489234421665,0.721926407640142,0.8061855670103093,0.9809492591120248,1.0,3/10,15.83%,PGLYRP3;NLRP3;HK1
prerank,carboxy-lyase activity (GO:0016831),0.2581855187756928,0.7211881882028751,0.8270676691729323,0.978750534453572,1.0,7/23,23.25%,GGCX;GAD1;AZIN2;UMPS;FAHD1;PISD;BCKDHA
prerank,deoxyribonuclease activity (GO:0004536),0.2939060056387103,0.7157235948056438,0.8214971209213052,0.9820217192070231,1.0,9/14,32.22%,MBD4;MRE11;DNASE1L2;APEX1;DNASE1L1;MAP1S;ZRANB3;NME1;ERCC5
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.22880380882027446,0.7150950579220783,0.864376130198915,0.9797328870542473,1.0,11/37,19.41%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;IARS2;FARSA;IARS1;YARS1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19494196508300177,0.7111870104703428,0.9436860068259386,0.9812198477713553,1.0,19/83,19.12%,USP11;OTUD4;USP12;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;USP42;USP9X;USP48;USP31;USP21;USP16
prerank,tropomyosin binding (GO:0005523),0.28089770180194296,0.7105361897545714,0.845437616387337,0.9791046084990407,1.0,2/16,9.02%,NEBL;TMOD2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.2689239050626902,-0.7101385402793725,0.8224489795918367,0.9510186054203726,1.0,6/14,21.80%,QDPR;ALDH1L2;DHFR;NOXRED1;BLVRB;PYCR3
prerank,5'-nucleotidase activity (GO:0008253),-0.27353423636670376,-0.7082279039744035,0.8583333333333333,0.949672106588514,1.0,4/13,22.12%,NT5C1A;NT5E;NT5C;ACP3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3007226683770961,-0.6971438717365754,0.8367346938775511,0.9574447323021467,1.0,5/10,31.29%,ANKRD13A;ANKRD13B;ANKRD13D;FAAP20;LAPTM5
prerank,omega peptidase activity (GO:0008242),0.1870815077058378,0.6924456174667857,0.9676320272572402,0.995874086080046,1.0,20/89,19.12%,USP11;OTUD4;USP12;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;GGT5;USP42;USP9X;USP48;USP31;USP21;USP16
prerank,CXCR chemokine receptor binding (GO:0045236),-0.29095744490510117,-0.690185647265078,0.8579545454545454,0.960741133519635,1.0,7/11,48.71%,CXCL12;CXCL5;CXCL1;PF4;PPBP;CXCL13;CXCL2
prerank,calcium channel inhibitor activity (GO:0019855),-0.27811070974513363,-0.686399562686316,0.8683693516699411,0.961017920918989,1.0,2/11,9.50%,SLC30A1;MCUB
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.2916326658715712,0.6820786530929857,0.8472803347280334,1.0,1.0,11/11,70.86%,CNGB1;HCN1;CNGA1;KCNA10;HCN2;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,cysteine-type peptidase activity (GO:0008234),0.1868263529236154,0.6814761380359018,0.968476357267951,1.0,1.0,17/73,19.12%,CAPN3;USP11;CASP3;USP12;USP18;USP26;ATG4D;USP40;CTSH;USP20;ATG4C;PDIA3;USP42;USP9X;USP48;USP21;USP16
prerank,nucleotidyltransferase activity (GO:0016779),0.2582141435478627,0.6801157348032246,0.8847583643122676,0.9989927933836216,1.0,5/19,14.82%,TENT4A;REV1;TUT4;TERT;CRPPA
prerank,kinesin binding (GO:0019894),-0.2248959410809933,-0.679029772345703,0.9010752688172043,0.9642148427219204,1.0,5/27,19.70%,ACTB;AP1AR;ATCAY;ARHGEF10;PRC1
prerank,adenylyltransferase activity (GO:0070566),0.24064792950125063,0.6729335384283499,0.9038817005545287,1.0,1.0,5/21,15.25%,OAS2;TENT4A;OAS3;PAPOLB;ABL1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.21376705820143083,-0.6720614629028087,0.9352051835853131,0.9669847830626638,1.0,8/29,24.76%,ACER2;GAA;PARG;ACER3;ENGASE;HPSE;PGGHG;GANAB
prerank,endopeptidase activator activity (GO:0061133),-0.2896044951340915,-0.6713800099474397,0.8734939759036144,0.9643850033136976,1.0,4/10,21.47%,ADRM1;PSMD14;PSENEN;PSME1
prerank,four-way junction DNA binding (GO:0000400),0.25549108653553243,0.6707375003817607,0.8936170212765957,1.0,1.0,6/17,21.15%,MSH6;MEN1;RAD51D;ABL1;XRCC2;RAD51C
prerank,aminopeptidase activity (GO:0004177),-0.21732440756807064,-0.6684204456421557,0.9208333333333333,0.9636654867294272,1.0,9/26,26.71%,ENPEP;LAP3;METAP1D;LNPEP;RNPEPL1;ERAP1;KDM8;XPNPEP1;JMJD7
prerank,tRNA binding (GO:0000049),0.20620115347241433,0.6649575201105465,0.9420289855072463,1.0,1.0,11/43,21.52%,TRMT9B;PSTK;NEMF;DARS2;NSUN2;TERT;NSUN6;ELP5;TRMT10C;EIF2A;DALRD3
prerank,pyridoxal phosphate binding (GO:0030170),-0.2350221240599957,-0.6648543468436628,0.9184549356223176,0.9633561063836874,1.0,9/20,28.59%,SRR;PYGB;THNSL2;PDXK;PNPO;SHMT2;AGXT;CBS;SHMT1
prerank,phosphatidate phosphatase activity (GO:0008195),0.2648771504666033,0.6606572963704764,0.8837675350701403,1.0,1.0,2/13,8.88%,LPIN1;PLPPR3
prerank,snRNA binding (GO:0017069),0.2032121736501204,0.6559384661773284,0.9391634980988594,1.0,1.0,14/42,23.82%,CCNT2;HNRNPU;LSM4;LSM11;LSM8;HEXIM2;SNU13;DDX39B;SNRPB2;LARP7;SART3;SF3B3;EFTUD2;SNRPC
prerank,RNA stem-loop binding (GO:0035613),0.2689863956983156,0.6479294603832896,0.8952772073921971,1.0,1.0,5/12,24.95%,EPRS1;CPEB3;DDX3X;CSDE1;MYH10
prerank,disordered domain specific binding (GO:0097718),0.22946732179310403,0.6452940680709087,0.9213893967093236,1.0,1.0,1/23,0.70%,HSPA1A
prerank,phosphatidylinositol kinase activity (GO:0052742),0.2520976882015714,0.6419590066726063,0.8987854251012146,1.0,1.0,4/15,16.00%,PIK3R3;PIK3CB;PI4KA;ATM
prerank,MHC protein binding (GO:0042287),-0.22343414389219657,-0.641895604714425,0.9102564102564102,0.9768628989249458,1.0,3/20,11.83%,TAP2;ATP5F1B;CD74
prerank,3'-5' exonuclease activity (GO:0008408),-0.18356712402761505,-0.6400695152062829,0.9793577981651376,0.974995848305507,1.0,16/45,31.86%,CNOT6L;REV3L;REXO4;TRIR;TOE1;ERI2;EXD1;EXOSC4;EXOSC5;EXOSC3;XRN2;ERI1;DIS3L2;NOCT;ISG20;APLF
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.26999836081164746,0.6389746674886287,0.9041916167664671,1.0,1.0,6/11,28.35%,NUDT4;NUDT11;DCPS;DCP2;NUDT3;NUDT5
prerank,MAP-kinase scaffold activity (GO:0005078),-0.2612780070142908,-0.6351180227434383,0.9106796116504854,0.9751034232715531,1.0,1/11,2.65%,IQGAP1
prerank,exopeptidase activity (GO:0008238),0.19200382958932324,0.6349248161673787,0.9575645756457565,1.0,1.0,8/50,15.33%,METAP2;CTSA;DPP8;CPA2;DPP10;CTSH;CNDP2;TRHDE
prerank,exoribonuclease activity (GO:0004532),-0.25733651382871686,-0.6341298123874441,0.8904382470119522,0.9726307759237622,1.0,5/12,26.87%,EXOSC1;ZC3H12A;EXOSC4;EXOSC5;EXOSC3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.24878586519313944,-0.6331368365121459,0.9032258064516129,0.9701062455582027,1.0,6/13,32.05%,KCNQ1;PRKAR2B;PRKAR1B;PKIA;PRKAR2A;CSK
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.21378013368083054,-0.6317800084613435,0.9567779960707269,0.9677613024417813,1.0,12/24,39.32%,DTYMK;NME6;NME2;AK4;PPIP5K1;PMVK;ITPKC;ITPKB;PPIP5K2;ITPKA;IP6K3;NME4
prerank,phosphate ion binding (GO:0042301),-0.26732887992381016,-0.6275779844501492,0.9271255060728745,0.9672443653478702,1.0,4/10,31.14%,PDE2A;ADSS1;ADSS2;CHST14
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21289037530894045,0.6261224596759047,0.9343629343629344,1.0,1.0,4/28,13.90%,RNASEH2A;POP4;AGO3;DICER1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22800525774695324,0.6250928681034625,0.9385796545105566,1.0,1.0,3/22,13.69%,DUSP29;MTMR2;DUSP19
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23155649204274353,-0.6181330077911149,0.941544885177453,0.9695136702573242,1.0,4/16,20.44%,SLC44A2;SLC44A1;SLC7A8;SLC5A7
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.19002960588590823,0.6169433678808051,0.9762340036563071,1.0,1.0,3/42,7.58%,CDKN2A;CCNT2;CCNYL1
prerank,O-methyltransferase activity (GO:0008171),0.26549024833551094,0.6135876784655752,0.9252136752136753,1.0,1.0,3/10,19.74%,BCDIN3D;COMT;COQ3
prerank,mannose binding (GO:0005537),-0.2435352642499142,-0.6119540292214479,0.9358178053830227,0.9697031423191214,1.0,1/12,4.00%,LMAN2L
prerank,microtubule motor activity (GO:0003777),0.18316348697573148,0.6109161647521419,0.9836956521739131,1.0,1.0,10/51,18.89%,DNAH1;KIF5C;KIF3C;KIF16B;KIF13B;KIF3A;SMC3;KIF1B;KIF3B;KIF1A
prerank,TBP-class protein binding (GO:0017025),-0.21390923138329257,-0.6103268554507574,0.9598393574297188,0.9675028159319171,1.0,4/21,17.42%,ESR1;AHR;HHEX;RUVBL1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.1979536543053233,0.6097722033735198,0.9566003616636528,1.0,1.0,9/33,23.21%,ANGEL2;EXOSC2;ANGEL1;USB1;DIS3L;CNOT8;PNLDC1;DCP2;PAN2
prerank,RNA methyltransferase activity (GO:0008173),0.22397440826559134,0.6049130118207705,0.93713163064833,1.0,1.0,2/19,8.94%,TRMT9B;BCDIN3D
prerank,water transmembrane transporter activity (GO:0005372),-0.2440523816471914,-0.5999647551535191,0.9503105590062112,0.9694816726109244,1.0,1/11,5.70%,AQP11
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.2597180749671558,-0.596971509584984,0.9393939393939394,0.9678970157923448,1.0,5/10,40.29%,BRCA2;MSL3;NAA50;NAA60;NAA40
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.2538709707014045,-0.5926675694041954,0.9414141414141414,0.9667709765859184,1.0,4/10,25.59%,CDA;GDA;ADA;DCTD
prerank,neuropeptide hormone activity (GO:0005184),0.2133165829145725,0.5922433367174376,0.9616858237547893,1.0,1.0,22/22,78.70%,VIP;GRP;PENK;PPY;HCRT;OXT;CORT;QRFP;GHRH;NPPA;ADCYAP1;UCN;CALCB;GAL;SPX;CRH;NMB;PNOC;NPFF;NPY;CCK;AGRP
prerank,vitamin D receptor binding (GO:0042809),0.23273358892751178,0.590384376736665,0.9637096774193549,1.0,1.0,2/14,9.58%,MED1;RXRA
prerank,ribonuclease P RNA binding (GO:0033204),0.24849377526245653,0.5894258849306164,0.9363449691991786,1.0,1.0,1/10,5.55%,POP4
prerank,CoA hydrolase activity (GO:0016289),0.2303680827938362,0.5879697893573587,0.9416195856873822,1.0,1.0,5/16,22.41%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,U6 snRNA binding (GO:0017070),0.23154772647599944,0.5876517474892904,0.9444444444444444,0.9993490498561145,1.0,6/14,26.06%,LSM4;LSM8;DDX39B;LARP7;SART3;PRPF8
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.21615421633455098,0.586463692459069,0.9658444022770398,0.9970871149352949,1.0,6/21,16.67%,WASF1;RYR2;WASF3;AKAP8;AKAP6;AKAP8L
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.17866770691342915,-0.5844921314496794,0.9888888888888889,0.9672788711241826,1.0,13/34,31.80%,CNOT6L;PAN3;TOE1;ERI2;EXOSC4;EXOSC5;EXOSC3;XRN2;ERI1;CNOT1;DIS3L2;NOCT;ISG20
prerank,gamma-tubulin binding (GO:0043015),0.2109739263832513,0.5768931790992377,0.9459459459459459,0.9985317662728032,1.0,4/21,14.01%,TUBGCP5;TUBGCP4;NDRG1;RAD51D
prerank,nuclear localization sequence binding (GO:0008139),0.2186683419341516,0.5729232661747049,0.9510763209393346,0.9973812697576157,1.0,4/18,16.46%,POM121;BRAP;TNPO2;IPO4
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.20006982067552428,0.5660666954959412,0.9844660194174757,0.9972004860534913,1.0,8/25,24.24%,TNKS2;PARP14;PARP4;PARP16;SIRT1;ART4;PARP10;TIPARP
prerank,ribonuclease P activity (GO:0004526),0.22916495633280215,0.5593946544325041,0.9573170731707317,0.9969020203580661,1.0,1/11,5.55%,POP4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.1850169665702304,0.5573107422794163,0.9794007490636704,0.994926137980024,1.0,1/31,0.58%,UBE2E2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2358949661225922,0.5513268868084871,0.9322709163346613,0.994064699881227,1.0,1/11,8.71%,CHRNB2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.20846244401398556,0.5429685544131535,0.9754716981132076,0.9939881760361371,1.0,5/17,22.41%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.1917880470766019,0.5243431592525409,0.9794776119402985,0.9965162829382643,1.0,20/21,59.62%,CHRNB2;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNA2;CHRNA6;DRD4;ANXA9;GRIA1;DRD1;CHRNA1;DRD5;CHRNA4;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5
prerank,nuclear import signal receptor activity (GO:0061608),0.20398858789592977,0.5171426006781812,0.9773584905660377,0.9955704713518725,1.0,4/15,22.18%,TNPO3;TNPO2;IPO4;RANBP6
prerank,3'-5' DNA helicase activity (GO:0043138),0.18975129082708778,0.48819989411476,0.9865125240847784,0.9986124372678937,1.0,1/16,3.36%,RECQL4
prerank,sodium channel activity (GO:0005272),0.14046502040516934,0.44228152585355995,0.9981851179673321,1.0,1.0,9/37,24.41%,GRIK5;GRIK2;SHROOM2;SCN8A;SCNN1A;SCN9A;ASIC4;ASIC2;HCN1
prerank,carbohydrate kinase activity (GO:0019200),0.18598958006402613,0.43663951074334995,0.9979166666666667,0.9994788077929657,1.0,11/11,81.41%,HK1;KHK;HK2;POMK;NAGK;GALK1;GNE;HK3;FGGY;XYLB;GALK2
prerank,nuclease activity (GO:0004518),0.11936917009650307,0.4006456232570142,1.0,0.9988233393467784,1.0,1/52,1.32%,RNASEH2A
